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Abstract 
Stroke is the second most common cause of death worldwide. However stroke is not 
invariably fatal and survivors may experience major physical, social and psychological 
problems. The United Kingdom government identified the improvement of the quality 
of life of stroke survivors as a key objective in the recent "Health of the Nation" 
consultative document. The concept of health related quality of life has developed 
over the past few years. Although there is no one universally agreed definition, there 
are several instruments which claim to measure at least some aspects of health 
related quality of life. These instruments have not been extensively tested in stroke 
patients, so the hypothesis which I shall test in this thesis is as follows: that a simple 
instrument can prove a feasible, valid, reliable, and clinically useful measure of health 
related quality of life in stroke survivors. 
I selected a simple measure of health related quality of life (the EuroQol 
questionnaire) and evaluated its validity in a sample of patients with stroke. A small, 
but important proportion of patients were unable to complete EuroQol questionnaires 
either by themselves or by interview, so I investigated whether a proxy (e. g. a spouse 
or carer) could assess the patient's health status after stroke accurately and without 
bias. Previous studies comparing one or more different health status instruments did 
not involve strictly random allocation, so could not provide reliable information on the 
"best" measure of quality of life to use in stroke patients. I therefore performed a 
study in a sample of survivors of stroke which directly compared the EuroQol and SF- 
36 by using a strict random allocation of questionnaires. It was not possible to 
compare quantitatively the reliability and validity of the EuroQol and SF-36; however, 
a qualitative comparison suggested their reliability was similar and they appeared to 
be sampling broadly the same areas of health. 
VIII 
I finally investigated patients' perception of their own quality of life after stroke. The 
data suggested that many disabled stroke survivors might not view survival in a 
dependent state as badly as one might expect. This somewhat surprising finding will 
inform decisions about whether to accept the high risks associated with certain 
treatments (e. g. thrombolysis) in order to reduce the chances of survival in a 
dependent state. Assessments of health related quality of life may therefore provide 
a more comprehensive and relevant view of the patients' outcome than simple 
measures of disability or impairment. 
ix 
Chapter One 
I Introduction: Measuring Health and Outcome 
after Disease 
1.1 Historical aspects 
1.1.1 Mortality 
John Graunt, a 17th century tradesman turned statistician, is credited with taking the 
first systematic approach to measuring the health of the population. He used the 
crude data of the London Bills of Mortality to construct the first life table, a table of 
probabilities of surviving to a given age (Greenwood, 1970). His interest also 
extended to measuring the frequency and outcome of specific diseases. For 
instance, he reported that, in a series of years, out of more than a quarter of a million 
deaths, only 392 were assigned to syphilis, from which he inferred that syphilis had 
been significantly under-reported as a cause of death. The publication of the life 
table and the appreciation of its potential weaknesses established Graunt's reputation 
as a pioneer medical statistician. His interest in measuring the health of the 
population and the outcome of specific diseases was, however, restricted to mortality. 
This may reflect simply that the acute fatal infectious diseases were the major public 
health concern of the time. It is not surprising that non-fatal chronic diseases were 
given scant attention. A list of causes of death in London for the year 1798-1799 
showed how infrequently stroke was diagnosed (Anonymous, 1800a; Anonymous, 
1800b). Of the 18,134 deaths that year, 4,843 were due to consumption and 1,111 to 
smallpox; only 249 were classified as "apoplexy or suddenly" (the 12th commonest 
cause of death). Epidemiology became established as a useful discipline to assess 
the distribution, incidence and outcome (usually mortality) of infectious disease. This 
work saw practical application in the cholera epidemic of 1854, when John Snow, 
using data from a simple observational epidemiological study, was able to identify the 
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intervention that directly led to successful disease prevention (Lilienfeld and Lilienfeld, 
1980): he took the handle off the public water pumps delivering contaminated 
drinking water. 
1.1.2 Morbidity 
Chronic diseases are, by definition, not immediately fatal, so mortality data cannot 
reliably assess the impact of chronic disease on the health of a population, yet few 
early studies aimed to examine the morbidity of the population. William Farr, a 
general practitioner and freelance medical journalist in the first half of the nineteenth 
century, was one of the first to estimate both the prevalence of morbidity and the 
proportion of patients permanently incapacitated by disease (Greenwood, 1970). 
Farr's data were scanty. As national data were not available, he had to base his 
analyses on reports from a few benefit societies and the returns relating to workers in 
the Royal Dockyards and employees of the East India Company. Starting with the 
assumption: 
"in manhood, for every death we may reckon two persons constantly sick" 
He estimated that approximately 600,000 people were constantly sick in England and 
Wales at any one time (population 14 million) and that approximately 2% of labourers 
were kept constantly at home by illness. Farr suggested that this might reduce the 
productive power of the community by one-seventeenth part. Clearly, interpretation 
of Fares estimates depends to a large extent on the basis by which he classified 
individuals as "sick". 
Farr, like Graunt, appreciated the need for a uniform international classification of 
diseases: 
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The advantages of a uniform statistical nomenclature, however imperfect, are so 
obvious, that it is surprising no attention has been paid to its enforcement in Bills of 
Mortality. Each disease has, in many instances, been denoted by three or four 
terms, and each term has been applied to as many different diseases....... The 
nomenclature is of as much importance in this department of inquiry as weights 
and measures in the physical sciences, and should be settled without delay. " 
(Registrar General of England and Wales, 1839) 
An internationally accepted classification of the causes of death was first published in 
1893 (World Health Organisation, 1967). It provided the first effective tool for 
measuring health within a population and comparing health between populations. 
When the major force of a disease was expressed as acute illness (of which acute 
infections provided the most notable example), the public health burden associated 
with it could be readily assessed by measurement of the occurrence of the disease, 
recovery from it and fatal outcome. 
However, classification of the causes of death did not solve the problem of measuring 
the public health burden of chronic diseases: 
"with the prominent place which the study of infectious and acute diseases has 
taken in the last few years, there has been a lamentable neglect ...... of the still 
more fundamental problems underlying the long list of constitutional and chronic 
diseases" (Anonymous 1902) 
As life expectancy has increased in the second half of the twentieth century and, 
correspondingly, peoples' expectations of a disease-free life have risen, medical 
interest began to focus on chronic diseases such as stroke. 
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1.2 Stroke: a major burden on society 
The burden of disease attributable to stroke is large. Stroke accounts annually for 
approximately 4.4 million deaths worldwide and is the second most common cause of 
death after ischaemic heart disease (Murray & Lopez, 1997). In Britain, stroke 
represents the third most common cause of death (after ischaemic heart disease and 
cancer) (The Secretary of State for Health, 1991). Approximately 105,000 British 
people suffer their first-ever stroke every year (Bamford et al. 1988). Of these, about 
31 % will be dead at one year after the stroke onset (Bamford et al. 1990). 
However, death is only one aspect of the public health burden attributable to stroke. 
About one third of patients still alive one year after their stroke require help with 
activities of daily living (Bamford et al. 1990), and stroke is one of the major causes of 
severe disability in Britain (Martin et al. 1988). Furthermore, only about one-sixth of 
patients who survive the acute phase of their stroke recover completely (i. e. to their 
pre-stroke state) (International Stroke Trial Collaborative Group, 1997). Many stroke 
survivors who are apparently not disabled report problems in "higher level" activities 
such as domestic management, participation in social activities and in their 
psychological well-being (Lawrence & Christie, 1979; Duncan et aL 1997). In 
particular, various studies have reported that depressive illness affects between 23% 
and 63% of patients in the first year after a stroke (Burvill et al. 1995; Wade et al. 
1987; Ebrahim et al. 1987), which is more than twice the proportion in the general 
elderly population (House, 1987) or in populations matched for physical disability 
(Folstein et al. 1977). 
Stroke therefore places a large burden of physical, psychological and social 
difficulties on the families and the carers of patients with stroke. The disease places 
a similarly large financial burden on the providers of health care and society in 
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general. Isard and Forbes recently estimated that stroke accounts for approximately 
4.3% of all Scottish NHS resources, and 5.5% of hospital resources (Isard & Forbes, 
1992). 
Stroke has been targeted as a public health priority in the United Kingdom in the 
recent "Health of The Nation" report. The Secretary of State for Health identified the 
following objective: 
"To reduce the occurrence of stroke and associated death and disability and to 
ensure the maximum quality of life for survivors" (The Secretary of State for 
Health, 1991) 
In order to achieve this objective, appropriate tools to measure the impact of stroke in 
individuals and in the population as a whole are needed. A single instrument is 
unlikely to fulfil these distinct applications. 
1.3 Assessing outcome after stroke 
1.3.1 Early approaches: development of stroke specific 
measures 
Dyken and White conducted the first randomised controlled trial in patients with acute 
stroke (Dyken & White, 1956). They wrote: 
"At first an elaborate system of physical grading of recovery was devised, but, as 
the experiment progressed, it became obvious that the most important point in 
evaluation was whether the patient lived or died" 
5 
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Around the same time, Rankin appreciated that death was not the only bad outcome 
after stroke, since many patients survived, yet had severe disability. In his study of 
the factors which determined the prognosis of stroke patients, he reported (as an 
incidental finding) a system to grade the degree of functional recovery (Rankin, 
1957): 
"Grade I. No significant disability. able to carry out all usual duties. 36 (19%) 
surviving patients. 
Grade II. Slight disability. unable to carry out some of previous activities but able 
to look after own affairs without assistance. 87 (45%) surviving patients. 
Grade Ill. Moderate disability. requiring some help but able to walk without 
assistance. 33 (17%) patients. 
Grade IV. Moderately severe disability. unable to walk without assistance and 
unable to attend to own bodily needs without assistance. 4 (2%) patients 
Grade V. Severe disability bedridden, incontinent and requiring constant nursing 
care and attention. 32 (17%) patients" 
About one third of the survivors in his study had moderate to severe disability. 
Rankin's system focused on the patient's ability to perform "usual duties", their level 
of mobility and ability to perform activities of daily living. Its content is therefore 
clearly relevant to patients with stroke. However, in common with other assessments 
of the time, it depended on a doctor (or other observer) making a supposedly 
objective assessment of the patient's outcome. The patient's subjective assessment 
of their own functioning made no contribution to the assessment. The paper did not 
specify how the observations were to be made; so the observer might, on the one 
hand, just grade the patients by quick reference to the medical records or, 
alternatively, make prolonged and detailed observation of the patient's abilities over 
several days. It is clear that administering the same scale with the same patient in 
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these two different ways could lead to very different gradings. Furthermore, Rankin 
did not describe how the scale was developed, how the different levels of outcome 
were arrived at and whether they were valid. Perhaps he considered the 
development of the scale an unimportant part of his study; in any event, although the 
Rankin scale was not developed with today's rigorous clinimetric methods, it is still 
widely used. This may be because it is so simple and relevant. 
Barham Carter, like Dyken and Rankin, also recognised that randomised trials of 
treatment for stroke should measure more than just the effect of treatment on death 
(Barham Carter, 1961). He conducted a randomised trial of anticoagulant therapy in 
76 patients with progressing stroke and, like Rankin, devised his own system for 
grading the patients' recovery: 
"The patients were followed for six months and then an assessment was made by 
clinical examination, dividing them into four groups: recovered, improved, not 
improved, and died. 
Recovered - This meant that the patient noticed slight or no disability and was able 
to resume normal life and to return to full work.... 
Improved - This meant some useful movement was possible at the elbow and 
wrist and that the patient required only slight assistance to get about and live a 
useful life....... 
Not improved - This implied no return of arm movement below the shoulder and a 
poor recovery in the leg so that considerable assistance was needed for the 
patient to get about. Return to work was not possible, and this group included the 
bedridden patient. " 
Barham Carter's system shared Rankin's emphasis on mobility, return to work and 
normal activities. However, it differed in two important respects. Firstly, Barham 
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Carter also graded patients on the severity of their neurological deficit. Although this 
system was not adopted by other investigators, the idea of using aspects of the 
neurological examination to assess patients' outcome after stroke became a popular 
approach and within several years many alternative scales for grading the results of 
the neurological examination had been proposed (Table 1.1). Secondly, Barham 
Cater's system classified patients according to their change in health with treatment, 
whereas Rankin classified patients according to their health state at follow up. This 
difference highlights the ambiguity that exists over what constitutes a measure of 
"outcome" (Kilgour-Christie & Watt, 1993). Barham Carter's scale could be 
considered as a measure of outcome, and the Rankin scale a measure of health 
status. Alternatively, both could be viewed as a measure of outcome. I will follow the 
latter approach in this thesis. 
All of the early methods to assess outcome after stroke were developed empirically, 
rather than on the basis of an underlying conceptual theory, by clinicians with an 
interest in stroke. Similar "specific" measures were developed at the same time for 
other chronic disorders (Kind, 1988). Subsequently, more general health measures 
have been developed which encompass a broader range of dimensions than any 
condition-specific system. Indeed, the measurement of health status has become a 
focus of interest for health researchers and policymakers and two distinct approaches 
to classify health have emerged. These are the International Classification of 
Impairments, Disabilities and Handicaps and the broader, overlapping, concept of 
Quality of Life. 
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1.4 International Classification of Impairments, 
Disabilities, and Handicaps 
In response to the growing number of different classifications and methods of grading 
outcome after disease, the World Health Organisation developed the International 
Classification of Impairments, Disabilities and Handicaps (ICIDH) to clarify the 
taxonomy of the consequences of disease (World Health Organisation, 1980). Each 
of these three categories were developed to represent a discrete and independent 
plane of experience consequent upon disease. 
1.4.1 Definition of terms 
Impairments are defined as the loss or abnormality of psychological, physiological, or 
anatomical structure or function. They are associated with signs on clinical 
examination, and so represent the focus of the routine medical examination. The 
elements of impairment included in the neurological examination have been widely 
used in the construction of a variety of so called "stroke scales", (Table 1.1). These 
scales, derived by arbitrarily summing scores related to various physical impairments 
detected during neurological examination, were developed to provide a means of 
describing the severity of the patients' stroke in randomised trials of medical 
interventions. The Mathew Scale, for example, was first used to describe patients at 
baseline and at follow up in a trial of glycerol (Table 1.2) (Mathew at aL 1972). 
Disability assesses function at the level of the person and is defined as: 
"any restriction or lack of ability to perform an activity in the manner or within the 
range considered normal for a human being. " 
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It is therefore concerned with the compound or integrated activities expected of the 
person or of the body as a whole, such as are represented by tasks, skills, and 
behaviours. 
Handicap is the highest level of measurement in this classification. It is defined as: 
"a disadvantage for a given individual (resulting from an impairment or a disability) 
that limits or prevents the fulfillment of a role that is normal (depending on age, sex 
and cultural factors) for that individual. " 
The ICIDH handicap section defines six basic "survival roles, " which describe 
disadvantage in orientation (the ability to perceive and understand the immediate 
environment including sight, hearing, and cognition), physical independence (from 
human or mechanical assistance), mobility (the distance one can move from one's 
bed), occupation (employment, domestic work and recreation), social integration and 
economic self sufficiency (including the ability to earn an income and the possession 
of resources enabling problems to be overcome). Handicap may be classified 
according to the disadvantage associated with deficiencies in each dimension. 
1.4.2 Application of the ICIDH to stroke 
The theoretical model of ICIDH provided a useful means of describing the 
consequences of disease because it enabled a clear distinction to be made between 
the intrinsic experience of disease that causes impairments and disability, and the 
external factors (e. g. poverty, poor environment) that lead to handicap. Furthermore, 
the clarity of the definition makes it more likely that assessment of the effect of an 
intervention will be carried out at an appropriate level. However, there are 
advantages and disadvantages when measuring outcome at each of these levels. 
10 
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Stroke scales became a popular means for assessing outcome after stroke. In the 
twenty year period between 1969 and 1990, over 20 different stroke scales were 
devised (van Gijn, 1992). Although these scales provided a relatively objective and 
sensitive means of assessing outcome, researchers recognised a number of 
shortcomings in the scales. The most serious difficulties were poor interpretability, 
little relevance to patients and limited generalisability (van Gijn, 1992; van Gijn & 
Warlow, 1992). In particular, many scales focus on impairments (i. e. the neurological 
signs), which are much less important to a patient's daily life than disability and 
handicap (i. e. what they can and what they actually do). In general, stroke scales, if 
they have any value at all, are probably more suitable for small scale trials being 
undertaken early in the development of an intervention. Such trials generally seek to 
examine whether the treatment has any effect at all on the disease process. Stroke 
scales are less suitable as a primary measure of outcome for large scale clinical trials 
which aim to determine the role of the intervention in routine clinical practice (van 
Gijn, 1992). Scales which assess impairment cannot provide estimates of the burden 
that stroke places on society and on health care providers; only scales that measure 
disability and handicap are relevant here. 
Handicap is at the other end of this hierarchical classification of outcome. In contrast 
to impairments, assessments of handicap provide information which is more relevant 
to patients and is more generalisable. However, these assessments are limited by 
the subjective and relatively insensitive nature of this outcome (many factors other 
than the disease or the intervention determine the eventual handicap). Furthermore, 
until recently, the measurement of handicap has been less well defined and tested 
than that of impairment or disability (van Gijn, 1992; Harwood et aL 1994a). The 
Oxford Handicap Scale was derived from the Rankin scale (Bamford et al. 1989); 
however, although it is termed a handicap scale, it focuses on disability rather than 
handicap and only covers the physical independence dimension of handicap in the 
11 
Chapter One 
ICIDH classification. Harwood and colleagues have recently developed a generic 
measure of handicap - the London Handicap Scale - based on the ICIDH dimensions 
of handicap (see above) (Harwood et al. 1994b). The London Handicap Scale 
comprises a classification questionnaire and a matrix of scale weights. The 
classification questionnaire has six questions, one for each dimension, each 
comprising a six point hierarchical scale of disadvantages in a self-completion format. 
The matrix of scale weights enables the severity of disadvantage in each dimension 
to be combined into an overall handicap score, ranging from 1 (no handicap) to 0 
(maximum handicap). Initial studies suggest that it has acceptable measurement 
attributes for group applications after stroke (Harwood et al. 1994b). 
Disability lies between impairment and handicap in the hierarchical classification 
proposed by the World Health Organisation and so represents a compromise 
between impairment and handicap in terms of relevance, sensitivity, objectivity and 
generalisability. It has become a widely accepted level at which to measure outcome 
after stroke. There are many different instruments which can measure disability. 
They generally focus on independence and the ability of patients to perform activities 
of daily living. Of these, the Barthel Index has become very widely used (Mahoney & 
Barthel, 1965; Wade & Langton Hewer, 1987; Wade, 1992). It includes ten activities 
of daily living and the maximum score is 100, Table 2. The scale is hierarchical, at 
least in patients with stroke, in that an ascending order of difficulty can be attributed 
to the activities listed (Wade & Langton Hewer, 1987). However, simple disability 
scales, such as the Barthel Index, have consistent ceiling effects. For example, a 
substantial proportion of patients after stroke report persistent problems in their daily 
life, yet score 100/100 on the Barthel Index which suggests they should have no 
significant disability (Wellwood et al. 1995; Duncan at al. 1997). 
12 
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Holbrook and Skilbeck recognised the limitations of scales which focus on self care 
(such as the Barthel Index) and developed the Frenchay Activities Index to examine 
broader aspects of everyday living after stroke (Holbrook and Skilbeck, 1983). The 
Frenchay Activities Index measures lifestyle in terms of complex domestic, leisure 
and social functioning and can be administered, by interview or self-completed 
questionnaire, in a few minutes. It does not appear to have the ceiling effect noted 
with the Barthel Index and principal components analysis suggests that it shows two 
traits: instrumental disability and some aspects of handicap (Schuling et al. 1993). 
Lindley and colleagues developed two simple questions to assess outcome after 
stroke in large scale epidemiological studies (Lindley et al. 1994). Their content 
includes aspects of disability ("do you require help from another person for everyday 
activities? ") and handicap ("do you feel that you have made a complete recovery from 
your stroke? "). With this approach patients may be classified as "dependent", 
"independent, but not fully recovered", and "fully recovered" and so the ceiling effects 
associated with simple measures of disability may be avoided. The relationship 
between these questions and measures of health related quality of life is examined in 
Chapter Eight. 
1.5 Quality of Life 
1.5.1 Background 
Life expectancy has increased substantially over the last 150 years. A century ago 
life expectancy at birth was only 44 years for males and 47 years for females; life 
expectancy is now 73 years for males and 78 years for females (The Secretary of 
State for Health, 1991). In spite of this, many major health problems remain 
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unresolved, and increased life expectancy has been associated with an increased 
prevalence of disability in the population (Gruenberg, 1977; Wilkins & Adams, 1983). 
This epidemiological transition has been associated with a change in attitudes; in that 
patients want to live better, and not merely longer. 
Society's main response to these problems continues to be increased investment in 
health care, including preventative, caring and curing interventions, and the last fifty 
years has seen the emergence of many dramatic new health care technologies. 
However, rising health care expenditures have emphasised the need to look at the 
relative costs and benefits of different interventions, and increasingly health care 
providers demand that additional expenditure is justified by improved health 
outcomes. 
Impairments and disabilities have been recognized as incomplete and inadequate 
measures of outcome in chronic disease (Harwood et al, 1994), and the growth of the 
consumer movement and criticism of the biomedical model has pointed to the need to 
bring patients' values and needs into the medical decision making process. These 
concerns created a demand for new indices of health which reflect patients' values 
and views. 
1.5.2 Defining health status 
Many definitions of health exist. Most are variants of the World Health Organisation 
definition: 
"Health is a state of complete physical, mental and social wellbeing and not merely 
the absence of disease or infirmity" (World Health Organisation, 1948) 
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Several groups have built on these constructs to develop concepts of health that can 
be operationalised. Bergner conceptualised health status as a multidimensional 
construct which contains those elements that are an integral part of the person but 
excludes those that exist and behave independently of that person (Bergner, 1985). 
She, therefore, has a notion of health status that "ends at the skin". Bergner 
identifies five interrelated dimensions of health status: 
1. The genetic foundation: forms the basic structure on which all other aspects of 
health status must build. 
2. The biochemical, physiological, or anatomic condition: includes disease, disability 
or handicap whether obvious or not. 
3. The functional condition: includes performance of the usual activities of life, such 
as working, walking and thinking. 
4. The mental condition: includes self-perception of mood and emotion. 
5. The health potential of the individual: includes longevity, functional potential, and 
the prognosis of the disease or disability. 
She proposed that four groups of other factors interact with health status: societal 
factors, health care system factors, social and familial factors and personal factors, 
see Figure 1.1. 
Ware has proposed a similar model of health, see Figure 1.2 (Ware, 1984). This 
model shows disease in the centre, and personal functioning, psychological distress 
and wellbeing, general health perceptions, and social/role functioning in the 
surrounding boxes. This model indicates that health status moves from 
characteristics at the centre (intrinsic to an individual) to characteristics outside an 
individual, in a behavioural, social and cultural perspective that links the experience of 
disease and treatment at the level of the individual, the immediate social environment, 
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or the larger society (Patrick & Erickson, 1993). Ware's emphasis on general health 
perceptions is a major difference between his model and that suggested by Bergner. 
1.5.3 What is Quality of Life? 
The use of the term "quality of life" has grown exponentially over the last 30 years 
(Testa & Simonson, 1996). Spitzer reviewed the content of 33 papers that included 
the term in their title in the five year period 1970-1974. He found the specific subject 
areas included: the contribution of the physician to quality of life of people, the quality 
of life of hospital patients, the quality of life in schools and universities, the quality of 
life in old age, and the quality of life in poverty. In more recent years, it has also been 
evoked as a target outcome for treatment in a number of specific diseases, 
particularly cancer, renal failure, hypertension, coronary artery bypass surgery, 
arthritis, hearing impairment and specific mental illnesses (Spitzer, 1987). Thus, the 
concept of quality of life is subject to numerous interpretations, but clearly designates 
a prominent goal in a wide range of endeavours of patient care, health care systems 
and social programs. To the layperson, quality of life is of the highest importance and 
acts as the driving force behind all actions (Leplege & Hunt, 1997). 
Quality of life has been conceptualised in a variety of ways. These meanings reflect 
the particular knowledge, experience, and values of each individual. Subjective 
definitions of quality of life include the following concepts: wellbeing, life satisfaction, 
morale and happiness. The judgement of how satisfied people are with their present 
state of affairs is based on a comparison with a standard that each individual sets for 
him or herself. Calman defined quality of life as the extent to which an individual's 
hopes and ambitions are matched by experience (Calman, 1984). 
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Alternatively, objective indicators may be used to assess quality of life. Social 
researchers have defined quality of life as the sum total of the individual's scores on 
characteristics that can be objectively determined, e. g. assets, housing, access to 
leisure facilities (Tate et al, 1996). Other less tangible aspects of human existence 
may also be considered, e. g. safety, respect, love and freedom. However, the health 
care system and its providers do not usually assume responsibility for these more 
global human concerns, even though they may adversely affect or be affected by 
disease and treatment. Therefore, a final more specific approach is to focus on those 
aspects of quality of life that are directly related to health, disease, treatment or policy 
(Brooks, 1991). Brooks argues that there is a risk in extending the definition of 
quality of life too far, and highlights the important potential distinction between health 
and non-health related aspects of quality of life: 
"If the focus is to be on health interventions, should we not be attempting to focus 
our analysis on health related entities. Are we in danger of becoming too holistic? 
One way to answer these questions would be to concentrate on what might be 
termed "health related quality of life,...... It would be necessary to select those 
domains and dimensions deemed of relevance, and to be explicit about defining 
such health related quality of life. " (Brooks, 1991) 
Torrance agrees that overall quality of life is an all-inclusive concept incorporating all 
factors that impact upon an individual's life; whereas health related quality of life 
includes only those factors that are part of an individual's health (Torrance, 1987). He 
suggests that physical functioning and emotional functioning, taken together, 
constitute health related quality of life. Social functioning, although important to an 
individual's overall quality of life, is considered 'beyond the skin" and not an aspect of 
health related quality of life (Torrance, 1987). This view that, for health studies, 
investigators should focus on health related issues and preferentially use the term 
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"health related quality of life" has been widely supported by many workers (Lohr, 
1992; Guyatt et al, 1993; Levine, 1995). However, the concept that quality of life can 
be dissected into its health and non-health-related components has been challenged: 
"This view fails to acknowledge the interconnectedness of health status with other 
aspects of existence such as changes in income, work status, personal 
relationships, coping strategies, responsibilities, self-image, and customary modes 
of being. This interconnectedness makes the project of specifically measuring 
health related quality of life improbable. ' (Hunt, 1995; Leplege & Hunt, 1997). 
The lack cf consensus regarding the conceptualisation of quality of life has created 
wide variation in its assessment. Gill and Feinstein attempted to clarify the meaning 
of the term "quality of life" by systematically reviewing 75 articles which included this 
term in their title (Gill & Feinstein, 1994). They were surprised to find that, despite the 
lack of a widely accepted operational definition of quality of life, very few articles 
included definitions of what they measured (Gill & Feinstein, 1994). Furthermore, no 
article distinguished quality of life, which takes account of how individuals might react 
to non-medical aspects of their lives (e. g. jobs, family, friends, and other life 
circumstances) from health related aspects of quality of life (Gill & Feinstein, 1994). 
1.5.4 Is health related quality of life equivalent to health 
status? 
Leplege and Hunt suggest that when the demand for quality of life measures arose, 
there were no such measures, and so the term "health related quality of life" was 
coined as a method of justifying the use of the existing health status measures under 
a new banner (Leplege & Hunt, 1997). This view is supported by the fact that many 
of the former health status instruments, such as the Sickness Impact Profile and the 
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Nottingham Health Profile, are now described as measures of health related quality of 
life. Alternatively, the absence of a MEDLINE term for health related quality of life, 
until recently, may have caused investigators to label their health related quality of life 
measures as measures of health status (personal communication, Paul Kind). 
However, most researchers now appear to use the terms "health status" and "health 
related quality of life" interchangeably (Spitzer, 1987; McDowell & Newell, 1996; 
Leplege & Hunt, 1997). This convention will be used from here on in this thesis. 
However, this approach has been criticised: 
"One of the striking differences between the notion of quality of life and that of 
health status is level of conceptualization. Quality of life as it is used in clinical 
research is a vague term without conceptual clarity. It is what investigators mean it 
to be. Conceptual frameworks for health status, on the other hand, have appeared 
in the literature, have been discussed and debated, and have provided the 
underpinnings of several measures. " (Bergner, 1989) 
1.5.5 Conceptual models for health related quality of life 
At least two models of health related quality of life have recently been proposed. 
These models have striking similarities with the earlier conceptualisations of health 
status. Wilson and Cleary proposed that measures of health can be thought of as 
existing on a continuum of increasing biological, social, and psychological complexity 
(Wilson & Cleary, 1995). This relationship is illustrated schematically in Figure 1.3. 
As with Bergner's model of health status, the model begins with biological and 
physiological variables. The next layer are symptom reports, which are expressions 
of subjective experiences that summarise and integrate data from a variety of 
sources. Functional status is the next integrative level. In addition to symptoms, the 
individual's motivation, beliefs, and local environment determine functional status. 
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General health perceptions represent an integration of all of the previous health 
concepts. General health perceptions are recognised as amongst the best predictors 
of the use of general medical and mental health services (Hunt et al. 1981). These 
perceptions are predicted to influence the individual's overall quality of life. 
Psychological influences can be classified in a variety of different ways in this model, 
e. g. depression could be classified as a biological factor, a measure of symptom 
status, or a measure of psychological functioning. 
This system provides a useful conceptual basis for linking traditional clinical variables 
with health related quality of life outcomes. It has much in common with another 
recent definition of health related quality of life: 
"Health related quality of life is the value assigned to duration of life as modified by 
impairments, functional states, perceptions and social opportunities that are 
influenced by disease, injury, treatment or policy" (Patrick and Erickson, 1993) 
Patrick and Erickson suggest five distinct semi-hierarchical health related quality of 
life concepts: opportunity, health perceptions, functional states, impairments, and 
death or duration of life. However, their approach differs from that proposed by 
Wilson and Cleary in that it specifically draws attention to the relationship between the 
quantity and quality of life, and aims to provide a basis for the comparison of the 
costs of different health care interventions. 
1.5.6 Current strategies for the measurement of quality of life 
The method used to measure quality of life will depend on the target population and 
the purpose of the assessments. Assessments may be grouped into those that best 
measure quality of life at the level of an individual patient or at the level of a whole 
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population. Four distinct approaches can be identified: generic measures of health 
related quality of life, disease specific measures, patient generated indices, and utility 
measures. 
1.5.6.1 Generic measures of health related quality of life (health status) 
Generic instruments seek to assess health concepts that represent basic human 
values and are relevant to everyone's health status and well-being. These 
instruments are the most widely used approach for the measurement of quality of life. 
The measures are called generic because they are both universally valued and are 
not specific to any particular age, disease, or treatment group (Ware, 1992). 
However, the problem (or advantage) with generic multidimensional health rating 
scales is that the choice of dimensions and the values attached to them are imposed 
on the patient. The value judgments are those of a group of health professionals, or 
at best, represent the view of the general public, and may differ importantly from 
patients' own values. These assessments are therefore potentially less relevant to 
patients with a particular disease, and less sensitive to change, than instruments 
which are either disease- or individual- specific. However, from the public health 
perspective, generic measures of health related quality of life are of greater value 
than disease- or individual- specific measures. Generic measures can be used to 
compare health gains from different interventions in different groups of patients. This 
might then allow health resources to be allocated equitably between competing 
disease groups in a way that maximises population health gain (Cairns, 1996) (for 
example, many hip replacements versus a few heart transplants - which gives greater 
health gain? ). 
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1.5.6.1.1 Development of generic measures of health related quality of life 
Health measures may be developed from a specific conceptual theory or empirically. 
A conceptual theory for a measure may justify its content and relate it to a broader 
body of theory, showing how the results obtained can be interpreted in light of the 
theory. In the empirical approach, a smaller number of items may be selected by 
statistical techniques from a larger pool of items, to provide the best possible 
prediction of the outcome of interest. Although the empirical approach has a practical 
appeal, the interpretation of results subsequently obtained with the measure may 
prove more difficult. In practice, most health status measures have been developed 
using a combination of both approaches. 
The Sickness Impact Profile was an early, influential measure. It was developed to 
provide an appropriate, valid, and sensitive measure of health status for use in 
assessing the outcome of health care services (Gilson et al. 1975). It was developed 
as a behaviourally based measure of sickness-related dysfunction. This measure 
was based on the assumption that the ultimately sought product of health services 
was the reduction in sickness, where sickness denotes the non-professional definition 
of illness based on lay observations. The content of the Sickness Impact Profile was 
developed empirically by asking patients, health care professionals, carers, and 
healthy individuals to provide statements of sickness related behaviour. In addition, 
the content of previous disease specific instruments was reviewed. This process 
yielded 312 unique statements that were grouped into 14 categories. This prototype 
was empirically refined to a final version with 136 statements in 12 categories. 
Patients' responses may be used to construct a score for each of the 12 categories, 
an aggregate score for each of the two dimensions (physical and psycho-social), or a 
global score for the questionnaire as a whole. 
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The Quality of Well-Being Scale was another early influential health measure. It 
summarised a patient's health status and symptoms in a single number that reflects a 
judgement on the social undesirability of the problem (Patrick et al. 1973). It consists 
of three ordinal scales on dimensions of daily activity: mobility, physical activity, and 
social activity. Scores on these scales can be linked with a separate classification of 
symptoms and problems. It has become widely used for health economic analyses. 
The Sickness Impact Profile influenced the content and development of later health 
status measures, such as the Nottingham Health Profile. One major difference is that 
the Nottingham Health Profile asks about feelings and emotional states directly, 
rather than via changes in behaviour. This emphasis on perceived health status 
recognises its importance as a predictor of need for, and utilisation of, health services 
(Hunt et al, 1981). 
The development of the Short Form 36 (SF-36), one of the newest health related 
quality of life measures, was strongly influenced by its underlying conceptual model 
(Ware & Sherboume, 1992; Ware, 1992). The SF-36 resulted from a process of 
questionnaire development which began during the Health Insurance Experiment, 
conducted by the Rand Corporation between 1974 and 1982, to construct the best 
possible scales for measuring a broad array of functioning and wellbeing concepts for 
children and working age adults. The Health Insurance Experiment was followed by 
the Medical Outcomes Study that provided the opportunity for a large-scale test of the 
feasibility of self-administered patient questionnaires and generic health scales for 
adults with chronic conditions, including the elderly. The Medical Outcomes Survey 
was based on a two dimensional model of health: physical and mental. In this 
framework, social health is not considered to be conceptually equivalent to the 
dimensions of physical and mental health and is incorporated primarily as an indicator 
of these dimensions (Ware, 1992). The Medical Outcomes Survey framework 
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describes five categories of indicators of physical and mental health: 1) clinical status, 
2) physical functioning and wellbeing, 3) mental functioning and wellbeing, 4) 
social/role functioning and wellbeing, and 5) general health perceptions. Functioning 
pertains to the ability to perform various daily activities and functions, whereas 
wellbeing refers to more subjective internal states not observable by others (such as 
symptoms and feelings). 
The EuroQol instrument was developed, by a collaborative multinational European 
group, as a generic instrument for the description and valuation of health related 
quality of life (The EuroQol Group, 1990). It was intended that the EuroQol should 
complement other forms of outcome measures, and should facilitate the collection of 
a common data set for reference purposes. The instrument was designed as a self 
completed questionnaire for use in large scale surveys of the community. It has 
therefore balanced the desire to cover all potentially relevant topics against the need 
to be practical. The EuroQol questionnaire covers five dimensions of health: mobility, 
self-care, activities, pain and mood; and was designed to produce a single index 
value of health for any given health state. It also includes a visual analogue scale 
that allows respondents to report their valuation of their own overall health state. The 
dimensions were selected following a detailed examination of the descriptive content 
of existing health status measures including the Quality of Wellbeing Scale, the 
Sickness Impact Profile, the Nottingham Health Profile, and the Rosser Index (Rosser 
& Watts, 1972). 
1.5.6.1.2 Empirical evidence for the determinants of generic measures of 
health related quality of life 
Lay attitudes to health are important as they may affect the meaning and 
performance of health status assessments. Herzlich's study of French lay-people 
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demonstrated that they could distinguish between negative and positive health 
concepts (Herzlich, 1973). This is important because it lends support to the World 
Health Organisation definition of health, i. e. health is not merely the absence of 
disease or infirmity. This finding has been confirmed in several more recent studies 
(Blaxter, 1990; van Dalen et al, 1994). Blaxter examined attitudes to health in a large 
United Kingdom "Health and Lifestyles Study". She also found that good health was 
viewed as a positive concept with many degrees (Blaxter, 1990), and clear evidence 
for the multidimensionality of health. Her respondents reported the following 
concepts of health most frequently: 1) unable to answer, 2) health represents the 
absence of disease (negative concept), 3) health is being functionally able, 4) health 
is being psychologically fit, 5) health is leading a healthy life, and 6) health is being in 
good health for age. Blaxter also found that the concepts of health differed with age, 
sex, education and whether individuals were talking about health in general or their 
own health in particular. 
The results from these studies provide empirical support for multidimensionality of 
health related quality of life, but also for the importance of positive aspects of health. 
However, generic health related quality of life measures have been criticised for 
containing items that may be irrelevant to people with the condition under study, and 
for omitting others that are pertinent (Bowling, 1995). Bowling examined which 
dimensions of life people perceive to be important in relation to quality of life and how 
different conditions impact on peoples' lives (Bowling, 1996). She found that 
respondents reported the following, most frequently, as being important to their lives: 
finances, standard of living, relationships, own health, health of relevant others, and 
social life and leisure. However, respondents identified a different set of issues as 
important for the effects of illness on life. For the effects of illness on life the most 
frequent responses were: ability to get out and about, ability to stand, ability to walk, 
ability to go out shopping; social life and leisure activities; work; symptoms; 
25 
Chapter One 
instrumental activities of daily living; psychological problems; and other restrictions on 
activities. Responses differed somewhat with age and gender. For example, women 
were more likely than men to identify psychological problems as important. 
Responses differed even more substantially with illness experience. For example, 
respondents with mental health disorders were most likely to report "availability to 
work" or "ability to work" as the first most important effect; whereas respondents with 
digestive or endocrine disorders were most likely to report "dietary restrictions". 
Bowling concludes that this finding supports the wider use of disease specific 
measures of outcome (Bowling, 1996). 
Williams and colleagues conducted a similar experiment to examine the content of 
existing generic measures of health related quality of life (Williams, 1995). They 
asked a random sample of the general public what the salient features of good or bad 
health were in themselves or in others. They found that simple measures (Rosser 
Index and EuroQoL) covered only about 26-36% of the items mentioned 
spontaneously by the respondents, and the more complex measures (Nottingham 
Health Profile, Quality of Wellbeing Scale, and the Sickness Impact Profile) provided 
between 50 and 60% coverage. However, the investigators considered 
approximately one third of the items mentioned by the public as not relevant to an 
index designed to appraise variations in health-related lifestyle. They also tested the 
importance of items in a prompted section of the interview. In these analyses they 
found there was little to choose between the various instruments. 
1.5.6.2 Disease specific measures 
Unlike a generic measure of health related quality of life, a disease-specific measure 
is designed specifically to examine the areas of concern for patients with that 
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particular disease. Including only the aspects of health related quality of life that are 
relevant to the disease should improve both the relevance and responsiveness of the 
measure (Guyatt et al. 1993). In some situations, disease specific measures are 
often no more responsive than generic measures because they are generally created 
by the addition of further items to existing generic measures of health related quality 
of life (Vickrey et al. 1992; Vickrey at al. 1995). 
1.5.6.3 Patient generated index (individual quality of life) 
Generic or disease specific measures of health related quality of life do not address 
goals or behaviours important to individual quality of life, such as attendance at 
religious services, playing darts, or personal finance. Moreover, apparently similar 
behaviours do not have the same importance for all individuals, and behaviours and 
events do not necessarily retain the same meaning for an individual over the course 
of an illness. Assessments of individual quality of life aim to quantify the person's 
level of functioning in those areas of life that he or she believes to be important and 
the relative importance of these areas (O'Boyle at aL 1992). Several groups have 
reported methods of assessing individual quality of life in patients with chronic 
problems (O'Boyle at al. 1992; Hickey at al. 1996; Paterson, 1996). However, it is 
unlikely that these assessments could be performed as an emergency, for example 
patients presenting with acute stroke. 
1.5.6.4 Utility measures 
These measures are derived from economic and decision theory and are designed to 
reflect the preferences of patients for differing outcomes in relation to death (Guyatt 
et al. 1993). Utility scores therefore aim to reflect a specific health state and its value 
to the patient. The utility is summarized as a single number along a continuum that 
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usually extends from death (0.0) to full health (1.0). Scores less than zero are 
possible and reflect health states worse than death. Utility scores are perhaps most 
relevant when they are derived directly from the individual patients who may be asked 
to rate the value of their own health state. Alternatively, patients' responses to certain 
multidimensional health profiles (such as the EuroQol) can also be converted to 
utilities using preferences derived from the general public (Dolan et al. 1995). Such 
utilities may be more useful from the public health perspective. 
1.6 What makes a good measure of outcome? 
1.6.1 Measurement must be related to purpose 
Many investigators appear to select measures of outcome simply on the basis of 
"brand familiarity". Whilst this might enhance the interpretability, and potential 
acceptance, of any subsequent results, a variety of other issues should also be 
considered when outcome measures are selected. These include the aim of the 
study, its underlying ethical principle, the level of measurement (i. e. is outcome to be 
assessed at the level of the individual or the population? ), the planned method of 
administration, and the attributes of the instrument in the population of interest 
(McDowell and Newell, 1996). 
The underlying ethical principle should be considered when investigators are 
selecting measures to value health. Potential valuations include those of the patient, 
the community, and the health care professionals. Researchers and clinicians must 
consider the relative merits of the valuations derived from each of these groups, as 
they may well differ (Leplege and Hunt, 1997). The ethical standpoint of health care 
providers is that of utilitarianism, i. e. doing the greatest good for the greatest number. 
28 
Chapter One 
This may create tensions with the ethical perspective of the individual clinician, which 
should be to make the care of the individual patient his first concern (General Medical 
Council, 1998). 
The issue that the content of the measure must reflect the purpose of the study has 
already been discussed, see Section 1.4.2 and Section 1.5.6. The majority of the 
instruments discussed so far were developed primarily, for use in populations of 
patients, for the purposes of: monitoring trends in health, evaluating the effects of 
health and social policies, and to assist the allocation of resources in relation to need 
(Ebrahim, 1995). There is increasing interest in using the same instruments at the 
level of individual patients. At this level the purposes of measurement might include: 
the diagnosis of the nature and severity of disease, assessment of prognosis, 
evaluation of the effects of treatment and the study of aetiological factors (Ebrahim, 
1995). Although some of these purposes appear similar, the same measure of 
outcome might not have the appropriate measurement attributes for both of these 
applications (Ebrahim, 1995). 
1.6.2 Measurement Attributes 
The essential attributes on which outcome measures are evaluated are their burden, 
validity, reliability, sensitivity to change and interpretability. 
1.6.2.1 Respondent and Administrative Burden 
The respondent burden is defined as the time, energy, and other demands placed on 
the person responding to the instrument (Scientific Advisory Committee, 1995). This 
has become particularly important as failure to respond (or not completing the data 
collection form) are the "Achilles heel" of quality of life assessments in clinical trials 
(Aaronson, 1992; Fallowfield, 1996). In stroke survivors, who often have cognitive, 
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speech and language deficits and may be unable to complete complex 
questionnaires, it is particularly important to minimise "respondent burden". 
Administrative burden is defined as the demands (time, financial cost and difficulty) 
placed on those who administer the instrument (Scientific Advisory Committee, 1995). 
This is an important factor in determining the resources required for any study. 
Large scale studies, involving many thousands of patients, require robust measures 
of health related quality of life with very low respondent and administrative burden. 
Such studies are being increasingly performed in patients with stroke. For example, 
two large randomised controlled trials, each involving about 20,000 patients, have 
recently been completed in patients with acute stroke (International Stroke Trial 
Collaborative Group, 1997; Chinese Acute Stroke Trial Collaborative Group, 1997). 
Similarly, public health researchers also need to assess the health related quality of 
life of large numbers of stroke patients to assess the quality of care given by health 
services (Working Group on Outcome Indicators for Stroke, 1997). 
1.6.2.2 Validity 
The validity of an instrument is defined as: 
"the degree to which the instrument measures what it purports to measure" 
(Scientific Advisory Committee, 1995) 
Many different approaches and a myriad of different terms have been used to 
describe the components of validity (Streiner and Norman, 1989), but the most 
important ones are: 
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Face or content validity refers to the extent to which a measure samples the 
important areas of interest. This aspect of validity is generally assessed in a 
qualitative manner. This process may be formalised by the use of lay and expert 
panels to judge the clarity, comprehensiveness and redundancy of items and scales 
of an instrument. 
Criterion validity is defined as the correlation of a scale with some other measure of 
the trait under study, ideally a "gold standard" which has been used and accepted in 
the field (Streiner and Norman, 1989). Criterion validity may be divided into two 
types: concurrent and predictive validity. With concurrent validity we correlate the 
new scale with a criterion measure. This is often impossible with quality of life 
assessments because of the absence of widely accepted criterion measures. 
Predictive validity refers to the extent to which patients' responses to a scale predict 
future important events, e. g. the predictive validity of a health related quality of life 
scale would refer to the extent to which patients' responses to the scale predicted 
their future health status. 
Construct validity is concerned with the degree of agreement or disagreement 
between a health related quality of life scale and some predefined relationship. 
These predefined relationships are referred to as (hypothetical) constructs. Construct 
validity may be demonstrated by showing convergent relationships with related 
variables or poor correlation (discriminant validity) with dissimilar, unrelated variables. 
Validation of an instrument may be considered as a process of hypothesis testing 
(Streiner and Norman, 1989). An alternative and more general definition is that 
validity describes the range of interpretations that can be appropriately placed on a 
measurement score (McDowell and Newell, 1996), i. e. what can we conclude about 
the person who produced particular scores on the test? 
31 
Chapter One 
1.6.2.3 Reliability 
Reliability is the extent to which a measure is free from random error in the population 
of interest (Guyatt et at 1993; Scientific Advisory Committee, 1995; Testa & 
Simonson, 1996). The reliability of a measurement is defined as the proportion of 
observed variation in scores that reflects actual variation in the aspect of health being 
measured (McDowell and Newell, 1996). Reliability may be measured by assessing 
an instrument's internal consistency or its reproducibility. Internal consistency is 
concerned with the extent to which the component items of a scale are inter-related 
(Streiner and Norman, 1989). Items showing high levels of internal correlation are 
assumed to be measuring the same underlying concept. A measure's reproducibility 
is the degree to which it yields consistent scores over time among respondents who 
are assumed not to have changed (test-retest reproducibility), or the extent to which 
different observers may administer it to a particular patient and achieve similar results 
(inter-observer reproducibility). 
Measures with poor reliability will be inefficient at distinguishing patients with different 
health states, because true differences in score may be obscured by random error. 
Instruments with good reproducibility can reliably distinguish changes in quality of life 
due to progression (or successful treatment) of the disease (true change) from 
changes due to random error in the measurement (change due to "noise"). In 
particular, instruments used to assess individuals longitudinally require better 
reproducibility than those which are used in cross-sectional studies. 
1.6.2.4 Sensitivity to change 
The sensitivity to change or responsiveness of an instrument refers to its ability to 
detect change, often defined as the minimum change considered to be important by 
the person being studied (or by their "significant others" or their carers). One may 
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think of it as the ratio of the "signal" (real change that has occurred over time) to the 
"noise" (the variability in the scores associated with the instrument's measurement 
error). Responsiveness is a function of both the validity and the reliability of the 
instrument. 
Sensitivity to change can be measured in several ways. Effect size may be 
calculated as the mean difference in outcome between the two measurements 
divided by the variability (the standard deviation) of the baseline measurement (Kazis 
et al. 1989; Fitzpatrick et a/. 1992b). However, this method of calculating effect size 
does not take account of the reproducibility of the measure and so instruments with 
poor test-retest reliability may yield spuriously high effect sizes with this approach 
(Ebrahim, 1995). Few measures of outcome which have been used in acute stroke 
trials to date have had their sensitivity to change explicitly measured. This is perhaps 
because, until recently, there has not been an effective treatment for stroke. 
1.6.2.5 Interpretability 
Interpretability is defined as the degree to which one can assign qualitative meaning 
to an instrument's quantitative scores (Scientific Advisory Committee, 1995). 
Instruments which place respondents into clinically sensible and distinct categories 
have immediate interpretability, but they are not necessarily valid, reliable or 
responsive. Numerical scores are less easy to interpret. It may be easier to interpret 
health related quality of life scores if the distribution of scores in different patient 
groups (and in the general population) is well characterised, or the change in scores 
associated with a particular type of life event, or the use of an effective treatment is 
known precisely. 
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1.6.2.6 Generalisability 
Several health related quality of life instruments (such as the SF-36, the Nottingham 
Health Profile, the EuroQol and the Sickness Impact Profile) have become very widely 
used (McDowell and Newell, 1996). Their validity and other measurement attributes 
have been examined in large community samples and many different patient groups, 
and appear to be generally acceptable and qualitatively similar (Jenkinson et al. 1993; 
Brazier et al. 1992; Ware, 1992; Brooks & with the EuroQol group, 1996; McDowell 
and Newell, 1996). It is therefore unclear whether these instruments need to be re- 
examined in every new patient group or population of interest. 
Although generic instruments aim to take a broad view of health, their content varies. 
Some instruments may be less relevant, and so perform less well, in certain patient or 
population groups. For example, Hayes and colleagues examined the suitability of 
the SF-36 questionnaire for the assessment of health status in older adults (Hayes et 
a/. 1995). They found that two fifths of the sample were unable to complete the 
questionnaires by themselves and had to be assessed by interview. They also 
reported that missing responses were concentrated on a small number of questions 
whose emphasis was on work or vigorous activities. Perhaps elderly people viewed 
such activities as irrelevant to their own lives. However, Hayes et al did not assess 
whether these findings affected the instrument's other measurement attributes in the 
elderly. 
The responsiveness of a measure may also be compromised by "ceiling effects" in 
which the patients with the maximal score may still have poor health related quality of 
life or "floor effects" in which patients with the worst score may deteriorate further 
(Guyatt et al. 1993). Floor and ceiling effects can only be identified if the actual 
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distribution of scores in the population of interest is known. This knowledge will also 
facilitate the interpretation of subsequent data generated with the instrument. 
In summary, although examination of the properties of generic health status 
instruments in a new population of interest will almost always generate useful 
information, it is particularly important in the following settings. Firstly, if the new 
patient group differs importantly from other groups in which the instrument has 
already been evaluated. Secondly, if specific problems are anticipated, e. g. problems 
with feasibility, as in the elderly. Thirdly, if the instrument is under consideration for 
use in an important and potentially expensive study (because clinicians may not 
implement the results of a study if they are unsure about the measure of outcome). 
1.7 Measuring health related quality of life after stroke 
Conventional impairment and disability scales focus on residual physical problems 
after stroke and do not measure the difficulties with psychological and social 
functioning that may have a greater impact on the patients' life. Furthermore, 
recovery in the physical domain of health may not lead to parallel improvement in 
psychological or social functioning. Psychological and social outcomes are very 
relevant to the patients' quality of. life (Goodare & Smith, 1995). They need to be 
enquired of specifically since doctors tend to focus on the patient's physical problems 
(Rothwell et aL 1997). 
Measuring quality of life may also be particularly relevant if the treatment being 
evaluated does not have a major impact on death or disability, yet improves outcome 
in more subtle ways that matter to the patient. Similarly, if the treatment has a 
mixture of beneficial and undesirable effects, measurement of quality of life may help 
clarify the overall balance of risk and benefit (Friedman et al. 1984; Croog et al. 
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1986). Furthermore, some measures of health related quality of life generate an 
overall estimate of health status or utility (see below), which is useful in assessing the 
economic impact of a treatment (e. g. cost-benefit analyses), and will probably 
become a standard requirement of the regulatory agencies for the licensing and 
approval of new treatments (Freemantle et al. 1995). 
Although it is now routine to measure health related quality of life in some areas of 
medical and public health research, little work has been done on the measurement of 
health related quality of life after stroke (de Haan et al. 1993a), and the selection of 
the most appropriate instrument is not clear. 
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1.8 Summary of Chapter One 
1. Stroke is a major public health problem. The disease places a great burden on 
patients, their families and on society at large. The burden is not just in human 
suffering, but also a financial one. 
2. Policymakers, health professionals, researchers and patients need detailed 
information on the burden of stroke as well as information on which treatments can 
reduce the burden. To measure outcome after stroke, and how it is influenced by 
treatment, requires suitable tools. Tools for the assessment of outcome at the 
level of the population, or groups of patients, will not necessarily be suitable for 
assessing outcome in individual patients. 
3. Health related quality of life, which focuses on the patient's subjective view of their 
own health, is now commonly measured. The United Kingdom government health 
policy aims to improve the quality of life of stroke survivors. 
4. Measures of health related quality of life must be valid, reliable, sensitive to 
change, and interpretable in the population of interest. Their administration must 
not place an excessive burden on either the subjects or the researchers. 
5. Little is known about health related quality of life after stroke. A systematic review 
of this area is needed to summarise the results of the completed studies, highlight 
any methodological problems, inform the design of appropriate future studies and 
help to set research priorities. 
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Table 1.1: Stroke scales (adapted from van Gijn, 1992) 
Author Year of publication 
Barham Carter 1961 
Meyer at al 1965 
Tuthill at al 1969 
Mathew at at 1972 
Fugl-Meyer at at 1975 
Norris 1976 
Kaste at al 1976 
Larsson at al 1976 
Fawer at al 1978 
Mulley at al 1978 
Admani 1978 
Woollard et al 1978 
Demeurisse at al 1980 
Norris and Hachinski 1982 
Feigenson 1982 
Hamrin and Wohlin 1982 
Orgogozo at al 1983 
Scandinavian Stroke Study Group 1985 
EC/IC Bypass Study Group 1985 
Cote at al 1986 
Orgogozo and Dartigues 1986 
Adams at al 1987 
Olesen at al 1988 
Reding 1990 
Loewen and Anderson 1990 
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Table 1.2: The Mathew Scale (Mathew et a/. 1972) 
Factor Score 
Mentation 
Level of consciousness 
Fully conscious 8 
Lethargic but mentally intact 6 
Obtunded 4 
Stuporous 2 
Comatose 0 
Orientation 
Oriented x3 6 
Oriented x2 4 
Oriented x1 2 
Disoriented 0 
Speech 
Reitan test 0-23 
Cranial nerves 
Homonymous hemianopia 
Intact 3 
Mild 2 
Moderate 
Severe 0 
Conjugate deviation of eyes 
Intact 3 
Mild 2 
Moderate I 
Severe 0 
Facial weakness 
Intact 3 
Mild 2 
Moderate 
Severe 0 
Motor power 
Normal strength 5 
Contracts against resistance 4 
Elevates against gravity 3 
Gravity eliminated 2 
Flicker 
No movements 0 
Performance or disability status scale 
Normal 28 
Mild impairment 21 
Moderate impairment 14 
Severe impairment 7 
Death 0 
Reflexes 
Normal 3 
Asymmetrical or pathological reflexes 2 
Clonus 1 
No reflexes elicited 0 
Sensation 
Normal 3 
Mild sensory abnormality 2 
Severe sensory abnormality 1 
No response to pain 0 
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Table 1.3: The Barthel Index (adapted from Manoney and Barthel, 1965) 
What the patient ACTUALLY DOES ? 
1) FEEDING Independent =10 
Needs some help =5 
Needs to be fed =0 
2) BATHING Able to wash all over =5 Q 
Needs help =0 
3) GROOMING Totally independent =5 
Dependent in some way =0 
4) DRESSING Totally independent = 10 Q 
Needs help with some items =5 
Unable to do any without help =0 
5) BOWELS No accidents =10 Q 
Occasional accident/ help with enema =5 
Incontinent =0 
Q 6) BLADDER No accidents = 10 
Occasional accident / use of device =5 
Incontinent =0 
7) TOILET Independent = 10 F-1 
Minor assistance =5 
Unable to use =0 
8) TRANSFER Totally independent = 15 
Minimal help needed = 10 F1 
Sit unaided, major help for transfer =5 
Unable =0 
Q 9) AMBULATION Independent for 50 metres = 15 
Walk 50 metres with help = 10 
Independent in wheelchair for 50 metres =5 
Immobile =0 
10) STAIRS Independent =10 Q 
Needs physical / verbal support =5 
Unable =0 
TOTAL: 
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Chapter Two 
2 The measurement of health related quality of 
life after stroke: a systematic review of 
existing studies 
2.1 Introduction 
In 1994, the Neurosciences Trials Unit at the Western General Hospital, Edinburgh, 
began to plan a randomised controlled trial of a neuroprotective agent (BW619C89) in 
patients with acute stroke. The primary outcome measure was to be the proportion of 
patients "dead or dependent" in activities of daily living six months after the stroke. 
This measure is robust but relatively insensitive. Neuroprotective agents act on the 
cerebral cortex and we predicted that they might well have effects on cortical function 
that would not be detected by an instrument to measure activities of daily living. In 
view of this we wished to explore the possibility of using a measurement of health 
related quality of life as a more sensitive and comprehensive measure of treatment 
effect. In particular, neuroprotective therapy might have long term adverse 
neuropsychiatric effects, which a health related quality of life instrument could detect 
(Dorman & Sandercock, 1996). Secondly, neuroprotective therapy might improve 
cerebral cortical function and so improve cognitive function; assessments which only 
measured physical disability could not detect improvements in cognitive function 
(Dorman et aL 1996). Thirdly, clinicians and purchasers of health care would be more 
likely to adopt and pay for neuroprotective treatment if it was not merely clinically 
effective, but also cost-effective. Furthermore, economic analyses are more useful, 
and informative, if they can assess the impact of treatment on health related quality 
of life as well as on survival and disability. 
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In 1994 relatively little work had been published on measurement of health related 
quality of life after stroke (de Haan et a/. 1993a; Adkins, 1993; Tate et al. 1996). In 
particular, we were unsure whether it was feasible to measure health related quality 
of life in a large scale stroke study. The selection of the "best" health related quality 
of life instrument for the planned randomised controlled trial was therefore critical. 
Firstly, we wished to be sure that the measurement properties of the relevant 
instruments was appropriate for the assessment of health related quality of life after 
stroke. Secondly, there seemed to be relatively little easily available literature, and so 
an extensive and thorough search (to detect what little there was) was particularly 
important. I therefore decided to systematically review the existing literature on the 
measurement of health related quality of life after stroke. A systematic review, rather 
than a traditional (non-systematic) one, would have several advantages for us. 
Firstly, the use of explicit criteria for the inclusion of studies and an extensive search 
strategy to identify all the potentially eligible studies, should reduce the bias that may 
occur when only certain subsets of data are reviewed. Secondly, it should allow other 
investigators to replicate ones review (Mulrow, 1987; Counsell et al. 1995). Thirdly, 
the diversity of studies reviewed allows the reasons for any consistencies and 
inconsistencies in the results to be explored (Mulrow, 1987). 
The aim of the review was to: identify all relevant studies which examined the 
measurement of health related quality of life after stroke, assess their 
methodological quality; and, on the basis of these results, select the "best" measure 
for use in a future large randomised controlled trial. 
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2.2 Methods of review 
2.2.1 Inclusion criteria 
I primarily sought to review all studies which assessed the measurement properties of 
measures of health related quality of life after stroke. I also sought to review articles 
that had assessed health related quality of life after stroke, because these studies 
might provide indirect evidence on the measurement of health related quality of life 
after stroke. 
There is no universally agreed definition of health related quality of life and the 
concept has evolved with time (see Chapter One). I therefore took a broad approach 
and aimed to identify: studies which used accepted quantitative measures of health 
related quality of life or health status (McDowell & Newell, 1996); articles which used 
a single questionnaire to measure multidimensional outcomes (in at least the 
physical, social and psychological dimensions of health); and, articles which included 
instruments to provide an assessment of overall (health related) quality of life. I 
excluded studies which used a battery of accepted unidimensional instruments. to 
assess health related quality of life after stroke since this approach is likely to place 
an excessive burden on patients, carers and administrators, and so would not be 
practical in a large randomised controlled trial. Some studies used a qualitative 
approach to assess health related quality of life after stroke. These were also 
excluded since this approach was unlikely to be applicable in our proposed trial or 
other large epidemiological studies. 
Although my search strategy included articles published to the end of 1997,1 did not 
consider studies published after August 1997 because some of these articles 
included work from this thesis (see Appendix 10). 
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2.2.2 Search strategy 
I used several strategies to identify relevant studies. Only studies published in full 
text, in English, were eligible. The primary strategy was a computerised bibliographic 
searching of the MEDLINE database from 1966 to 1997. The final search was 
performed in June 1998 using the Ovid for Windows software. I used a modified 
version of the Cochrane Stroke Group's search strategy for stroke related articles 
(Counsell, 1998) and combined this with a search for articles related to outcome 
(Table 2.1). The latter search was devised by examining the Medline subject 
headings and the indexing of studies known to be relevant. This search strategy was 
then validated by comparing its sensitivity against a gold standard of relevant articles 
produced by searching five volumes of the journal Stroke by hand (Counsell, 1998). 
used the same strategy to search the EMBASE database from 1980 to 1997. 
reviewed the titles and abstracts of all articles identified by these searches. I 
obtained copies of, and read in full, articles that appeared to meet the inclusion 
criteria for this study. 
I also used several other methods to identify relevant articles. I hand-searched the 
journals Cerebrovascular Diseases and European Journal of Neurology (which are 
not indexed in MEDLINE). I reviewed the bibliography of an existing systematic 
review of the stroke outcome literature (Warbuton and Long, 1994) and the 
bibliographies of other relevant studies and reviews (Anderson, 1992; De Haan at al, 
1993a; Adkins, 1993; Tate et al, 1996); and reviewed my personal collection of 
studies relating to the measurement of health related quality of life after stroke. I also 
had many informal discussions with other researchers. I did not, however, formally 
survey the opinions of experts regarding the measurement of health related quality of 
life after stroke. I sought the expert opinion of Carl Counsell regarding the 
development of the search strategy for this systematic review. 
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2.2.3 Data extraction and synthesis 
I assessed the quality of evaluation of health related quality of life instruments after 
stroke by extracting the following data, as suggested by previous authors (Scientific 
Advisory Committee, 1995; McDowell & Newell, 1996): 
i) Aim of study 
Was the purpose of the study clearly stated? 
ii) Description of measure and conceptual basis 
Was the instrument adequately described, if not well known? Was the conceptual 
model explained or was an appropriate reference cited? 
iii) Generalisability 
Were the characteristics of sample (e. g. socioeconomic status, comorbid conditions 
and clinical details) described? 
iv) Testing conditions 
How and where was the instrument administered? 
v) Practicality 
Was information provided on the time required to complete (administer) the 
instrument? Was the feasibility of the instrument and the frequency of missing data 
or non-response reported? Can the instrument be administered in alternative forms? 
Is the instrument available in different languages? 
vi) Size of study 
Was it clearly documented? 
vii) Validity 
Were the different aspects of validity considered? See Chapter One. 
viii) Reliability 
Was test-retest reliability examined as well as internal consistency? See Chapter 
One. 
ix) Sensitivity to change 
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Was this assessed longuitudinally? 
x) Interpretability 
Are reference standards available? 
2.3 Results 
2.3.1 Search strategy 
I screened 1531 titles and abstracts retrieved by the Medline search, and read 38 of 
them in full. Of these, 20 fulfilled the inclusion criteria. The EMBASE search 
retrieved a total of 1420 titles and abstracts. However, the majority of the relevant 
articles had already been identified by the Medline search. I read a further seven 
articles in full and included two of them in the review. Two further studies were 
identified from expert comment and reading reference lists of published articles. In 
total, I identified 24 articles that fulfilled the inclusion criteria for the systematic review. 
Hand-searching five volumes of the journal Stroke (years 1993 to the end of 1997) 
identified 14 articles which satisfied the inclusion criteria for the current review, Table 
2.2. The final Medline search identified all but one of these articles (Table 2.2). 
Therefore, this electronic search strategy had an excellent sensitivity for identifying 
relevant articles in the indexed journals (sensitivity = 93%). The EMBASE search 
had equivalent sensitivity, Table 2.2. The other handsearching did not identify any 
additional relevant articles. 
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2.3.2 Measurement attributes of quality of life measures after 
stroke 
I identified 24 articles which fulfilled the inclusion criteria. These referred to the 
results from 20 independent studies and involved at least 2330 patients, Table 2.3. 
Three studies which used the Sickness Impact Profile generated multiple publications 
(Nydevik et al, 1991 and 1993; Schuling et al, 1993(a) and 1993(b); De Haan et al, 
1993 and 1995 and Sneeuw et al 1997). The most commonly used instruments were 
the Sickness Impact Profile, the Nottingham Health Profile and SF-36. They 
accounted for 18 of the 24 articles. Two studies did not examine multiple dimensions 
of health and exclusively assessed overall health related quality of life (AhIsio et al, 
1984; Kwa et al, 1996). 
The instruments and the conceptual basis for measurement was well described in the 
studies which used the visual analogue scales, Sickness Impact Profile, Nottingham 
Health Profile, and SF-36. The questionnaires created by Niemi, Viitanen and Astrom 
were poorly described and explained, Table 2.3. A substantial minority of the articles 
(11 of the 24) provided inadequate descriptions of the baseline characteristics of their 
sample, Table 2.3. 
The primary aim for the majority of the studies was to assess quality of life after 
stroke and determine which factors influenced it. Only six articles primarily assessed 
the measurement properties of health related quality of life instruments in stroke 
survivors. This subgroup of studies included only 682 patients. Of these studies, one 
aimed to assess validity, two aimed to examine the validity of assessments by 
proxies, one examined both feasibility and test-retest reliability, one solely examined 
test-retest reliability, and one study assessed sensitivity to change. 
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However, many of the remaining studies produced useful indirect information on the 
measurement of health related quality of life after stroke, Table 2.5. 
2.3.2.1 Feasibility and practicality of health related quality of life 
assessments after stroke 
In nearly all the studies, some patients were unable to have their health related quality 
of life assessed. In general, the more severely affected stroke patients could not be 
assessed because of communication, cognitive or other problems which limited their 
ability to participate in interviews or to complete complex questionnaires. Overall, 
about one-quarter of all surviving patients were unable to complete health related 
quality of life assessments, Table 2.4. 
Only one study sought formally to measure the feasibility of health related quality of 
life assessments Esser et al. 1995). The study included only 16 patients, and all 
had made an excellent recovery, so the sample was not representative. Only three 
studies assessed the time required to complete the relevant questionnaires, Table 
2.4. Anderson attempted to use the Nottingham Health Profile in The Greenwich 
Stroke Study: 
"in the pilot study it became clear that the number of statements and their random 
ordering posed problems for patients. Ultimately only the statements relating to 
emotional distress and social isolation were presented to patients. " (Anderson R., 
1992). 
The setting of the study, method of questionnaire administration and frequency of 
missing data was poorly reported, Table 2.4. 
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2.3.2.2 Validity 
Anderson and colleagues in Perth were the only investigators to primarily examine the 
validity of health related quality of life assessments. They administered the SF-36 by 
interview to 90 patients one year after the index stroke. They found evidence for 
construct validity. The mean scores for patients dependent in self care and with 
mental ill-health were significantly different from patients without these problems 
(Anderson et al. 1996). However, they found less evidence for concurrent validity; 
scores on the social functioning domain of the SF-36 were only poorly correlated with 
those measured with the Adelaide Activities Profile (Anderson et al. 1996). Ahisio 
and coworkers examined the validity of quality of life assessments with a simple 
visual analogue scale (Ahlsio et al. 1984). They used interviews to establish the 
concurrent validity of this method as well as demonstrating construct validity in other 
ways. 
Many of the other articles provided indirect evidence for the validity of assessments 
with the Sickness Impact Profile, Nottingham Health Profile and SF-36, Table 2.5. 
For instance, de Haan and colleagues examined the relationship between patients' 
responses to the Sickness Impact Profile and measures of disability and impairment. 
They found evidence for discriminant validity: the correlation with scales of 
impairment decreased from the Barthel (mean r2=47.5%) to the Rankin (mean 
r2=36.5%) to the Sickness Impact Profile (mean r2=33%) (de Haan et aL 1993b). 
Segal and Schall assessed the validity of carers' assessments of the patients' 
functioning with the SF-36 (Segal & Schall, 1994). They found that agreement 
between the proxy and direct patient assessment was only "poor to moderate" for all 
the domains except physical functioning. However, they did not investigate whether 
there was a systematic bias between the response from the proxy and the patient. 
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Sneeuw and colleagues also assessed the validity of proxy assessments of the 
patients' functioning with the Sickness Impact Profile (Sneeuw et al, 1997). They 
found better agreement for most of the domains of the Sickness Impact Profile, but 
they also found some evidence that proxies systematically rated patients as having 
more problems than patients did themselves. 
2.3.2.3 Reliability 
Two studies examined the test-retest reliability of health related quality of life 
assessments after stroke: Visser and colleagues examined the test-retest reliability 
of the NHP and SIP in patients with myocardial infarction or stroke (Visser et al. 
1995). Unfortunately, they reported the reliability of the assessments for both groups 
of patients combined. The value of their study is also limited because they used an 
inappropriate statistical measure (association rather than agreement) to examine 
reliability (McDowell and Newell, 1996). Gompertz and his colleagues examined the 
test-retest reliability of the Nottingham Health Profile in a small group of 21 patients 
(Gompertz et al. 1993). They selected these individuals from patients who responded 
to the original questionnaire without prompting. They found the reproducibility of the 
Nottingham Health Profile was inadequate for monitoring individual patients. 
2.3.2.4 Sensitivity to change 
Schuling and colleagues attempted to investigate the sensitivity to change of the 
Sickness Impact Profile in patients' with stroke. They found little difference in patient 
scores between 8 and 26 weeks and concluded that the instrument had inadequate 
sensitivity to change. However, this conclusion may not be justified because they 
made no efforts to identify patients who had actually changed and overall there was 
no significant difference in the patients' level of disability. 
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2.3.3 Pattern of health related quality of life in cohorts of 
stroke patients 
Many of the articles examined the impact of stroke on patients' quality of life. The 
results were surprisingly consistent: irrespective of the measure used, the majority of 
the large studies with controls found that patients reported problems in all of the 
domains, as well as their overall quality of life, Table 2.5. Similarly, the predictors of 
poor overall quality of life were remarkably consistent: poor physical functioning and 
low mood appeared to be independent predictors of poor overall quality of life 
whenever it was assessed. The Greenwich Stroke Study provided insights into the 
consequences of stroke for both the patients and also their supporters by the use of a 
combination of qualitative and quantitative assessments (Anderson R., 1992). 
2.4 Discussion 
This study identified a small number of published studies that had formally 
investigated the measurement of health related quality of life after stroke. Most of the 
available studies were published in the last five years (1992-1997), and used 
established generic measures of health related quality of life, particularly the Sickness 
Impact Profile, Nottingham Health Profile and SF-36. By contrast, several of the 
earlier studies created instruments specifically for use in their studies; unfortunately 
these were generally poorly described and perhaps for this reason had not used 
subsequently. 
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2.4.1 Choice of instrument for proposed randomised 
controlled trial 
The Sickness Impact Profile measures health status by assessing the way sickness 
changes daily activities and behaviour (Gilson at al, 1975). The instrument is relatively 
long and consists of 136 statements in 12 categories. I found indirect evidence for its 
concurrent, construct and discriminant validity after stroke. Its concentration on 
behaviour has several advantages over recording feelings in survivors of stroke. 
Behaviours are observable and so more accessible to external validation (McDowell & 
Newell, 1996). Sneeuw and colleagues support this since they found moderate 
agreement between proxy and patient assessments of patients' functioning (Sneeuw 
at al, 1997). They also examined the internal consistency of each of the subscales. 
This was relatively poor and ranged from 0.36 to 0.85 ("Eating" to "Bodycare and 
Movement" respectively). As yet, there have been no good studies on its test-retest 
reliability. Visser and colleagues examined its feasibility. However, they selected a 
small group of non-disabled stroke survivors who were all able to self complete the 
questionnaire with a mean time of 24 minutes (Visser et al, 1995). This contrasts with 
the other studies, in which it was administered by interview and a substantial 
proportion of patients were unable to provide appropriate responses. Its length and 
these concerns regarding its feasibility make it unlikely to be suitable for use in large 
scale epidemiological studies. 
The Nottingham Health Profile was designed to give a brief indication of perceived 
physical, social and emotional health problems (Hunt et al, 1981). It differs from the 
Sickness Impact Profile in that it asks directly about feelings and emotional states. 
The Nottingham Health Profile has two parts: Part I contains 38 items grouped into 
six domains, whereas Part 2 provides a brief indicator of handicap, and contains 
seven items that record the effect of health problems on occupation, jobs around the 
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house, personal relationships, social life, sex life, hobbies and holidays. Most of the 
studies simply used Part 1 (Part 2 was used by Visser and colleagues and Harwood 
and his colleagues Esser et al, 1995; Harwood et al, 1994)). Ebrahim and 
colleagues provided indirect evidence for its construct and concurrent validity when 
used after stroke (Ebrahim et al, 1986). They also found that the reproducibility of 
the NHP, although moderate, was inadequate to support its use in individual patients 
(Gompertz et al, 1993). The Nottingham Health Profile may also be too complex for 
use in a large epidemiological study - it was found to be excessively complex in the 
pilot study of the Greenwich Stroke Study (Anderson, 1992). The Nottingham Health 
Profile has been copyrighted and should only be used with the written permission 
(and possibly the payment of royalties to) of its authors. 
The SF-36 was designed as a generic indicator of health status (Ware & Donald- 
Sherboume, 1992). The items were drawn from a larger 245 item Medical Outcomes 
Study questionnaire. It assesses outcome in 8 domains and has become one of the 
most widely used health questionnaires. The New England Health Institute estimated 
that by 1992 a million forms were being administered each year. Although it appears 
to have reasonable validity when administered by interview after stroke, its validity 
when completed by proxies appears questionable (Segal & Schall, 1994). 
Furthermore, its feasibility, reliability and sensitivity to change remain unclear. 
The choice of health related quality of life questionnaire for the future proposed study 
remains unclear. No single instrument has been adequately evaluated in patients 
with stroke; and so, none of the instruments currently identified, can be 
recommended for use after stroke on what is known about their measurement 
attributes in this particular patient group. I did not identify any studies that attempted 
to compare directly the measurement attributes of the available instruments. The 
56 
Chapter Two 
instruments could also be distinguished on their conceptual basis and content; but, as 
yet, this has not been done. 
2.4.2 Implications for future research 
Measurement of health related quality of life after stroke is likely to be unreliable if the 
instrument places too great a burden on the patient. If a health related quality of life 
instrument is easy to administer (or self-complete), it is likely to be more widely 
adopted in stroke research studies. In the majority of the studies reviewed the 
questionnaires were administered by interview, but even with this help patients could 
often not complete the assessment. Simpler instruments are more likely to be 
completed - so improving the power of the study, reducing the risk of bias and also 
reducing the resources required to conduct the study. The benefits and 
disadvantages of simpler instruments should be examined in future studies. Future 
studies should also compare directly the feasibility and other measurement properties 
of the available instruments. 
2.4.3 Limitations of review 
My resources were limited, so I aimed to be systematic but focussed. My searching 
was limited in several respects. I only searched Medline and EMBASE, rather than 
any of the other electronic databases. I also excluded non-English language studies 
and those published in abstract form only, since I did not have access to translation 
facilities and because abstracts do not contain enough information to allow a reliable 
assessment of the study quality. I did not attempt to identify unpublished studies 
because searching for this type of material is very time-consuming and - unlike 
searches for unpublished randomised controlled trials - the results would be of 
uncertain value. I also did not attempt a comprehensive survey of experts in this 
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area, though I did have extensive discussions with Dr Paul Kind, University of York. It 
is also possible that biases in interpretation of the inclusion criteria and extraction of 
the data have affected my results and that I have missed some relevant studies, but 
my search strategy was more comprehensive than that used in previous reviews of 
this area. Furthermore, I was able to demonstrate the high sensitivity of my Medline 
search strategy by comparing its results with those obtained by manually searching 
the journal Stroke. Therefore, despite the above limitations, I feel the results of this 
review are valid. 
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2.5 Summary of Chapter Two 
1. A systematic search of the literature identified 24 eligible studies, but the majority 
were small, used complex instruments and had methodological weaknesses. 
2. Several different generic instruments (Nottingham Health Profile, Sickness Impact 
Profile and the SF-36) were used to assess health related quality of life after 
stroke. However, their validity and other measurement properties were not 
adequately evaluated. There were no studies directly comparing one instrument 
with another in a group of stroke patients. 
3. A significant number of patients were unable to complete or participate in 
assessments of their health related quality of life. This may reflect the complex 
nature of the instruments used so far. The feasibility and accuracy of health 
related quality of life assessments by a surrogate for the patient has not been fully 
explored. 
4. Short and simple instruments may reduce the burden on respondents and thereby 
yield better response frequencies. Future research should directly compare the 
feasibility, validity and reliability of current health related quality of life instruments 
with a shorter and less complex instrument. 
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Table 2.1 Medline/Embase search to identify studies on the 
measurement of health related quality of life after stroke (modified from 
Counsell, 1998) 
Indexinn Terms Notes 
1 cerebrovascular disorders/ 
2 cerebral artery diseases/ 
3 cerebral embolism. ti, ab, sh. and thrombosis/ 
4 carotid artery thrombosis/ 
5 wallenberg's syndrome/ 
6 cerebral hemorrhage/ 
7 cerebral infarction/ 
8 cerebral ischemia/ 
9 stroke$. tw. 
10 cerebrovascular$. tw. 
11 (cerebral or cerebellar or brainstem or vertebrobasilar). tw. 
12 (infarct$ or ischaemi$ or thrombo$ or emboli$). tw. 
13 11 and 12 
14 (cerebral or intracerebral or intracranial or parenchymal 
or brain or intraventricular or brainstem or cerebellar or 
infratentorial or supratentorial). tw. 
15 (haemorrhage or hemorrhage or haematoma or hematoma). tw. 
16 14 and 15 
17 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 13 or 16 The final search for articles 
related to stroke 
18 health status/ 
19 health status. tw. 
20 health status. tw. 
21 quality of life/ 
22 quality of life. tw. 
23 outcome. ti, ab, sh. and "Process Assessment (Health Care)"/ 
24 disability evaluation/ 
25 stroke assessment/ 
26 questionnaires/ 
27 depressive disorder/ 
28 "Outcome Assessment (Health Care)"/ 
29 18 or 19 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 A broad search for any article 
to do with QoL or outcome 
30 17 and 29 
31 limit 30 to human 
32 limit 31 to journal article 
33 limit 32 to english language 
Y indicates Medline index term 
°. tw. " is a search for title or abstract words. "$" is a truncation term. 
The "or" operator means an article only has to include one of the terms identified. 
The "and" operator means an article must be found in both sets. 
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Table 2.2 Articles identified by handsearching Stroke 1993-1997 
Year Month Title First 
author 
Retrieved 
by Medline 
Retrieved 
by 
EMBASE 
1993 Aug The Frenchay Activities Index... Schuling N Y 
1993 Aug A comparison of 5 stroke scales with .. De Haan y y 
1994 July Prognosis of young adults with ischemic stroke Kappelle y y 
1994 Dec Determining functional/health status... Segal y Y 
1995 March Impact of stroke type and lesion location on QoL.. De Haan y y 
1995 Nov Clinical meaning of Rankin handicap grades... De Haan Y N 
1996 Sep QoL after stroke... King y y 
1996 Oct Validation of SF-36... Anderson y y 
1997 March Health status of individuals with mild stroke.. Duncan y y 
1997 Aug Assessing QoL after stroke: proxy Sneeuw y y 
1997 Oct Use of heath utilities index with stroke... Mathias Y Y 
1997 Oct Is the EuroQol a valid... Dorman y y 
1997 Oct Proxy EuroQol Dorman y y 
1997 Nov A stroke adapted version of the SIP.. Van y y 
Straten 
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Chapter Three 
3 Is the EuroQol a valid measure of health 
related quality of life after stroke? 
3.1 Introduction 
There are several valid instruments for the measurement of single aspects of 
psychological, social or physical outcome after stroke (Johnson et al. 1995; Wade et 
a/. 1985; Lindley et al. 1994; Wellwood et al. 1995). However, the use of a series of 
such assessments may subject patients to an unacceptable burden and so reduce 
the overall frequency and completeness of response. 
The EuroQol is a generic instrument for the measurement of health related quality of 
life (The EuroQol Group, 1990), (see Appendix 2). It measures aspects of quality of 
life that are highly relevant to stroke patients. It is short and simple enough that many 
stroke patients (despite cognitive, motor and sensory deficits) may be able to 
complete the form without help. It provides a simple descriptive profile of health in 
five dimensions (mobility, self care, social, pain and psychological), each with three 
levels. The patient's health state can therefore be classified into one of 243 (35) 
theoretically possible health states, each of which has been assigned a utility (i. e. 
value to the patient) (Dolan et al. 1995). These utilities were assigned by a group of 
stroke-free individuals and so probably require further validation, but they might allow 
the EuroQol instrument to be used for the economic evaluation of health care 
interventions and also the relative cost-utility of treatments for stroke compared with 
interventions for other diseases (e. g. cardiac transplantation). The EuroQol also 
includes a visual analogue scale on which patients rate their own health between 0 
and 100, so providing an overall numeric estimate of their health related quality of life. 
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Although the EuroQol is a valid assessment of health related quality of life in the 
general population (The EuroQol Group, 1990; Brazier et al. 1993; Brooks & with the 
EuroQol group, 1996), its validity has not been adequately assessed after stroke. I 
therefore assessed certain aspects of its validity by comparing it with a variety of 
widely used and previously validated instruments in a group of prospectively studied 
stroke patients. 
3.2 Methods 
3.2.1 Validity 
Validity is the degree to which an instrument measures what it is intended to 
measure, (Chapter One). There are at least four aspects to validity (Hobart et al. 
1996). Face validity involves a subjective assessment of whether or not the 
instrument measures what it is intended to measure. Content validity is a subjective 
assessment of how well the domain of interest is sampled. I did not examine these 
aspects of validity quantitatively in the current study. Neither did I assess criterion 
validity, which involves comparison of the results of the instrument under study 
against those of a gold-standard, because there is no gold standard for the 
measurement of health related quality of life. I therefore focused on the concurrent 
(convergent) validity and compared outcome in each domain of the EuroQol with an 
assessment of function in the same domain using a standard instrument (see below). 
I examined the discriminant validity of the EuroQol in two ways: by assessing the 
relationships between the individual domains of the EuroQol and also by examining 
whether it could distinguish groups of patients with different types and severities of 
stroke (and therefore likely to have different health related quality of life outcomes). 
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3.2.2 Patients 
All patients with acute stroke (first or recurrent) who attend our hospital, as either 
inpatients or outpatients, were prospectively identified and assessed by experienced 
stroke physicians as part of a prospective stroke register. These assessments 
included examination of the patients' clinical status as well as an estimate of the 
patients' pre-stroke level of functioning using the Oxford Handicap Scale (Bamford et 
al. 1989). Details of eligible patients were included in the stroke register, (Appendix 1 
for registration form). I selected patients from the register who had survived at least 3 
months after their stroke and who lived within an approximate 10 mile radius of the 
hospital (determined by scrutiny of their post codes). The NHS central registry Office 
of Population Censuses and Surveys notified me of the death of any patients enrolled 
in the register. I excluded 12 patients whose vital status could not be confirmed by 
the office of Population Censuses and Surveys on the day the sampling frame was 
assembled. For the current study, I aimed to examine the validity of the EuroQol in 
consecutive surviving patients from two distinct time periods. As a pilot study, I 
examined the validity of the EuroQol in a group of patients who might be considered 
longer term survivors. Of 98 consecutive patients registered between 1 October 1990 
and 18 May 1991,36 were still alive at the start of the present study. Twenty eight of 
this group (78% of survivors) were contactable and willing to participate. Three 
hundred and forty five patients were assessed and registered at our hospital between 
31 May 1993 and the 20 April 1995. Of these, 193 were alive at the start of the 
current study. One hundred and twenty four of these patients (64% of surviving 
patients) were contactable and willing to be interviewed. Both groups of patients will 
be considered together for the purpose of this study. 
72 
Chapter Three 
3.2.3 Assessments 
All patients were visited by a research nurse (FW) in their place of residence. The 
nurse administered the modified simple questions (SQ) (see Chapter Eight), EuroQol, 
Frenchay Activities Index (FAI) (Wade et al. 1985), Hospital Anxiety and Depression 
Scale (HADS) (Zigmond & Snaith, 1983) and VAS pain scale as questionnaires for 
self-completion when possible. When patients could not complete these 
questionnaires by themselves, they were administered by interview. The modified SQ 
and EuroQol were always administered first, to limit interaction with the subsequent 
questionnaires. The nurse assessed the Barthel Index (BI) and the Office of 
Population Censuses and Surveys (OPCS) disability scores by direct questioning at 
the end of the interview (Mahoney & Barthel, 1965; Wellwood et al. 1995). The 
OPCS disability instrument includes a communication subscale which I used to 
identify patients who had significant problems with communication. 
3.2.4 Analysis 
I initially assessed the concurrent validity by calculating the median score and 
interquartile range for the appropriate unidimensional instrument for each level in the 
corresponding domain of the EuroQol. I used the Kruskal Wallis one way analysis of 
variance to assess the significance of the differences between these distributions. I 
also assessed the convergence between each domain of the EuroQol and the 
relevant standard instrument with the Spearman rank method. For the assessment of 
discriminant validity I determined the outcomes of the EuroQol for patients with 
different stroke syndromes (defined at baseline by clinical examination) (Bamford et 
al. 1991). I tested the discriminant validity further by examining responses to the 
EuroQol for patients with differing stroke severities. I based my assessment of stroke 
severity on their predicted prognosis at baseline. This predicted prognosis was 
calculated using a validated prognostic model designed to predict each patients' 
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probability of being alive and independent at six months (Counsell et al. 1996). The 
variables in this model were: age, pre-existing disability, marital status, verbal 
component of the Glasgow coma score, the ability to lift both arms against gravity and 
the ability to walk without help from another person (Counsell et al. 1996). I also 
estimated the correlation between the domains of the EuroQol using the Spearman 
rank method with a two-tailed test of significance to determine the degree by which 
the different domains of the EuroQol discriminate between the different constructs of 
health related quality of life. 
I determined the independent explanatory factors of overall health related quality of 
life (based on the visual analogue scale) by multiple linear regression, using a method 
of forward selection of variables. I examined whether the assumptions of linearity and 
homogeneity of variance held for the data by plotting the distributions of the residuals. 
All analyses were performed using "Access 2.0" (Microsoft Corporation) and the 
statistical software package "SPSS for Windows" (Release 6.1). 
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3.3 Results 
152 patients participated in the study. Of these, 92 patients (61 %) were able to 
complete the questionnaires without help; the remaining 60 (39%) could only be 
assessed by interview. Using the OPCS communication subscale (a score of over 
five implies "very difficult for strangers to understand or worse") the interviewer rated 
six of the interviewed patients as having significant difficulties in communication. I 
excluded the data on these six patients from the analyses. 
The patients were assessed at a median interval of 72 weeks after the onset of the 
index stroke (interquartile range: 43 to 104 weeks). Thirty-six percent of patients had 
not been admitted to hospital for treatment during the acute phase of their stroke. 
Patients are normally only admitted to our hospital during the acute phase if in-patient 
nursing or rehabilitation is required. The characteristics of the patients recorded at 
the time of registration following their index stroke are shown in Table 3.1 and their 
functional status at the time of assessment is shown in Table 3.2. About one third of 
patients reported dependency in activities of daily living, one third were independent 
but had persisting problems and the remaining third were independent and with no 
stroke related problems. Patients who could not complete the EuroQol questionnaire 
themselves had significantly worse functional ability than those who could complete it 
(p <0.0001). 
The median score (and interquartile range) with the standard instruments are shown 
for groups defined by their responses to the mobility, self care, social, pain and 
psychological functioning domains of the EuroQol (Table 3.3). The median scores 
with the standard instruments were ordered appropriately (increasing dysfunction 
reported with the EuroQol was associated with lower scores on the standard 
instruments) and differed significantly from each other (p50.0002 in all domains). 
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I also examined convergence between each domain of the EuroQol and the standard 
instrument with the Spearman rank method (Table 3.4). Bivariate correlations were 
moderately good for all domains except psychological functioning with the EuroQol 
and the depression subscale of the HADS. However, the patient estimates of overall 
health related quality of life correlated most closely with this subscale of the HADS 
(Table 3.4). 
The pattern of outcomes reported by the questionnaire component of the EuroQol for 
each of the major stroke syndromes (defined by clinical examination at baseline) are 
shown in Figure 3.1. For all domains, the worst outcomes were observed in patients 
with the most extensive cortical strokes (total anterior circulation strokes, TACS). The 
best outcomes were observed in patients with posterior circulation strokes (POCS). A 
similar pattern was observed for the numeric estimates of overall health related 
quality of life. I also assessed discriminant validity in patients ordered by baseline 
stroke severity (lower tertile, the predicted probability of good outcome was 0.006 to 
0.339; middle tertile, the predicted probability of good outcome was 0.339 to 0.530; 
upper tertile, the predicted probability of good outcome was 0.530 to 0.908). With the 
exception of the psychological functioning domain, better predicted prognosis was 
associated with better reported health status at follow up, Figure 3.2. Patients with 
the highest predicted probability of good outcome at baseline had significantly higher 
reported overall health related quality of life (mean score 73/100 for patients in top 
tertile versus 62/100 for patients in the middle tertile and 62/100 for patients in the 
lower tertile, p<0.05). 
The bivariate correlations between each of the individual domains of the EuroQol 
instrument are shown in Table 3.5. Mobility correlated best with social functioning 
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(Spearman rank correlation coefficient 0.56) and least well with the psychological 
outcome (Spearman rank correlation coefficient 0.28). 
The significant independent explanatory factors of the patient estimates of overall 
health related quality of life are shown in Table 3.6. An examination of the residuals 
confirmed that the assumptions of linearity and homogeneity had been met. 
3.4 Discussion 
I have investigated some aspects of the validity of the EuroQol in stroke patients by 
comparing responses to the EuroQol with those to validated instruments for the 
assessment of mobility, self care, social functioning, pain and psychological 
functioning. Concurrent validity was good; patients who reported problems on the 
EuroQol also reported dysfunction with the relevant standard instrument for that 
domain. The EuroQol was valid both in patients who could complete questionnaires 
themselves and among more severely affected patients who could only be assessed 
by interview. 
3.4.1 Construct validity: does health related quality of life 
differ according to stroke type and severity? 
The discriminant validity of the EuroQol was demonstrated by outcome profiles which 
distinguished between the major stroke syndromes classified by the Oxford 
Community Stroke Project method (Bamford et aL 1991). This classification has 
several properties: it describes groups of patients with a characteristic natural history 
and prognosis (Bamford et al. 1991; Anderson at al. 1994), it has been shown to be 
moderately reproducible for patients seen in the acute phase of stroke (Lindley et a!. 
1993), and it classifies patients according to the underlying mechanism and pathology 
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(Lindgren et al. 1994; Wardlaw et al. 1996). de Haan and coworkers have reported 
that lesion location and stroke severity influence health related quality of life 
measured six months after stroke with the Sickness Impact Profile (de Haan et al. 
1995); in particular, patients with infratentorial strokes had better health status 
outcomes than patients with supratentorial strokes. Like de Haan et al, I found that 
health related quality of life was worst in all domains for patients with total anterior 
circulation strokes and best in patients with posterior circulation strokes. Outcomes 
were similar in patients with partial anterior circulation strokes and with lacunar 
strokes, which is consistent with the epidemiological data which suggested that partial 
anterior circulation strokes and lacunar strokes have a very similar prognosis 
(Bamford et al. 1991). The different stroke syndromes studied were defined by the 
extent rather than the severity (i. e. prognosis) of the neurological deficit, so I also 
looked to see if health status was different for patients with differing degrees of stroke 
severity. Patients with less severe strokes (i. e. good predicted prognosis) had better 
outcomes as assessed by the EuroQol. The convergent relationships between the 
mobility, self care and social functioning domains of the EuroQol further supported its 
construct validity, as functioning in all these domains was closely related to the 
patients' physical functioning. I found good discriminant validity since mobility, self 
care and social functioning correlated much better with each other than with the 
domains assessing pain and psychological functioning. 
3.4.2 Validity of overall estimates of health related quality of 
life 
it is difficult to assess the validity of the numeric estimates of overall health related 
quality of life as this domain is difficult to define and is highly subjective. I could not 
assess its concurrent convergent validity as I could not identify other validated 
instruments which claimed to measure a similar outcome. However, the visual 
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analogue scale for estimating overall health related quality of life does at least appear 
to have discriminant validity since I found differences in the mean estimates of overall 
health related quality of life across the different stroke syndromes and severities. 
These follow a similar trend to the health outcome profiles; the lowest reported mean 
health related quality of life was observed in patients suffering TACS and highest 
mean estimate of health related quality of life was reported by patients who had 
suffered POCS. These observed trends were not statistically significant. Linear 
multiple regression modeling revealed that the statistically significant independent 
explanatory factors of good overall health related quality of life were the absence of 
depression on the HADS depression subscale, good social functioning on the 
Frenchay Activities Index and the absence of pain on the VAS pain scale. These 
three variables explained approximately 38% of the variability in the estimates of 
overall health related quality of life. The relationship between psychological, social 
functioning and pain and the estimates of overall health related quality of life in our 
study, provides strong support for the validity of the measurement of overall health 
related quality of life by the EuroQol, as psychological outcome has been reported to 
be as important as physical disablement in determining quality of life after stroke (see 
Chapter 2). Kwa and colleagues, using a similar visual analogue scale to investigate 
quality of life after stroke (Kwa et al. 1996), reported that dependency (measured with 
the Rankin score), infarct volume and aphasia were significant independent predictors 
of quality of life. However, only 22% of the total variation in the quality of life scores 
was explained by their model. In my model, physical functioning was not a significant 
independent explanatory factor of overall health related quality of life after stroke. 
This was probably not because physical functioning was unimportant to the patients, 
but merely a reflection of the close relationship between a patient's physical and 
social functioning (see Table 3.5). 
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3.4.3 Face and content validity 
The face and content validity of a measure refers to its clarity, clinical credibility and 
completeness (McDowell & Newell, 1996). Although, I selected the EuroQol for this 
study because of its simplicity, clarity and content, I did not assess these subjective 
parameters quantitatively. However, our qualitative experience provided some 
support for its face and content validity - we found few patients asked for clarification 
of the questions (personal communication, Fiona Waddell). Further, albeit indirect, 
support for its face and content validity is provided by my study of the feasibility of the 
EuroQol after stroke (see Chapter Five). Future studies should examine which 
dimensions of life are perceived to be important by stroke patients, their families, and 
their health care personnel. 
3.4.4 Appropriateness of study population 
Although many of the patients were studied more than one year after the stroke, the 
study cohort included a good mix of "dependent", "independent but not fully 
recovered" and "fully recovered" patients. Very few patients (<10%) were unable to 
complete the EuroQol, either by themselves or by interview. This study population 
was ideal, as the measurement of "quality of life" outcomes is only meaningful in 
patients who can either complete assessments without help or communicate their 
views to an interviewer; the validity of proxy completed EuroQol questionnaires is 
unclear and is examined in detail in Chapter Four. Furthermore, it may not be 
appropriate to test the validity of the EuroQol until at least one year after the index 
stroke as health related quality of life may not be stable before then (Astrom et al. 
1992). 
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3.4.5 Usefulness of the EuroQol in different study designs 
These data support the EuroQol as a useful measure of health status after stroke. Its 
simplicity is a definite advantage, as many stroke survivors find more complex 
instruments difficult to complete without help. Moreover, simple categorical data of 
the type generated by the EuroQol can convey a surprisingly large amount of 
information. Simple measures of this type are particularly well suited for use in large 
randomised controlled trials, audits and screening projects (Lindley et al. 1994; 
Mahoney et al. 1994 
The EuroQol appears to be a reasonably valid measure which can be administered as 
either a questionnaire for self completion in patients with mild to moderate stroke or 
by interview in patients with significant neurological problems. If further studies 
confirm its reliability and feasibility in survivors of acute stroke, it could be usefully 
applied in a variety of ways ranging from routine clinical screening of patients for 
psychosocial problems after stroke, to the measurement of outcome in large 
randomised controlled trials and audit studies. 
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3.5 Summary of Chapter Three 
1. The EuroQol is short and simple and many stroke patients can complete it without 
help. It measures several key aspects of health that are highly relevant to patients 
with stroke: mobility, self care, social functioning, pain, psychological functioning 
and overall health related quality of life. This gives it excellent face and content 
validity. 
2. The concurrent validity of the EuroQol questionnaire was good. Patients who 
reported problems with the EuroQol also reported problems with standard outcome 
instruments. 
3. The discriminant validity of the EuroQol was confirmed. The scores could 
distinguish between patients with different stroke syndromes and different stroke 
severities. Its construct validity was confirmed by the convergent relationships 
between the mobility, self care and social functioning domains. Divergent 
relationships between these three domains and the domains which assessed pain 
and psychological functioning provided further support for its construct validity. 
4. The numeric estimates of overall health related quality of life also appeared to be 
valid in that they were best explained by the patient's psychological functioning, 
social functioning and the level of pain. 
5. The EuroQol was valid amongst patients who could complete questionnaires 
themselves and also among more severely affected patients who could only be 
assessed by interview. 
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Table 3.1: Characteristics of 146 patients without severe 
communication difficulties at the time of inclusion in the stroke register 
n (%) 
Admitted for acute stroke 90 (62) 
Level of function before index stroke 
OHS s2a 133 (91) 
OHS 2: 3 b 13 (9) 
Living alone prior to stroke 37 (25) 
Employed prior to stroke 24 (16) 
Stroke syndrome 
Total anterior circulation stroke syndrome 11 (8) 
Partial anterior circulation stroke syndrome 59 (40) 
Lacunar stroke syndrome 40 (27) 
Posterior circulation stroke syndrome 25 (17) 
Uncertain 11 (8) 
Stroke severity at baseline 
Reduced conscious level 13 (9) 
Unable to walk without help 46 (32) 
ge A r%w 
<50 8 (5) 
50 to 70 67 (46) 
>70 71 (49) 
Oxford Handicap Score S2 implies that the patient was independent in activities of 
daily living 
b Oxford Handicap Score i3 implies that the patient was dependent in activities of 
daily living 
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TABLE 3.2: Functional ability of patients assessed by responses to the 
"simple questions" in patients unable to complete them without help 
(interview-completed) and in patients able to complete the 
questionnaires at the time of the interview (self-completed) 
Functional ability Interview- Self- All patients 
completed* completed* (n=146) 
(n=54) 
n (%) 
(n=92) 
n (%) 
n (%) 
Independent and no problems 2 (4) 39 (42) 41 (28) 
Independent, and persisting problems 19 (35) 30 (33) 49 (34) 
Dependent 31 (57) 20 (22) 51 (35) 
Unknown 2 (4) 3 (3) 5 (3) 
* Patients who required interview had significantly worse functional ability (chi 
squared = 30.6, df = 2, p< 0.0001) 
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TABLE 3.3: The concurrent validity of the EuroQol in survivors of acute 
stroke 
Domain of the EuroQol Number Median score on Interquartile Chi-square 
with this unidimensional range (2p)* 
response instrument 
"Mobility" OPCS locomotion subscale 
No problems 52 0 (0 - 0) 
Some problems 89 3 (0 - 7) 54.5 
Confined to bed 4 11.5 (11.5 -11.5) (<0.0001) 
"Self Care" 
No problems 
Some problems 
Unable 
"Social" 
No problems 
Some problems 
Unable 
"Pain" 
No pain 
Moderate pain 
Extreme pain 
"Mood" 
Not anxious or depressed 
Moderately anxious or depressed 
Extremely anxious or depressed 
"Mood" 
Not anxious or depressed 
Moderately anxious or depressed 
Extremely anxious or depressed 
Barthel Index 
93 20 (20 - 20) 
37 18 (17 - 20) 65.0 
13 9 (6 - 12) (<0.0001) 
Frenchay Activities Index 
61 31 (25 - 36) 
60 18 (10 - 26) 52.1 
23 7 (3-5-12.5) (<0.0001) 
Visual analogue pain scale 
68 0 (0 - 0) 
61 20 (0 - 45) 71.0 
11 60 (50 - 70) (<0.0001) 
HADS Anxiety Score 
78 3 (1 - 5) 
49 8 (6 - 11) 41.3 
7 12 (8 - 13) (<0.0001) 
HADS Depression Score 
78 3 (2 - 6) 
49 7 (3 - 8) 16.9 
77 (4 - 9) (0.0002) 
*Kruskal Wallis 1-way ANOVA used to assess the significance of the differences 
between the distributions. 
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Table 3.5: Convergent-discriminant validity: correlations between each 
domain of the EuroQol health status instrument with the other five. 
Independent Self care Social Pain Mood Overall 
variable functioning HRQoL 
r (n) r (n) r (n) r (n) r (n) 
Mobility 0.46 (145) 0.56 (145) 0.43 (144) 0.28a (143) -0.43 (142) 
Self care 0.61 (145) 0.34 (141) 0.24b (143) -0.288 (142) 
Social 0.35 (144) 0.35 (144) -0.49 (142) 
Pain 0.31 (143) -0.40 (141) 
Mood -0.34 (140) 
r= Spearman rank correlation coefficient 
n= number included in analysis (number not constant because of missing data) 
a p=0.001 
b p=0.005 
For all other correlations shown, p<0.0001 
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Chapter Four 
4 Are proxy assessments of health status after 
stroke with the EuroQol questionnaire 
feasible, accurate and unbiased? 
4.1 Introduction 
It is often difficult to measure the health related quality of life of patients with stroke 
because physical and cognitive (e. g. dysphasia, confusion, attention, or visuo-spatial 
neglect) problems limit their ability to complete complex questionnaires or participate 
in interviews (Kwa et at 1996). Asking someone else, such as the carer, may be the 
only way to assess quality of life for a patient who is unable to complete the 
questionnaire themselves (this is often referred to as a proxy measure). Proxy 
measures of the SF-36 were disappointingly inaccurate (Segal & Schall, 1994). 
However, rating of a patients' functioning on the EuroQol by a proxy could prove to 
be more accurate, since much of the information sought is concrete and observable. 
I therefore examined whether a proxy could assess a stroke patient's health related 
quality of life with the EuroQol accurately and without bias. 
4.2 Methods 
4.2.1 Patients & Assessments 
I described, in Chapter 3, a study of the validity of the EuroQol questionnaire in a 
series of 152 patients from our prospective registry of inpatients and outpatients with 
first (or recurrent) stroke. I also used this series of patients to examine the feasibility 
and validity of proxy assessments of health related quality of life after stroke. 
Patients could select the person they considered to be the most appropriate proxy 
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for them; we asked all patients to choose someone who knew them well (e. g. close 
relative, friend or carer) and who could be available at the time of the interview. The 
study nurse asked these proxies to complete a EuroQol questionnaire (preferably in 
a separate room) on behalf of the patient. If a proxy was not available at the time of 
the interview, I contacted them by post. 
4.2.2 Analysis 
I calculated the level of agreement for the categorical data items of the EuroQol 
between the assessments by the patient and their proxy of the patients' health 
status. I did not use a correlation coefficient (e. g. Spearman rank) to assess 
agreement because it only measures association and would be constant under 
deviations of scale or bias (Brennan & Silman, 1992). I therefore used the kappa 
statistic, which measures the amount of agreement beyond that which could be 
expected by chance (Brennan & Silman, 1992; Altman, 1993). I calculated the 
variance of the kappa statistic using Altman's method (Altman, 1993). As the scale 
items had three levels of response I used all three levels for the estimation of kappa. 
I assessed agreement separately for patients who were able to complete the 
EuroQol questionnaire themselves and those who could not complete the EuroQol 
themselves and consequently had to be interviewed. Unfortunately, there are no 
absolute definitions for the interpretation of any given kappa statistic. I planned to 
base my interpretation of the kappa statistic on the following widely cited guidelines: 
<0.2 implies poor agreement, 0.21 to 0.40 implies fair agreement, 0.41 to 0.60 
implies moderate agreement, 0.61 to 0.80 implies good agreement, 0.81 to 1.00 
implies very good agreement (Landis & Koch, 1977; Altman, 1993; Brennan & 
Silman, 1992). 
92 
Chapter Four 
The analysis of the continuous data from the visual analogue scale on overall health 
related quality of life was more complex. Differences between the patient and their 
proxy in their estimates of the patients' overall health related quality of life might be 
due to observer error, systematic differences (i. e. bias), or random effects (i. e. the 
play of chance). To display the raw data, I planned to plot a simple scatterplot and 
calculate a linear correlation coefficient. However, this plot gives little information on 
systematic differences, so I also performed a Bland and Altman analysis which plots 
the difference between the two estimates against the mean of the two estimates 
(Bland & Altman, 1986). The EuroQol is bounded at 0 and 100, which limits the 
value of a Bland and Altman plot, so I also used a factorial analysis of variance 
(SPSS for Windows, Release 6.1) to calculate the intraclass correlation coefficient, 
an appropriate measure of agreement for continuous data (Morton & Dobson, 1989; 
McDowell and Newell, 1996). 
4.3 Results 
152 patients participated in the study. Of these, 92 (61%) were able to complete the 
questionnaires independently and the remaining 60 patients (39%) could only be 
assessed by interview, see Chapter 3. The interviewer rated six of these 60 patients 
as having significant difficulties in communication by the OPCS communication 
subscale (all scored >5 which implies they are very difficult for strangers to 
understand or worse). I excluded the data on these six patients from the analyses 
as it was almost exclusively derived from the carer, not the patient, and so was not 
informative for the current analyses (which required that the patient should be able to 
provide information directly and equally well by interview or self-completed 
questionnaire). A proxy was available and completed a form for 130 patients (86%): 
94 of 130 forms (72%) were completed at the time of the home visit and 36 were 
returned later by post (of these, 16 were completed within one day of the patient 
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assessment and all but one were completed within 7 days of the patient 
assessment). 
Agreement between the proxies' and the patients' estimate of health related quality 
of life is shown in Table 4.1. Agreement was better for patients who were able to 
self-complete the EuroQol than for patients who required the EuroQol to be 
administered by interview. For both groups, agreement was best for the self care 
domain and worst for the domain assessing psychological outcome. For the more 
severely affected patients (assuming that the reasons for being unable to self- 
complete are generally stroke related), agreement was only fair for the pain and 
social functioning domains and no better than chance alone for the psychological 
functioning domain (kappa=0.05,95% Cl: zero to 0.43). 
Plotting the differences between the patient and proxy estimate of overall health 
related quality of life against the mean score (Bland and Altman plot) showed an 
expected distribution for a score bounded at zero and 100 (Figure 4.1). For all 
patients combined, the mean of the differences between the patient and proxy 
estimates of overall health related quality of life was 2 (95% confidence interval for a 
pair of differences = -38 to 42, Table 4.2); this indicates that the proxy estimates of 
overall health related quality of life were not significantly different to the patients. A 
factorial analysis of variance also suggested that there was no statistically significant 
variance between patient and proxy numeric estimates of overall health status. For 
all patients combined, the intraclass correlation coefficient (a measure of the 
agreement between the patient and proxy estimates of overall health status) was 
moderate with an intradass correlation coefficient of 0.49 (p < 0.0001). Agreement 
for the estimates of overall health related quality of life was better for the subgroup of 
patients who were able to complete the EuroQol themselves. The intraclass 
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correlation coefficients for those able to complete was 0.53 compared with 0.32 for 
patients unable to complete by themselves. 
Using the categorical data, a higher proportion of patients reported "no problems" in 
each of the five domains than did their proxies (Table 4.3). In these categorical 
domains of the EuroQol, the proxy estimated the level of functioning to be the same 
as that reported by the patient for 466 of the potential 640 outcomes. For 100 
outcomes, the proxy estimated the functioning to be worse than that estimated by 
the patient. By contrast, there were only 74 outcomes for which the proxy estimate 
of the patients' functioning was better than that reported by the patient (test for 
symmetry, p<0.05). 
4.4 Discussion 
Many stroke survivors are unable to complete questionnaires measuring health 
status by themselves. The use of a proxy to assess a patient's health related quality 
of life should help increase the proportion of patients in trials and surveys of stroke 
therapy who have complete data. This should improve the quality and 
generalisability of the data. In the current study, I could obtain proxy assessments 
for 86% of the patients which suggested that proxy assessment of health related 
quality of life after stroke was generally feasible. My analyses suggested that the 
patient and their proxy agreed reasonably well in their assessment of some aspects 
of the patients' health related quality of life after stroke, particularly for mobility and 
self care. Agreement was less good for social functioning, pain and the overall 
estimate of health related quality of life and even worse for psychological functioning. 
The degree of agreement between proxy and patient varied and was better among 
less severely affected patients who completed the initial EuroQol themselves. 
However, proxy assessments would be of value if they could also be used in more 
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severely affected patients, who were unable to complete questionnaires themselves. 
The degree of agreement among patients who were more severely affected and had 
to have the EuroQol by interview may therefore provide a more realistic guide to the 
value of proxy assessments. 
4.4.1 Are proxy assessments less accurate among more 
severely affected patients? 
In this study, the agreement was apparently less among more severely affected 
patients. This loss of agreement could have been due to observer error by the proxy 
or a systematic difference due to the different mode of questionnaire administration. 
The latter notion is supported by a recent report which suggests that patients give a 
more optimistic picture of their health status when assessed by interview than by 
self-completed questionnaire (Weinberger et aL 1996). Furthermore, random errors 
may be important, as the sample size was quite small (especially for the subgroup 
analysis in Table 1) so the 95% confidence interval around each estimate of 
agreement is wide and does not exclude the possibility of substantially better 
agreement. There are a number of other possible sources for less than perfect 
agreement. When a patient and their proxy appear to disagree about the patients' 
health status after a stroke, the following factors may contribute to the disagreement: 
the domain under study, systematic differences in perceived health (i. e. bias), 
relationship of the proxy to the patient, random error and the choice of statistic to 
measure agreement. The poor agreement for social functioning, pain, psychological 
functioning and overall health related quality of life probably reflected the subjective 
nature of these domains. 
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4.4.2 Whose assessment is most valid? 
The proxy tended to report the patients' problems as more severe than did the 
patient. This suggests that proxy assessments of health related quality of life do 
indeed differ systematically from self-assessments. Were the patients more 
optimistic about their health status than their proxies, did the patients adjust to or fail 
to perceive their own deficits, or were the proxy responders being pessimistic? The 
patients' view is likely to be more valid, as health related quality of life instruments 
primarily aim to assess the patients' subjective perception of their own health. 
However, I cannot be certain, since there is no accepted "gold standard" for the 
measurement of HRQoL. 
4.4.3 Choice of proxy 
I allowed the patient to decide who could act as their proxy (rather than stipulate that 
they must choose a spouse or a close family member). It is possible that some of 
the proxies were selected simply because they were available and so might not have 
known the patient well enough to complete the assessment accurately. If allowing 
the patient to choose the proxy does introduce some extra measurement error, the 
error might not be reduced by insisting that a family member is used as the proxy: 
regrettably not all blood relations are sufficiently familiar to assess their relatives' 
health related quality of life reliably! Furthermore, many patients do not have any 
family members living nearby and so a relatively imprecise estimate by a close friend 
may well be better than a very imprecise estimate from a distant family member and 
is likely to be better than no estimate at all. 
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4.4.4 Are these results generalisable to more severely 
affected patients? 
In my study, patients had to be able to complete the EuroQol either by themselves or 
by interview. I could not have assessed whether the proxy responses were valid for 
the patients who were unable to complete the EuroQol. Although I observed worse 
agreement for the patients who required the EuroQol to be administered by 
interview, I cannot necessarily infer that the agreement would have been even worse 
for even more severely affected patients (who have greater difficulties with 
communication) because the observed differences in agreement may have been due 
to the method of questionnaire administration (Weinberger et at 1996). However, it 
seems likely that the use of proxies for patients who have difficulties with 
communication will have greater bias and measurement error because their 
relatives, friends and carers will almost certainly have less insight into their perceived 
HRQoL. 
4.4.5 Other factors influencing proxy agreement 
The distribution of the random error is likely to be strongly influenced by the 
reproducibility of the EuroQol. In other words, some domains may be more prone to 
measurement error than others. It is possible that the more subjective domains have 
the worst reproducibility. A number of methodological factors may have caused me 
to underestimate the true level of agreement between patients and their proxies. 
Firstly, as the EuroQol assesses the patients' health related quality of life on the day 
of completion, any delay in getting assessments from proxies who were not available 
at the time of the interview might have reduced the true level of agreement (as some 
of the patients could have changed). This effect is unlikely to be important as the 
majority of assessments (72%) were performed at the time of the home visit and 
nearly all of the remaining assessments were completed within 7 days of the home 
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visit. An unweighted kappa statistic may also underestimate the true level of 
agreement, because it ignores the ordering of the three levels of the EuroQol. 
Furthermore, the interval differences between each of the three levels of the EuroQol 
("no problems", "some problems" and "severe problems") are unlikely to be equal. 
The difference between "no problems" and "some problems" may be bigger than that 
between "some problems" and "severe problems". Weighting the kappa statistic to 
get round these problems is not necessarily the solution, since any weights will 
inevitably be arbitrary (Brennan & Silman, 1992; Svensson, 1993). Finally, the 
dependence of the kappa statistic on the prevalence of the underlying attribute being 
measured complicates its interpretation (Brennan & Silman, 1992). Alternatively, it is 
also possible that I have overestimated the true level of agreement because I cannot 
be sure that some of the questionnaires returned by post were not completed with 
some input from the patient. 
4.4.6 Use of proxies in randomised controlled trials 
In a randomised trial or survey which measures HRQoL, allowing a proxy to respond 
on behalf of the patient has potential disadvantages: it may increase random error 
and so reduce the statistical power of the study to detect the treatment effect, 
particularly for the domain of psychological functioning (Woods, 1995) and it may 
also introduce bias. In an observational study, such bias might make the overall 
outcome appear worse than if the patient had responded. In a randomised trial, if 
the treatment were effective, this might reduce the number of patients with poor 
outcome who can only be assessed by proxy in the treatment group (but not in the 
control group) and so exaggerate the treatment effect. This type of bias would, 
however, not be expected to affect the direction of the treatment effect or its 
statistical significance (personal communication, Jim Slattery). Furthermore, the 
above bias is not unique to the EuroQol as proxy assessments of more objective 
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outcomes, e. g. disability, are affected by a similar bias (Lindley et al. 1994). In 
general, such "second order" biases are unlikely to be important. However, the use 
of proxy responses is also likely to ensure a higher overall response rate which might 
reduce the risk of random error and bias. 
In summary, a proxy assessment appears feasible in a wide variety of patients. The 
proxy assessed the domains of mobility and self care accurately and without major 
bias, although there was a slight tendency for them to take a generally somewhat 
more pessimistic view of the patients' overall HRQoL. Therefore, for at least these 
domains, it seems reasonable to use proxy responses for the EuroQol in stroke 
patients who cannot complete questionnaires by themselves (especially if face-to- 
face interviews are not practicable). Proxy assessments of social functioning, pain, 
and overall health related quality of life were associated with more error and must be 
interpreted more cautiously. Proxy assessments of psychological functioning were 
the least reliable, particularly in patients who required the EuroQol to be 
administered by interview, in whom they were no more accurate than chance alone. 
These findings are consistent with other evaluations of ratings by proxies (Guyatt et 
al. 1993; Rothman et al. 1991). In general, allowing the use of proxy response 
where necessary may be preferable to forbidding them in randomised controlled 
trials and many types of observational studies. However, where the focus of an 
observational study is an aspect of health related quality of life other than physical 
functioning, the use of proxy responses may not be a good idea. 
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4.5 Summary of Chapter Four 
1. Proxy assessments of health related quality of life in a wide range of stroke 
survivors were found to be feasible. We were able to obtain proxy assessments 
easily in approximately 86% of our patients. 
2. The proxy assessed the domains of mobility and self care accurately. Proxy 
agreement was less good for social functioning, pain and the overall estimate of 
health related quality of life, and even worse for psychological functioning. 
Therefore, proxy respondents are capable of assessing disability, dependency 
and some impairments. They are unlikely to be able to assess quality of life. 
3. The degree of agreement between proxy and patient varied and was better 
among less severely affected patients who completed the initial EuroQol 
themselves. This may be because the relatives, friends and carers of more 
severely affected patients (who have greater problems with communication) may 
have less insight into the patients' perceived health related quality of life. 
Alternatively, it may have been due to the different mode of questionnaire 
administration (interview rather than self completion). 
4. The proxy tended to report the patients' problems as more severe than did the 
patient. The patients' view is likely to be more valid, as health related quality of 
life instruments primarily aim to assess the patients' unique perception of their 
own health. 
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Table 4.1: Agreement between categorical data items on EuroQol 
questionnaires completed by the patient and by a proxya for the same 
patient 
Health outcome domains nb agreement kappa 
(categorical data) (%) (95 % confidence interval) 
Agreement for patients who self completed initial Euro0ol 
Mobility 80 78 0.57 (0.39 - 0.74) 
Self care 78 83 0.62 (0.43 - 0.81) 
Social functioning 79 76 0.57 (0.41 - 0.74) 
Pain 78 74 0.54 (0.36 - 0.71) 
Depression and/or anxiety 76 67 0.38 (0.18 - 0.58) 
Agreement for patients who completed initial EuroQol by interview 
Mobility 50 84 0.48 (0.16 - 0.81) 
Self care 50 76 0.62 (0.44 - 0.81) 
Social functioning 48 67 0.37 (0.12 - 0.62) 
Pain 50 60 0.30 (0.06 - 0.54) 
Depression and/or anxiety 50 54 0.05 (0.00 - 0.43) 
Agreement for all patients combined 
Mobility 130 80 0.60 (0.46 - 0.74) 
Self care 128 80 0.64 (0.51 - 0.77) 
Social functioning 127 72 0.56 (0.44 - 0.69) 
Pain 128 69 0.45 (0.30 - 0.59) 
Depression and/or anxiety 126 62 0.30 (0.14 - 0.45) 
this could be a carer, relative or close friend 
b number with available data 
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Table 4.2: Agreement between patient and proxy assessments of overall 
health related quality of life 
n* Mean overall HRQoL (SD) Mean of paired Intraclass 
differences (SD) correlation 
Patients Proxies coefficient 
Self-completed 76 69.8 (18.0) 65.4 (19.0) 4.4 (17.2) 0.53 
Interview 46 55.0 (22.3) 56.2 (16.8) -1.2 (23.8) 0.32 
All 122 64.2 (20.9) 62.0 (18.7) 2.2 (20.0) 0.49 
* number of patients for whom there was an assessment of overall health related 
quality of life for both patient and proxy 
t analysis based only on patients (or proxies) for whom there was a corresponding 
proxy (or patient) assessment of health related quality of life. None of the 
differences were statistically significant. 
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Table 4.3: Proportion of patients with "no problems" in each of the five 
domains as assessed by the patients themselves and by their proxy 
Health outcome domains Number of patients who Number of patients for whom 
reported: the proxy assessed: 
"no problems" 
n (%) 
"no problems" 
n (%) 
Mobility (N=130) 44 (34) 43 (33) 
Self care (N=128) 80 (63) 73 (57) 
Social functioning (N=127) 51 (40) 45 (35) 
Pain (N=128) 60 (47) 51 (40) 
Depression \ anxiety (N=126) 70 (56) 59 (47) 
N= number of patients for whom there was an assessment in the domain of patients 
health related quality of life by both the patient and their proxy 
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Figure 4.1: Difference between patient and carer estimate of overall 
health related quality of life plotted against mean overall health related 
quality of life (Bland and Altman plot). 
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A negative difference implies that the patient scored their overall health related 
quality of life as less than that estimated by the carer. Mean of differences = 2; 95% 
confidence interval for a pair of differences =- 38 to 42. 
An overall score of 100 implies best imaginable health related quality of life and zero 
implies worst imaginable HRQoL. 
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5A randomised parallel group comparison of 
the feasibility of the EuroQol and SF-36 after 
stroke 
5.1 Introduction 
The EuroQol and SF-36 are widely used generic instruments for the measurement of 
health status which have been validated after stroke (Anderson at at 1996, Chapter 
3). Both instruments were designed to be delivered by post and then be completed 
by the patient, although a variety of other methods of administration have also been 
employed. The SF-36 is very widely used (over a million SF-36 questionnaires were 
completed in 1992) (The MOS Trust, 1992), but it is also longer and more complex, 
and so may not be feasible in patients with stroke. As yet, however, these 
instruments have only been compared indirectly (i. e. not concurrently) or compared 
in studies with a non-random crossover design (i. e. both instruments were 
administered sequentially in the same order to all patients) in a variety of different 
patient groups (Brazier et at 1993; Hollingworth at aL 1995; Brazier at at 1996; 
Essink-Bot at at 1997). These studies could be prone to biases whose effects might 
be as large as, if not larger than, any true differences between instruments. In 
particular, the indirect comparisons are particularly vulnerable to biases arising from 
differences between the study populations, whereas the non-random crossover 
studies are vulnerable to biases arising from ordering effects (i. e. the response to an 
instrument may differ if it is administered independently). These biases would be 
avoided in a direct randomised comparison as the process of randomisation aims to 
ensure that all study groups are similar. Furthermore, none of these studies have 
examined the properties of either instrument in patients with stroke, and so their 
relevance is debatable. 
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When investigators choose a health status instrument for a particular study they 
must take account of the intended application, the planned method of administration 
and the attributes of the instrument in the population being examined. The ease of 
completion is important (Scientific Advisory Committee, 1995), as it is likely to 
determine both the frequency of response and the number of items of missing data. 
If many recipients do not respond, or return only incomplete questionnaires this may 
introduce a number of biases, make interpretation difficult and reduce the 
generalisability of the results. Furthermore, if poor outcome is more common among 
non-respondents a non-linear interaction might occur between response frequency 
and the statistical power of the study to detect moderate differences between the two 
treatment groups, i. e. small falls in response frequency may lead to large reductions 
in statistical power. Moreover, if the patients have cognitive, motor, speech or 
language deficits (such as those present in stroke survivors) they may not be able to 
complete complex questionnaires. 
Despite these considerations, response frequency was not mentioned in several 
recent papers on the selection of health related quality of life instruments (Guyatt at 
al. 1993; Coste at al. 1995; Testa & Simonson, 1996). As far as I am aware, there 
have been no randomised comparisons of the response to differing health related 
quality of life instruments. I postulated that the brevity and simplicity of the EuroQol 
questionnaire (five separate questions and a visual analogue scale) would achieve a 
significantly better response in stroke survivors than the SF-36 (34 separate 
questions). I therefore performed a randomised controlled trial to compare the 
response to postal versions of the EuroQol and SF-36 instruments. 
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5.2 Methods 
5.2.1 Selection of patients 
All United Kingdom (UK) patients who had been entered in the International Stroke 
Trial (IST) between 2 March 1993 and 31 May 1995 were considered for the current 
study. The IST is a multicentre international randomised controlled trial of 
antithrombotic therapy in patients presenting within 48 hours of onset of ischaemic 
stroke (International Stroke Trial Collaborative Group, 1997). I included UK patients 
randomised in the IST who were not known to be dead at the time of the survey. 
The NHS central registry Office of Population Censuses and Surveys notified me of 
deaths of patients in the study. I excluded patients whose vital status could not be 
confirmed by the Office of Population Censuses and Surveys. I also excluded 
patients if there were insufficient details to allow postal contact with either the patient 
or their general practitioner, or if they had previously contacted the Trial Coordinating 
Centre and asked not to be followed-up. 
5.2.2 Randomisation 
I randomised eligible patients using an allocation code generated by an adaptive 
randomisation algorithm (minimization)(White & Freedman, 1978), to postal follow-up 
with either the EuroQol or the SF-36 instrument. The algorithm aimed to balance the 
two groups for age, sex, stroke syndrome (using the Oxford Community Stroke 
Project Classification) (Bamford et aL 1991) and the time from stroke onset to 
follow-up in weeks. 
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5.2.3 Instruments 
EuroQol provides a simple descriptive profile of health status in five domains and an 
overall numeric estimate of health related quality of life (The EuroQol Group, 1990). 
The SF-36 was developed in the USA from a larger battery of health status 
instruments employed in the Medical Outcomes Study and covers eight domains of 
health related quality of life (Ware & Donald Sherbourne, 1992; Brazier et al. 1992; 
Jenkinson et al. 1993). I incorporated both instruments, unaltered in format or 
content, into questionnaire booklets which included additional questions recording 
the patients address, type of residence, functional outcome after stroke (modified 
simple questions, see Chapter Eight) and whether or not the patient completed the 
form independently, (see Appendix 2& 3). The questionnaire booklets were 
identical in all respects other than the nature of the health related quality of life 
instrument. I posted questionnaire booklets containing the appropriate instrument to 
all eligible patients with a personalised letter and a reply-paid envelope. The letter 
explained the purpose of the study and asked subjects to respond without help if 
possible, and if not, to pass the questionnaire on to a close relative or care-giver 
willing to respond on the patients behalf. A reminder letter and further questionnaire 
was sent to any patient who had not responded within two weeks. Thereafter, no 
further attempts were made to contact non-respondents. I marked individual 
questionnaire booklets with labels which included details of the patient's name, 
address, trial identifying number and questionnaire allocation. I generated all letters 
and labels directly from the database using a computerised mail-merge programme. 
5.2.4 Outcome assessment 
The primary measures of outcome for each instrument were: the frequency of 
response after both the first mailing and a reminder, and the number of forms with 
"no domains of missing data". For the SF-36, the domain was defined as missing 
when there were insufficient data to calculate an overall score for that domain after 
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interpolation of missing values (Medical Outcomes Trust, 1994). As the EuroQol 
was much shorter, any missing data resulted in a "domain of missing data". I planned 
exploratory analyses to examine the relationships between stroke syndrome and the 
frequency of response. 
5.2.5 Power Calculations & Statistical analysis 
The study was powered (power = 0.95 = (1-ß), a=0.05) to detect an absolute 
difference in overall response frequency of 5%, i. e. of 50 forms per 1,000 between 
the two groups, assuming an overall mean response frequency of 75%. Odds ratios 
and confidence intervals were calculated using Epilnfo Version 5 (Center for Disease 
Control, Atlanta, Georgia). 
5.3 Results 
Of the 4,016 patients randomised by the UK centres in the International Stroke Trial 
between March 1993 and May 1995, I excluded 1,763. The reasons for exclusion 
were: 1,154 patients had died prior to the start of the study, 247 patients could not 
be easily traced by the Office of Population Censuses and Surveys to confirm 
survival, 238 patients had insufficient general practitioner or patient contact details 
and 124 patients were involved in other ongoing studies of health related quality of 
life. The remaining 2,253 patients were randomised; 1,125 to receive a EuroQol 
questionnaire and 1,128 a SF-36 questionnaire. The study groups were well 
matched for age, sex and distribution of baseline stroke syndromes, (Table 5.1). 
The median time interval between stroke onset and form completion was 56 weeks 
in both groups (range: 17 to 125 weeks in both groups). No errors in form allocation 
or dispatch were detected for either the EuroQol or SF-36 questionnaires. 
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Response was significantly more frequent in patients allocated the EuroQol 
instrument, 80% after one reminder versus 75% for the SF-36, (equivalent to a 35% 
increase in the odds of response with the EuroQol compared to the SF-36,95% 
confidence interval: 10 to 66% odds increase, p=0.003), Table 5.2. A significant 
proportion of all respondents responded only after a reminder (17% of all 
respondents for the EuroQol versus 20% for the SF-36, p>0.05). For both 
instruments about half of all completed forms were completed by the patients (51% 
for the EuroQol and 50% for SF-36), and the remainder were filled in by carers. 
Allocation to the EuroQol increased the odds of response with complete data by 64% 
(95% confidence interval: 38 to 95% odds increase, p<0.0001) and also significantly 
reduced the overall level of missing data. 
Missing data for the SF-36 was concentrated in the physical role limitations and 
emotional role limitations domains, (Table 5.3). Missing data for the EuroQol was 
most frequent in the domain which assessed overall health related quality of life 
(Table 5.4). 
Respondents to the EuroQol questionnaire reported dependency in activities of 
everyday living as assessed by the modified "simple dependency question" 
significantly more frequently than patients allocated to follow-up with the SF-36 (40% 
increase in odds, 95% confidence interval 18% - 166% increase in odds), (Table 
5.5). 
Patients were less likely to complete and return the forms themselves if they had had 
a more extensive neurological deficit (total anterior circulation infarct). Conversely, 
patients with less extensive strokes, not causing deficits of cognitive function 
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(lacunar and posterior circulation strokes) were most likely to complete and return 
the questionnaires without help, (Table 5.6). 
5.4 Discussion 
To my knowledge, this is the first study which has directly compared the relative 
merits of two commonly used health status measures in a formal randomised 
manner. I found a significantly higher overall response frequency in stroke patients 
allocated to follow-up with the EuroQol questionnaire, and among responders to the 
EuroQol the proportion of missing data was smaller than for the SF-36. The 
observed difference in overall response frequency, although only modest in 
absolute terms (approximately 50 additional forms returned per thousand mailed) is 
of definite practical significance and would translate to a shortfall of approximately 
1000 completed forms in a large survey with 20 000 subjects studied by SF-36 rather 
than the EuroQol. 
The amount of missing data among responders was significantly different between 
the two instruments. Allocation to the EuroQol increased the odds of 'response with 
the questionnaire having no domains of missing data" by 64% (95% CI 38% to 95% 
increase). The instrument with the best "response" and "response with no missing 
data" frequency is preferable. A higher response rate increases the efficiency of any 
study and reduces the resources used to chase-up non-respondents and seek items 
of missing data. The more complete the response the less the risk of bias by the 
empirical allocation of arbitrary values (e. g. worst possible outcomes in a sensitivity 
analysis) to missing items of data. This is particularly an issue where the 
intervention might affect response frequency and data quality; for instance, an 
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effective treatment for stroke might reduce the frequency of non-response in the 
treatment group and so bias any estimate of the size and direction of the treatment 
effect. 
In this study, less than half of all patients completed the questionnaires themselves. 
This suggests that the problems experienced with completion of either instrument 
were independent of its characteristics, and are more likely to be a consequence of 
the frequent cognitive and motor deficits found after stroke. Nevertheless, the 
significantly better overall response frequency and data quality observed in patients 
randomised to receive the EuroQol suggests that it is the more practicable of the two 
for stroke. This is probably because the EuroQol is shorter, simpler and asks 
questions that are more relevant to survivors of stroke. Previous studies of the SF- 
36 in an elderly population have demonstrated that missing responses tended to be 
concentrated on items regarded as inappropriate to patients e. g. questions with an 
emphasis on work or vigorous activity (Hayes et al. 1995). A similar pattern of 
missing data was observed in the current study. 
5.4.1 Proxy completed responses 
Relatively few patients completed the EuroQol or the SF-36 themselves, so it is 
legitimate to ask whether or not the carer completed questionnaires gave a valid 
assessment of patients' health status. Segal examined agreement between 
survivors of acute stroke and their proxies for responses to the SF-36. Agreement 
was poor for all domains except physical functioning (Segal & Schall, 1994). This is 
likely to reflect the relatively subjective nature of many of the items in the SF-36, and 
raises concerns about the use of proxy assessments of health related quality of life 
with the SF-36. I have discussed the validity of proxy assessments of health related 
quality of life with the EuroQol in detail in Chapter 4. 
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5.4.2 Differences in response by patients in different 
categories of stroke type 
In this study, patients with large cortical strokes (TACI) were the group that were 
least likely to complete the questionnaire themselves. About one fifth of this group 
completed the forms themselves, which is half the average of 50% self-completed. 
This probably reflects the particularly severe nature of the motor, cognitive and visual 
problems associated with this particular clinical syndrome. The low response 
frequency confirms the difficulty of measuring quality of life in a group of patients 
who are likely to have the lowest health related quality of life. This study illustrates 
how response frequency may differ in different types of patients, and highlights how 
non-randomised comparisons of different instruments might be confounded by 
differences of case mix in subgroups of the study population. Thus, it is always 
essential to consider whether or not it is appropriate to generalise the performance 
of an instrument in a specific type of patient to a mixed population of patients. 
5.4.3 Response frequency may have important effects on 
assessment of outcome 
Although feasibility and the acceptability of an instrument are important, there are 
many other attributes which guide the choice of instrument for a particular study 
(Guyatt et aL 1993; Scientific Advisory Committee, 1995). Other attributes include 
conceptual model, reliability, validity, responsiveness, interpretability and availability 
of the instrument in different forms and languages. A major problem with current 
statistical approaches to testing an instrument's measurement attributes, e. g. test- 
retest reliability or sensitivity to change, is that these assessments are based solely 
on data from respondents. An instrument's calculated measurement attributes may 
be affected by its response frequency. For instance, a complex and detailed 
instrument might demonstrate excellent sensitivity to change (in patients who 
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responded), but poor overall frequency of response. However, this may not be the 
consequence of the responsive nature of the instrument, but simply selection by the 
instrument of patients who had actually changed (and so were more motivated to 
respond). The converse is also a practical problem, as poor frequency of response 
might occur in those patients with poor health related quality of life. This was 
certainly noted among patients with the severest strokes in the current study. An 
instrument's responsiveness is therefore likely to be particularly dependent upon it 
being acceptable and feasible for use by such groups. In this study, respondents 
allocated to the EuroQol instrument reported significantly worse functional outcomes. 
As the treatment groups were well balanced for baseline prognostic risk, it suggests 
that the EuroQol instrument was more acceptable to dependent patients and their 
care-givers. This higher level of response from patients with poor outcomes is likely 
to improve the power of the EuroQol questionnaire for detecting differences in health 
related quality of life between the treatment and control groups at follow-up. Thus, 
paradoxically, a simple brief instrument with a high response frequency (e. g. the 
EuroQol) may have more power to detect differences at follow-up than a more 
detailed and complex measure with a lower frequency of response (e. g. the SF-36). 
Therefore, any critical assessment of an instrument's measurement characteristics 
must include consideration of the overall level of response. 
5.4.4 Maximising follow up 
Large randomised controlled trials, audit studies and surveys need to use practicable 
and cost effective means to obtain rapid, standardized, and blinded follow-up in large 
numbers of patients. Postal administration of questionnaires could meet these 
needs, but the validity of follow-up by post would be compromised if the response 
frequency were low. Postal follow-up alone may not be acceptable in randomised 
controlled trials, as analysis and interpretation of results based on data from only 
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80% of the study population - the maximal level of response observed in the current 
study - could be misleading. One solution might be to use other modes of 
administration (e. g. interviewer or telephone) to obtain data from patients who did not 
respond to a postal questionnaire. However, certain parts of these questionnaires 
(e.. g. the EuroQol visaul analogue scale) may be more difficult to administer by 
phone. The validity of these latter alternatives requires further study. 
5.4.5 Conclusions 
In conclusion, I found higher response frequency and superior data quality in stroke 
survivors followed up by the EuroQol questionnaire compared with the SF-36. I felt 
that the response with the EuroQol was better and more complete because the 
questionnaire was simpler and shorter. The principle that simple questionnaires with 
high response frequencies may be preferable is relevant to researchers who use 
health related quality of life instruments (and researchers who develop new 
instruments). Whether these issues are relevant when the instrument is 
administered by alternative means, e. g. face-to-face interview, remains to be 
established. 
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5.5 Summary of Chapter Five 
1. Non-randomised comparisons of response frequencies of different health related 
quality of life measures are unreliable because they may be confounded by 
differences in patient populations and effects from the co-administration of other 
questionnaires. 
2.1 studied response frequency to the postal administration of the EuroQol and SF- 
36 after stroke using a direct randomised parallel group design. 
3. I found a significantly higher response frequency and significantly less missing 
data in patients allocated to follow up with the EuroQol. The use of the EuroQol 
rather than the SF-36 could therefore reduce bias and improve the generalisability 
of the study. 
4. A significantly higher proportion of patients with poor outcome responded to the 
EuroQol questionnaire than the SF-36. Thus, the EuroQol may have more power 
to detect differences in health related quality of life between groups of stroke 
patients with marked impairment than a more detailed and complex measure with 
a lower frequency of response. 
5. Patients with large cortical strokes were least likely to respond; only about one 
fifth of this group completed the forms themselves. Patients with less extensive 
strokes, not causing deficits of cognitive function (lacunar and posterior circulation 
strokes) were most likely to complete and return the questionnaires without help. 
Thus non-randomised comparisons of different instruments might be confounded 
by differences of case mix in subgroups of the study population. 
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TABLE 5.1: Characteristics at the time of entry to the International 
Stroke Trial in the 2,253 patients randomised between the EuroQol and 
SF-36 
Questionnaire allocated 
SF-36 EuroQol 
n=1128 n=1125 
n (%) n (%) 
Male sex 600 (53) 598 (53) 
Age 
< 50 45 (4) 56 (5) 
50-60 129 (11) 119 (11) 
60-70 259 (23) 274 (24) 
70-80 421 (37) 416 (37) 
>80 274 (24) 260 (23) 
Stroke syndrome 
TACS 244 (22) 247 (22) 
PACS 474 (42) 476 (42) 
LACS 292 (26) 285 (25) 
POCS 118 (11) 117 (10) 
TACS = total anterior circulation stroke syndrome 
PACS = partial anterior circulation stroke syndrome 
LACS = lacunar stroke syndrome 
POCS = posterior circulation stroke syndrome 
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TABLE 5.2: Comparison of response frequency and completeness of 
data for the EuroQol and SF 36 
Measure of Questionnaire allocated Absolute Odds ratio of p 
performance SF-36 EuroQol difference response 
n=1128 n=1125 (95% Cl) 
n (%) n (%) 
Response 
Response to first 
mailing 
Response after 
two mailings 
Complete Data 
No missing data 
679 (60%) 
849 (75%) 
616 (55%)c 
747 (66%) 6% 1.31 (1.10 to 1.56) a 0.002 
905 (80%) 5% 1.35 (1.10 to 1.66) a 0.003 
747 (66%) 11% 1.64 (1.38 to 1.95) b <0.0001 
a Odds of response, comparing Eurogol with the SF-36 (odds >1 indicate EuroQol better). 
b Odds of response with no missing data, comparing Euroqol with the SF-36 (odds >1 
indicate EuroQol better). 
c Questionnaires with no missing data (after interpolation of missing values where possible) for 
the SF-36- 
d Questionnaires with no missing data (for the EuroQol any missing data resulted in a missing 
domain). 
119 
Chapter Five 
TABLE 5.3: Frequency of missing data in each domain of the SF-36 
SF-36 
n=849 
Questionnaires with ý1 missing domain* 
Domains n (%) 
Physical functioning 75 (9) 
Bodily pain 26 (3) 
Physical role limitations 137 (16) 
General Health 99 (12) 
Vitality 54 (6) 
Social functioning 16 (2) 
Emotional role limitations 162 (19) 
Mental health 52 (6) 
* Domains with insufficient data to calculate score (after interpolation of missing 
values where possible) for the SF-36. 
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Table 5.4: Frequency of missing data in each domain of the EuroQol 
questionnaire 
EuroQol 
n=905 
Questionnaires with z: 1 miss ing domain* 
Domain n( %) 
Mobility 35 (4) 
Self care 30 (3) 
Usual activities 25 (3) 
Pain 34 (4) 
Anxiety / depression 49 (5) 
Overall numeric estimate of HRQoL 75 (8) 
*For the EuroQol any missing data resulted in a missing domain. 
HRQoL = health related quality of life 
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TABLE 5.5: Comparison of functional outcome reported by respondents 
Follow up instrument Absolute Odds ratio p 
allocation difference (95 % Cl) 
SF 36 EuroQol 
n=1,128 n=1,125 
n (%) n (%) 
Overall number returned 849 (75%) 905 (80%) 
Number of respondents 564 (50%) 657 (58%) 8% 1.40 (1.18 - 1.66) 0.00006 
reporting dependency in 
ADL 
Number of 188 (17%) 243 (22%) 5% 1.38 (1.11 - 1.71) 0.003 
questionnaires 
completed without help 
by respondents 
dependent in ADL 
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TABLE 5.6: Influence of stroke syndrome at baseline on whether the 
patient or the carer completed the questionnaire 
Completed by Completed by Total 
patient carer 
n (%) n (%) n (%) 
TACS (n=491) 97 (20) 251 (51) 348 (71) 
PACS (n=950) 382 (40) 348 (37) 730 (77) 
LACS (n=577) 281 (49) 186 (32) 467 (81) 
POCS (n=235) 113 (48) 80 (34) 193 (82) 
All Syndromes 873 (39)$ 865 * (38) 1738 (77)* 
n=2253 
* chi squared for heterogeneity amongst stroke syndromes 17.41, DF=3 
p=0.0006 
$ 
chi squared for heterogeneity amongst patient completed data 107.9, DF=3 
p<0.0001 
4 16 forms returned with missing data regarding who completed the form 
TALS, PACS, LACS, POCS abbreviations as in Table I 
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6 Is the EuroQol reliable after stroke? 
6.1 Introduction 
Reliability is the extent to which a measure is free from random error in the population 
of interest (Scientific Advisory Committee, 1995; Guyatt et al. 1993; Testa & 
Simonson, 1996), and refers to its internal consistency as well as its reproducibility, 
(Chapter One). A measure's reproducibility is the degree to which it yields consistent 
scores over time among respondents who are assumed not to have changed (test- 
retest reproducibility) or the extent to which different observers may administer it to a 
particular patient and achieve similar results (inter-observer reproducibility). 
Measures with poor reliability will be less efficient at distinguishing patients with 
different health states because true differences in score may be obscured by random 
error. 
The Nottingham Health Profile is the only health related quality of life which has had 
its reproducibility specifically examined after stroke (Gompertz et al. 1993). Gompertz 
and colleagues found it had inadequate reproducibility for monitoring individual 
patients after stroke, but adequate reliability for assessing groups. The EuroQol and 
SF-36 also appear to have inadequate reliability for individual-patient applications 
(Brazier et al. 1992; van Agt et al. 1994; McHomey & Tarlov, 1995; Brooks & with the 
EuroQol group, 1996; Andresen at al. 1996). However, their reliability in stroke 
patients has not been assessed (see Chapter Two). I therefore aimed to assess the 
test-retest reliability of both instruments in a group of patients after stroke. 
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6.2 Methods 
6.2.1 Patients and allocation to the EuroQol or SF-36 
In the previous chapter, I examined response rates to postal versions of the EuroQol 
and SF-36; I randomly allocated patients to receive either the EuroQol or the SF-36. 
I have already described the methods used to identify patients and the format of the 
instruments in Section 5.2. I then randomly sampled one third of the patients who 
had responded within approximately three weeks to the first questionnaire, for repeat 
testing with the same health related quality of life instrument (test-retest reliability). I 
posted the second questionnaire booklet containing the appropriate instrument to all 
eligible patients with a personalised letter and a reply-paid envelope. The letter 
explained the purpose of the repeat questionnaire and asked the subjects to respond 
if possible without the help of another person, and if not, to give the questionnaire to a 
close relative or care-giver who was willing to respond on the patient's behalf. I sent 
a reminder letter and further identical questionnaire to any patient who had not 
responded within 14 days. I made no further attempts to contact non-respondents 
thereafter as this was unlikely to yield significant further improvements in response. I 
marked individual questionnaire booklets with labels that included details of the 
patient's name, address, trial identifying number and questionnaire allocation. I 
generated all letters and labels directly from the randomisation code using a 
computerised mail-merge programme. 
6.2.2 Statistical analysis 
Reliability is a generic term used to indicate both the internal consistency of a scale 
and its reproducibility (Deyo et aL 1991). I assessed the internal consistency, the 
extent to which items within a dimension are correlated with each other, among the 
items comprising each of the domains of the SF-36 using Cronbach's alpha 
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coefficient (SPSS for Windows, Release 6.1). I calculated alpha coefficients for each 
of the eight SF-36 domains using responses to the initial questionnaires. Accepted 
minimal standards for alpha coefficients are 0.7 for group comparisons and 
coefficients greater than 0.9 for comparisons between individual patients or the same 
patient over time (Scientific Advisory Committee, 1995). 
I examined test-retest reliability in several ways. The primary method of analysis was 
by calculating agreement statistics. I only performed these analyses for patients who 
had complete data on test and retest for any particular domain. For the categorical 
domains of the EuroQol, I used an unweighted kappa statistic to calculate agreement 
beyond that which might be expected by chance (Morton & Dobson, 1989). I used 
the intraclass correlation coefficient (ICC) to examine agreement for the continuous 
data generated by the eight domains of the SF-36 and the visual analogue scale (and 
utilities) of the EuroQol (Morton & Dobson, 1989). For these data, I also calculated 
the arithmetic mean and standard deviation of the differences between the test and 
retest administration to provide additional information on the reproducibility of these 
assessments. 
To aid the clinical interpretation of the findings, I also aimed to determine the 
frequency of "potentially important differences" between test and retest for both 
instruments. For the five categorical domains of the EuroQol, I considered that any 
change in score was potentially important, since each of the three levels are all 
explicitly defined. Since "important clinical change" is harder to define for the SF-36, I 
examined the frequency of differences of varying size. 
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6.3 Results 
Of the 4,016 patients randomised by the United Kingdom centres in the International 
Stroke Trial between 2 March 93 and 31 May 1995,2,253 (56%) patients were known 
to be alive and at a known address at the start of the present study. Of these, 1,125 
were randomised to receive a EuroQol questionnaire and 1,128 to a SF-36 
questionnaire, (Figure 6.1). Patients received the intial questionnaires after a mean 
period of 64 weeks (SD 30) from their stroke. The response frequency was 
significantly greater in patients allocated to the EuroQol (80% allocated EuroQol 
versus 75% SF-36 responded after one reminder, p=0.003). Of these respondents, 
271 were selected at random to receive a further EuroQol questionnaire and 253 
were randomised to follow-up with an additional SF-36 (fewer patients received a 
repeat SF-36 because a smaller proportion responded to the intial questionnaire). 
Both groups had had similar characteristics at the time they entered the International 
Stroke Trial, (Table 6.1). 
Two hundred and thirty four (86%) of the patients allocated to a second EuroQol 
responded and, of these, 122 (52%) completed it without help. Of the 111 repeat 
EuroQol questionnaires completed with the help of another person (data on who 
completed it was missing for one patient), 94 were completed with the help of the 
same individual that helped with completion of the first. Of the 122 patients who 
managed to complete the EuroQol without help, 54 were independent in activities of 
daily living. Only seven of the 112 patients (6%) who required help with the 
questionnaire were independent in activities of daily living. 
A similar proportion (83%) of patients allocated to a second SF-36 responded and, of 
these, 106 (51%) patients completed it without help (58 of these 106 patients were 
independent in activities of daily living). Of the 101 remaining forms completed with 
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the help of another person (data on who completed it was missing for two patients), 
79 were completed with the help of the same individual that helped with completion of 
the first. Of these 101 patients, 16 (16%) were independent in activities of daily living. 
The mean period between completion of the initial questionnaire and posting of the 
repeat questionnaire was 21 (SD 7) days for the SF-36 and 21 (SD 9) days for the 
EuroQol. There were no significant differences in time from the stroke which lead to 
entry into the IST for patients who did or did not require help with form completion for 
either instrument. 
Reproducibility ranged from moderate to good for the five descriptive domains of the 
EuroQol (kappa statistics range from 0.63 to 0.80), (Table 6.2). For these domains, 
reproducibility was best for mobility (kappa = 0.80) and worst for psychological 
functioning (kappa = 0.63). There were no significant differences in score between 
test and retest for any of these five domains (Table 6.2). Test-retest reliability was 
consistently better for questionnaires completed by the patients than for those 
completed with the help of proxies. Although the overall assessments of HRQoL with 
the EuroQol and the EuroQol utilities had excellent reproducibility (judged by the 
intraclass correlation coefficients), the standard deviation of the differences between 
test and retest for these domains were significant (Table 6.2). 
128 
Chapter Six 
Table 6.4 shows the internal consistency for the SF-36. Cronbach alpha reliability 
coefficients were 0.8 or greater for all the domains, suggesting very good or excellent 
internal consistency. I have reported test-retest reliability separately for the forms 
completed by the patients, for the forms completed on behalf of patients by a proxy 
and for all forms combined (Table 6.5). The mean of the difference between test and 
retest ranged from -1.8 to 3.1 for the different domains. The standard deviation of the 
differences between test and retest were substantial for all domains, but particularly 
for the two role functioning domains. The intraclass correlation coefficients were 
generally acceptable or good for all the domains, except mental health (intraclass 
correlation coefficient = 0.28). For all eight domains, reproducibility was better when 
the patient assessed HRQoL than when a proxy did. 
Tables 6.3 and 6.6 report the frequency of potentially important disagreements 
between test and retest for both instruments. For the self care, activities, pain and 
psychological functioning domains of the EuroQol, more than 15% of respondents 
report a "potentially important difference' in health between test and retest (Table 
6.3). A substantial proportion of patients reported differences of 20 points, or greater, 
between test and retest for all the domains of the SF-36 (Table 6.6). 
6.4 Discussion 
I found that the test-retest reliability of the EuroQol and SF-36 was generally 
moderate when assessed after stroke. For both instruments, I observed the worst 
reproducibility in the domains which examined psychological functioning. Mental 
health measured with the SF-36 had particularly poor reliability (intraclass correlation 
coefficient=0.28). This may be explained by the subjective nature of this domain, or 
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there may be a mathematical explanation. The intraclass correlation coefficient 
compares the variance between the patients with the total variance (Deyo et al. 
1991); since all the patients had relatively similar outcomes for this domain the 
intraclass correlation coefficient would therefore be expected to be small in this 
particular sample. 
6.4.1 Interpretation of agreement statistics 
The difficulty with grading the results of agreement statistics has been raised in 
Chapter Four. For example, there is no consensus about the "meaning of kappa=0.5" 
(Brennan & Silman, 1992; McDowell and Newell, 1996). Furthermore, authors are 
inconsistent in reporting the clinical significance of any given kappa value or 
intraclass correlation coefficient (Deyo et al. 1991). I therefore examined the mean 
and standard deviation of the differences and the frequency of potentially important 
disagreement for both the SF-36 and EuroQol to try to clarify the practical 
implications of our findings. I did not find substantial mean differences between test 
and retest for any of the domains of the SF-36, or for the assessment of overall 
HRQoL using the EuroQol "thermometer". However, although the agreement 
statistics suggested that the reliability was generally moderate or good, I found the 
standard deviations of the differences were large for most domains (approximately t 
20) and even larger for the physical and emotional role functioning domains. This 
degree of variability means that neither instrument would be suitable for serial studies 
within the same stroke patient or for making serial comparisons between individual 
patients after stroke. "Potentially important disagreement" was also frequent. 
However, interpretation of the frequency of disagreements is complicated by the 
different number of levels for each of the domains of the SF-36. My findings do 
indicate that either instrument would function adequately to compare groups of 
patients, such as in a parallel group randomised controlled trial. 
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6.4.2 Explanations for less than perfect reproducibility 
There were a number of potential sources for poor test-retest reproducibility in the 
current study. These included the nature of the domain under study, whether the 
patients completed the questionnaires themselves, change in the patients' health 
state between test and retest and measurement error. 
6.4.2.1 Stroke severity 
I consistently observed better reliability when the patients completed the 
questionnaire by themselves than when a proxy completed it on the patient's behalf. 
However, these instruments were designed to assess a patient's uniquely personal 
view of their own health state and so, by definition, were not designed for use by a 
proxy (Testa & Simonson, 1996). 
I might have underestimated the reproducibility of the assessments in patients who 
required help to complete the questionnaires, because about a fifth of patients sought 
help from a different person for the first and second questionnaires. It might also be 
that HRQoL is less stable for more severely affected patients who are unable to 
complete the questionnaires themselves (usually because of physical and cognitive 
deficits after the stroke) (Kwa et al. 1996). In this situation, rating of the patient's 
health status by individuals other than the patient (e. g. a family member, friend or 
carer) may be the only means of assessing the patient's HRQoL. Although these 
proxy assessments were not as reproducible, and may not be as valid (Segall & 
Schall, 1994; Chapter Four), as those performed by the patients themselves, they 
appeared to be at least reasonably reliable in the current study. 
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6.4.2.2 Change in patient's health between test and retest 
Poor test-retest reproducibility may be due in part to change in the patients' health 
state between the initial test and the subsequent retest. For both instruments, I 
observed worst reproducibility in the domains which assessed psychological 
functioning. This is not surprising, as this is arguably the most subjective domain and 
therefore likely to be subject to the greatest day-to-day variation. 
I assessed reproducibility over an interval of several weeks, when the patients' 
neurological status was likely to be stable. I considered this period to be long enough 
to minimise memory effects, but short enough that a real change in the patients' 
health was unlikely. Some investigators suggest that patients who report a change in 
health state during the study period should be excluded from comparisons of test- 
retest reliability to identify the "noise" associated with the instrument (Scientific 
Advisory Committee, 1995; Ruta et al. 1994). I did not do this, as this does not give 
an indication of the true "noise" in the population of interest and this is the variability 
above which a measure must be responsive to detect change in a treatment group. 
6.4.2.3 Content or wording of instrument 
Measurement error associated with the instrument can result from either a lack of 
intelligibility or ambiguity in its wording. It may also occur if patients find the content 
lacks relevance to their situation. Elderly people may not regard some of the 
questions of the SF-36 about work or vigorous activities (domains of physical and 
emotional role functioning) as relevant to them (Hayes et aL 1995). In my study (in 
which the mean age of the patients was 70 years), these domains had relatively poor 
test-retest reliability. 
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6.4.3 SF-36 in this study compared with others 
The internal consistency of the SF-36 has been consistently estimated as very good 
or excellent (McDowell and Newell, 1996). The estimates for the internal consistency 
of the SF-36 by postal questionnaire in this study, are therefore consistent with these 
estimates, as well as those reported by Anderson and coworkers in their study of the 
validity of the SF-36 when administered by interview after stroke (Anderson et al. 
1996). The estimates from this study for the reproducibility of the SF-36 in stroke 
patients are also consistent with those obtained in other patient groups which suggest 
it is only adequate for group applications (McHomey & Tarlov, 1995; Weinberger et 
al. 1996; Ruta at al. 1994; Andresen at al. 1996). Weinberger and colleagues 
reported that the mode of administration (face-to-face interview, self-completed 
questionnaire or telephone interview) did not appear to affect the reproducibility of the 
SF-36 (Weinberger et al. 1996). The SF-36 is, therefore, likely to be reasonably 
reliable in stroke patients regardless of the mode of questionnaire administration. 
6.4.4 Comparison of the reliability of the EuroQol and SF-36 
I was only able to compare the test-retest reliability of the EuroQol and SF-36 
indirectly in a qualitative manner as no one statistical technique could be used to 
assess the agreement for both categorical and continuous data. Within this limit, 
both instruments appeared to have similar reliability. I could have reclassified the 
outcome data with the SF-36 into several new categories to make a direct 
comparison with the EuroQol possible. However, this kind of arbitrary approach 
would be hard to validate. I therefore reported the frequency of what I considered 
might be "potentially important differences" for both instruments. This would at least 
allow a broad qualitative comparison of the reliability of the two instruments. There is 
no consensus over what a clinically meaningful change for either instrument might be, 
so even this approach has limited value. As the mobility, self care, social functioning, 
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pain and psychological domains of the EuroQol have just three distinct levels (for 
example mobility: I have no problems in walking about (1), I have some problems in 
walking about (2), I am confined to bed (3)) we considered any change for these 
domains as potentially important. The definition of a potentially important change with 
the SF-36 is more controversial. Some investigators consider differences of five 
points in any of its domains as potentially important (Ruta at aL 1994). However, this 
difference is not directly comparable with a change of one level for the EuroQol. I 
therefore reported the frequency of disagreement for four empirically chosen 
differences in score (5,10,20 and 40 points). These results need to be interpreted in 
the context of the number of items contributing to the scoring of each domain (e. g. 
there are only four levels for physical role functioning, see Table 7.2). Overall, they 
support the conclusion that unless investigators are seeking to identify very large 
differences (e. g. >40 points with the SF-36), neither instrument is likely to be effective 
at reliably identifying change over time in HRQoL within an individual patient after a 
stroke. 
I was only able to compare the reliability of the EuroQol and SF-36 indirectly. The 
groups who received the initial EuroQol and SF-36 were similar, but there were 
inevitably some differences between the groups who were sent repeat 
questionnaires, since some selection bias had taken place at this stage. An 
alternative approach would have been to give all patients both instruments twice (test- 
retest). I felt, however, that this would place an unacceptable burden on patients and 
so might have adversely affected the response rates. The comparison may also have 
been biased because the EuroQol asks patients to report their health state on that 
particular day, whereas the SF-36 asks patients about their health over the previous 
four weeks. I was therefore surprised that the qualitative estimates of reliability of the 
SF-36 and EuroQol were so similar. This suggests that either day-to-day fluctuation 
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in a patients health state was small or that the patients did not pay much attention to 
the exact wording of the questionnaires. 
In summary, both the EuroQol and SF-36 have acceptable, and qualitatively similar, 
test-retest reliability when administered after stroke and completed by patients or their 
proxies. Either instrument might function effectively as a discriminatory measure for 
assessing HRQoL outcomes in groups of patients, as in a large parallel group 
randomised controlled trial or an audit study. Sample size calculations for 
observational studies and randomised trials must take the reliability of both 
instruments into account. Doing so will generally increase the sample size, but 
should reduce the risk of a "false negative" or type II statistical error. These data do 
not support the use of either instrument for serial assessments in individual patients, 
unless very large differences over time are expected. 
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6.5 Summary of Chapter Six 
1. Reproducibility ranged from moderate to good for the five descriptive domains of 
the EuroQol (kappa statistics ranged from 0.63 to 0.80). The overall assessments 
of health related quality of life and the EuroQol utilities had excellent 
reproducibility. 
2. All the domains of the SF-36 had very good or excellent internal consistency. 
3. Test-retest reliability for the SF-36, assessed by intraclass correlation coefficients, 
was moderate or good for all the domains except mental health (ICC=0.28). The 
mean of the absolute difference between test and retest was less than 4 for all 
domains. However, the standard deviations of the differences were large for all 
domains. 
4. For both instruments, the frequency of potentially important differences between 
test and retest was substantial. Neither instrument is therefore likely to be reliable 
at identifying change within an individual patient after stroke. However, either 
instrument might function effectively as a discriminatory measure for assessing 
health related quality of life outcomes in groups of patients after stroke. 
5. Both the EuroQol and SF-36 have qualitatively similar reproducibility after stroke. 
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Table 6.1: Characteristics at time of randomisation in the International 
Stroke Trial in the 524 patients participating in the reliability studies. 
Questionnaire allocation 
SF-36 (n=253)8 EuroQol (n=271) b 
n (%) n (%) 
Male 140 (55) 147 (54) 
Age 
<50 12 (5) 19 (7) 
50 to 60 32 (12) 26 (10) 
60 to 70 63 (25) 67 (25) 
70 to 80 99 (39) 95 (35) 
>80 47 (19) 64 (23) 
Stroke syndrome 
TACS 52 (21) 51 (19) 
PACS 102(40) 117 (43) 
LACS 69 (27) 74 (27) 
POLS 30 (12) 29 (11) 
e Randomly sampled from 849 patients who responded to an initial questionnaire 
b Randomly sampled from 905 patients who responded to an initial questionnaire 
No statistically significant differences between the groups were observed 
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Chapter Six 
Table 6.3: Test-retest reliability of the EuroQol: the frequency of 
"potentially important differences" between test and retest * 
Domain % with potentially 
important 
differences 
(95% Cl) 
Mobility 6 (4 to 11) 
Self care 17 (12 to 22) 
Activities 20 (15 to 26) 
Pain 16 (11 to 21) 
Mood 20(14 to 25) 
* defined as score for that domain changing by at least one level between test 
and retest 
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Table 6.4: Internal consistency of the SF-36 among the 849 initial 
respondents 
Functional domains Internal consistency 
Cronbach « 
Physical functioning 0.95 
Physical role functioning 0.94 
Social functioning 0.80 
Bodily pain 0.87 
Mental health 0.86 
Emotional role functioning 0.96 
General health 0.83 
Vitality 0.81 
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Figure 6.1: Flow of patients through study 
Randomised in IST: 4,016 patients 
I Eligible for present study: 2,253 patients 
Randomisation 
1: 1 
Follow-up with EuroQol: 1,125 patients 
Responded*: 905 patients 
[One third (271) randomly sampled for retest 
Responded': 234 (86%) patients 
Follow-up with SF-36: 1,128 patients 
Responded*: 849 patients 
One third (253) randomly sampled for retest 
Responded*: 209 (83%) patients 
* to two mailings 
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7 How do scores on the EuroQol relate to 
scores on the SF-36 in the same patient? 
7.1 Introduction 
The EuroQol and SF-36 are widely used to measure several aspects of health related 
quality of life (Anderson et aL 1993; McDowell and Newell, 1996). The EuroQol 
assesses outcome in six broad areas (mobility, self care, activities, pain, 
psychological functioning, and self reported overall health related quality of life) and 
also provides a utility score for overall health related quality of life (The EuroQol 
Group, 1990). The SF-36 assesses eight domains: physical functioning, physical 
role functioning, social functioning, bodily pain, mental health, psychological role 
functioning, vitality and general health (Ware & Donald Sherboume, 1992; Medical 
Outcomes Trust, 1994). At first sight, many of the domains of the SF-36 are similar 
to those of the EuroQol: for example, the mobility question in the EuroQol appears to 
relate closely to the physical functioning questions on the SF-36. However, the 
relationship between the domains of each of these instruments has not been well- 
defined (Brazier at aL 1993; Brazier at al. 1996). Moreover, the degree to which a 
change in health related quality of life is reflected in changes in scores of the relevant 
domains of the EuroQol and SF-36 is unknown. 
A clearer understanding of the relationship between these instruments might help 
improve the interpretation of a change of score with either instrument. Furthermore, 
as both instruments aim to measure health related quality of life there should be a 
strong correlation between responses on the two instruments. A poor correlation 
might suggest poor validity of one or both of the measures. I therefore administered 
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both the EuroQol and SF-36 to a group of patients after stroke to compare their 
responses to these instruments. 
7.2 Methods 
7.2.1 Patients and allocation to the EuroQol or SF-36 
In the previous two chapters, I compared the frequency of response to the postal 
administration of the EuroQol and SF-36, and the reproducibility of these 
assessments. I described the methods used to identify patients and the format of the 
instruments in Chapter Five. I subsequently described the method used to select a 
subsample of respondents to the initial questionnaires for a comparison of their 
reproducibility in Chapter Six. At the same time, I randomly selected one third of 
patients who had responded within approximately three weeks to the first EuroQol for 
repeat testing with the SF-36, and two thirds of the patients who had responded within 
approximately three weeks to the first SF-36 for repeat testing with the EuroQol - see 
Figure 7.1. These patients were completely separate from those included in the study 
of the reproducibility described in the preceding chapter. The planned (and actual) 
flow of patients is laid out in Figure 7.1. 
I posted the second questionnaire booklet containing the appropriate instrument to all 
eligible patients with a personalised letter and a reply-paid envelope. The letter 
explained the purpose of the repeat questionnaire and asked the subjects to respond 
if possible without the help of another person, and if not, to give the questionnaire to a 
close relative or care-giver who was willing to respond on the patient's behalf. I sent 
a reminder letter and further identical questionnaire to any patient who had not 
responded within 14 days. I made no further attempts to contact non-respondents 
thereafter. I marked individual questionnaire booklets with labels that included details 
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of the patient's name, address, trial identifying number and questionnaire allocation. I 
generated all letters and labels directly from the randomisation code using a 
computerised mail-merge programme. 
7.2.2 Statistical analysis 
The ability of a questionnaire to discriminate between different levels of health is an 
important aspect of validity (Streiner and Norman, 1989; Guyatt et al. 1993). This is 
determined in part by whether a measure can define a full range of potential health 
states, and whether it is sensitive over this range. Patients who are at the lowest 
score on a measure will have no scope to show any further decline of health ("floor" 
effects) (Streiner and Norman, 1989; Guyatt et al. 1993). Similarly, if the majority of 
patients score near the top of the measure, it will have little scope to show 
improvements in health ("ceiling" effects) (Streiner and Norman, 1989; Guyatt et al. 
1993). I therefore initially assessed the distribution of scores, and levels of missing 
data, for both instruments. 
"Ordering" effects are a potentially important source of bias in an unbalanced cross- 
over study. For instance, completing the EuroQol questionnaire first might affect the 
patients' subsequent response to the SF-36. I therefore used a simple factorial one 
way analysis of variance to investigate whether ordering effects occured after the 
administration of either the EuroQol or SF-36. I restricted these analyses to the 
comparable domains of both instruments, to avoid the problems which may arise from 
multiple testing. 
The construct validity of both instruments was assessed further by testing the 
relationship between the EuroQol and SF-36 domains. Thus, the relationship 
between comparable domains on the EuroQol and SF-36 (such as physical 
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functioning on the SF-36 and mobility on the EuroQol) should be higher than between 
less comparable domains (such as physical functioning on the SF-36 and 
psychological functioning on the EuroQol). In contrast, the domains which examine 
more general aspects of health (such as overall health related quality of life on the 
EuroQoi) should be moderately correlated with all the other domains. I examined 
these relationships in two separate ways. I initially calculated patients' mean score, 
for each domain of the SF-36, for patients categorised according to their response to 
the corresponding EuroQol domain. These analyses were performed to facilitate the 
interpretation of patients' scores with the SF-36. I subsequently calculated correlation 
coefficients between the domains of the EuroQol and each of the domains of the SF- 
36. All analyses were performed using "Access 2.0" (Microsoft Corporation) and the 
statistical software package "SPSS for Windows" (Release 6.1). 
7.3 Results 
Of the 905 respondents to the initial EuroQol, 272 (one-third of respondents) were 
selected at random to receive a subsequent SF-36. A separate 505 patients (two- 
thirds of respondents) were selected at random from the respondents to the initial SF- 
36 to receive a EuroQol questionnaire (Figure 7.1). Four hundred and fifty eight 
(91%) of those allocated to the EuroQol questionnaire responded. A slightly lower 
proportion (85%) of the patients allocated to the SF-36 questionnaire responded 
(Figure 7.1). 
I performed a simple one way factorial analysis of variance to assess the effect of the 
questionnaire ordering (i. e. "EuroQol then SF-36" or "SF-36 then EuroQol") on the 
relationship between EuroQol and SF-36 scores for comparable domains. The 
"ordering term" was not a significant determinant of the relationship between the 
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EuroQol and SF-36 scores in the eight analyses performed (Table 7.1). 1 therefore 
combined all the data for the remaining analyses. 
The distribution of scores for the SF-36 are described in Table 7.2. The proportion of 
responses with missing data ranged from 2% to 16% (social functioning and 
psychological role functioning respectively). A substantial proportion of respondents 
scored the minimum possible score (zero out of a possible 100, i. e. the floor of the 
scale - the worst possible outcome) for the domains of physical role functioning and 
emotional role functioning. About one-quarter of patients scored the maximum score 
for the bodily pain and psychological functioning domains of the SF-36. 
The distribution of patients' responses to the categorical domains of the EuroQol are 
described in Table 7.3. The proportion of missing data (approximately 3%) was very 
similar for each of these five domains (Table 7.3). Although each of the domains had 
only three potential levels of response, the data were not particularly skewed (Table 
7.3). Examination of the distribution of overall estimates of health related quality of 
life with the EuroQol visual analogue scale or the EuroQol utility scores does not 
suggest problems with ceiling or floor effects (Figures 7.2 and 7.3). 
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The relationships between patients' responses to the EuroQol and SF-36 
questionnaires are presented in Tables 7.4 and 7.5. Table 7.4 presents the mean 
scores for the relevant SF-36 domains for patients categorised according to their 
response to the comparable EuroQol domain. For almost all of the domains, the 
mean scores were ordered appropriately and were significantly different between the 
groups. Indeed, physical functioning, social functioning and pain measured with the 
SF-36 were particularly closely related to the corresponding domains on the EuroQol. 
However, there was no difference in the mean scores for the physical role functioning 
domain between patients reporting "some" or "severe" problems with the EuroQol. 
Futhermore, there was only a weak relationship between the mental health domain 
(SF-36) and psychological functioning domain (EuroQol) (Table 7.4) 
Table 7.5 reports the correlation between each of the domains of the EuroQol and 
those of the SF-36. The physical functioning domain on the SF-36 correlated most 
closely with the mobility, self care and activities domain of the EuroQol; it correlated 
less closely with the pain and psychological domains of the EuroQol. Social 
functioning on the SF-36 was moderately correlated with all the domains of the 
EuroQol. Bodily pain was most closely correlated with the pain domain of the 
EuroQol. In contrast, mental health correlated only poorly with psychological 
functioning measured with the EuroQol. The vitality and general health domains of 
the SF-36 correlated particularly strongly with the overall health related quality of life 
domain of the EuroQol, but also moderately with the other domains of the EuroQol. 
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7.4 Discussion 
7.4.1 Relationship between the EuroQol and SF-36 
I observed a close relationship between the domains which assessed physical 
functioning, social functioning, bodily pain and overall health related quality of life. 
Therefore, although the EuroQol and SF-36 questionnaires differ substantially in their 
background, structure, content, length, and also the time period to which they refer, 
these results suggest that they are generally sampling similar areas of health. This 
finding supports the notion that there are several key dimensions which comprise 
health related quality of life, as well as providing further support for the construct 
validity of the assessments of these domains with either instrument. 
The correlation between patients' responses to the mental health domain of the SF- 
36 and the psychological functioning domain of the EuroQol was not very impressive. 
There are several possible explanations for this. Firstly, it is possible that these 
domains, although superficially similar, are measuring different constructs. This is 
supported by the fact that the EuroQol item focuses on anxiety and depression, 
whereas the SF-36 mental health scale includes positive emotions as well (e. g. 
feeling calm and peaceful). The psychological role functioning domain of the SF-36, 
which emphasises anxiety and depression, correlated much better with the EuroQol 
psychological functioning domain than did the mental health domain of the SF-36 
(Spearman rank correlation coefficient 0.43 versus 0.21). However, an alternative 
explanation is that one, or both, of these domains has poor measurement properties 
in patients with stroke. There are several pointers to this. Firstly, the assessments of 
mental health with the SF-36 were clustered around the middle of the scale (mean 
score 61, standard deviation 12) and so did not appear to take full advantage of the 
potential breadth of the scale. Secondly, the reproducibility of the mental health 
assessments with the SF-36 was also particularly poor (intraclass correlation 
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coefficient = 0.28) (Chapter Six). Finally, approximately half of all these 
questionnaires were completed with the help of proxies and the validity of these proxy 
assessments are particularly questionable for the domain of psychological functioning 
(Segal & Schall, 1994)(Chapter Four). 
It has been difficult to establish the validity of the numerical assessments of overall 
health related quality of life with the EuroQol because this domain is difficult to define 
and is highly subjective (Chapter Three). However, the general health domain of the 
SF-36 appears to examine a similar construct (Ware, 1992). It aims to assess an 
individual's general health perceptions and satisfaction and, as with the EuroQol, 
these general health perceptions appear to provide an approach by which different 
components of health such as disease, functioning, symptoms and feelings can be 
integrated (Ware, 1992). The strong correlation (Pearson correlation coefficient = 
0.66) between patients' responses to these domains supports the view that both 
these domains are measuring the same underlying trait. The validity of these 
assessments is further supported by the moderate correlation of the assessments of 
overall health related quality of life with the other domains of the SF-36. 
7.4.2 Interpretability 
Studies of interventions must show that the observed changes in patients that are due 
to the intervention are important and substantial enough to warrant further 
consideration in medical practice and policy planning (Testa & Simonson, 1996). One 
approach to the definition of clinical meaningfulness is the use of anchor-based 
interpretations (Lydick & Epstein, 1993). These definitions represent instances where 
the changes in quality of life measures were compared, or anchored, to other clinical 
changes or results. The descriptive nature of the categorical levels of the EuroQol 
questionnaire could be considered as potential anchors e. g. in the current study, a 
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change of 40 points in the physical functioning scale of the SF-36 appeared to be 
equivalent to the difference between "no problems" and "some problems" in the 
categorical mobility domain of the EuroQol. However, several factors limit the 
usefulness of this approach. Firstly, clinicians may be unsure about the significance 
of the above change in the EuroQol, i. e. what is the meaning of "some" problems. 
Secondly, the amount of change judged significant may differ with the population and 
the treatment under study. Thirdly, most scales are not linear, i. e. not an interval 
scale; therefore, a change of 10 units at the high end of the scale may not be the 
same as a similar-sized change at the low end of the scale. 
The problem with defining clinical significance with health related quality of life 
measures reflects the newness of these measures and our lack of experience with 
them (Lydick & Epstein, 1993). Therefore, presenting these correlations should 
improve familiarity with these measures and help clinicians develop an intuitive feeling 
about the relevance of any change. 
7.4.3 Distribution of scores 
The large number of patients scoring the minimum score (worst outcome) in the 
physical and emotional role functioning domains of the SF-36 suggests that floor 
effects may be present in these domains. The observation that the mean scores for 
the physical role functioning domain did not distinguish between patients classified as 
having "moderate" or "severe" problems by the mobility or self care domains of the 
EuroQol confirms this suspicion. The role functioning domains may therefore not 
measure the consequences of more severe disabilities and this might reduce 
responsiveness in these domains. Other investigators have reported similar findings 
in studies of the SF-36 in the elderly (Brazier et al. 1996), and groups of patients with 
other diagnoses (Anderson at al. 1993). 
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7.4.4 Methodological Issues 
The lower frequency of response and lower levels of data completeness in patients 
followed up with the SF-36 compared with the EuroQol are consistent with the result 
of the direct randomised comparison of their feasibility after stroke (Chapter Five). I 
used an interpolation procedure to reduce the proportion of missing data (missing 
items were substituted with the mean response to other items) (Medical Outcomes 
Trust, 1994), and so these results underestimate the underlying level of missing data 
for the SF-36. Brazier and colleagues have expressed concerns over the validity of 
these interpolation procedures (Brazier et aL 1996). They suggest that where 
patients omit items because they do not appear relevant to them, this may indicate 
that the respondent is in fact unable to perform that particular activity or function and 
so the average response to the other items could be misleading if interpolation is 
used for missing values (Brazier at a/. 1996). 
The cross-over design employed in this study seems to have been valid as there did 
not appear to be any significant carryover or other ordering effects. Furthermore, the 
study of test-retest reliability demonstrated that the patients did not change 
significantly in any of the domains of health related quality of life between test and 
retest (Chapter Six). These findings justified the combined analysis of all the data 
irrespective of the order of questionnaire administration. 
7.4.5 Conclusions 
In summary, despite fundamental differences in their background, design and format 
the domains of the EuroQol and SF-36 measured broadly similar aspects of health 
related quality of life. The weak relationship between the assessment of mental 
health with the SF-36 and psychological functioning with the EuroQol may reflect a 
difference in content or more fundamental problems with the validity or reliability of 
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the items in either of these domains. Unfortunately, it is difficult to resolve which of 
these explanations applies as no reference instruments were administered 
concurrently. This study has provided the first empirical qualitative evidence by which 
data on the SF-36 after stroke may be interpreted. 
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7.5 Summary of Chapter Seven 
1. The EuroQol and SF-36 both aim to measure health related quality of life. 
However, the relationship between comparable domains of each instrument has 
not been defined. 
2. The domains for both instruments which assesssed physical functioning, social 
functioning, bodily pain and overall health related quality of life correlated closely. 
This also provides further support for the construct validity of these domains in 
both instruments. 
3. The mental health domain of the SF-36 correlated only poorly with the 
psychological functioning domain of the EuroQol. This is likely to represent either 
differences in content for both domains or measurement error. 
4. A significant number of patients scored the minimum score in the physical and 
emotional role functioning domains of the SF-36. This suggested that these 
domains may not measure the consequences of more severe disabilities and this 
might reduce the responsiveness in these domains, i. e. a "floor" effect. 
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Chapter Seven 
Figure 7.1: Flow of patients through cross validation study 
1 Randomised in IST: 4,016 patients 1 
Eligible for present study: 2,253 patients 
Randomisation 
1: 1 
Follow-up with EuroQol: 1,125 patients I 
Responded*: 905 patients 
One third (272) randomly sampled: given SF-36 
Responded: 230 (85%) patients 
Follow-up with SF-36: 1,128 patients 
Responded*: 849 patents 
I Two thirds (505) randomly sampled: given EQ 
161 
Responded: 458 (91 %) patients 
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Chapter Eight 
8 Are the modified "simple questions" a valid 
and reliable measure of health related quality 
of life? 
8.1 Introduction 
Lindley and colleagues developed two "simple questions", one to assess dependency 
and one to assess recovery after stroke (see Table 8.1 for original wording). Their 
aim was to determine whether a minimalist measurement tool could be a valid and 
inexpensive means to assess outcome in large randomised controlled trials and 
epidemiological studies (Lindley et aL 1994). These questions have been used in two 
recent randomised controlled trials in patients with stroke (Kay et al. 1995; 
International Stroke Trial Collaborative Group, 1997). The data were analysed in 
different ways in each of these studies: in the trial of low molecular weight heparin, 
the simple dependency question was used to provide an estimate of the proportion of 
patients disabled at follow up (Kay et al. 1995). In the IST, both questions were used 
together to classify patients into one of three hierarchical levels of outcome 
(dependent, independent but not recovered, independent and fully recovered) 
(International Stroke Trial Collaborative Group, 1997). Although this hierarchical 
classification has intuitive appeal, its relationship with other classifications of outcome 
(e. g. health related quality of life or the WHO Classification of Impairments, 
Disabilities and Handicaps) is not dear. 
Lindley's initial assessment of the measurement attributes of the questions suggested 
they had good validity and acceptable reliability (Lindley et aL 1994). However, a 
more recent study highlighted some ambiguities in the wording (Dennis of aL 1997a). 
Some patients who answered yes to the dependency question meant they needed 
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help from a person, in addition to their normal helper, and not that they needed help 
from any person at all (Dennis et al. 1997a). Similarly, other patients answered yes to 
the recovery question when they meant they had stopped recovering, and not that 
they had returned to their pre-stroke state (Dennis et al. 1997a). These ambiguities 
reduced the questions' validity and reliability and so reduced their power to detect true 
differences in outcome. 
Dennis and colleagues proposed a modification to both questions to try and improve 
their clarity, validity and reliability (Dennis at al. 1997a). They removed the clause 
referring to "another person" from the dependency question to give "Do you need help 
from anybody with everyday activities? " and reworded the recovery question to give 
"Has the stroke left you with any problems? ". I examined the validity of these 
modified questions in the current study. I examined whether the modified 
dependency question is a valid measure of dependency and whether the combined 
use of the questions to classify patients into one of three outcome groups 
(dependent, independent with problems and independent with no persisting problems) 
is a valid measure of overall health related quality of life. I also assessed the test- 
retest reliability of this classification and the agreement between patients and their 
proxies for responses to the modified simple questions, because patients are often 
unable to complete questionnaires or participate in interviews after stroke. 
8.2 Methods 
8.2.1 Selection of patients 
8.2.1.1 Lothian Stroke Register Series 
I studied the validity, and the proxy validity, of the modified simple questions in a 
series of 152 patients from our prospective registry of inpatients and outpatients with 
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first (or recurrent) stroke. The patients, and their proxies, were asked the questions 
as part of a longer interview to examine the validity of the EuroQol questionnaire after 
stroke (Chapters Three and Four). I have described how we identified the patients 
and their proxies and how we administered the instruments in Sections 3.2 and 4.2. 
Briefly, all patients were visited by a research nurse at home. The nurse 
administered the modified simple questions, the EuroQol (The EuroQol Group, 1990), 
the Frenchay Activities Index (Wade et al. 1985), the Hospital Anxiety and Depression 
Scale (HADS) (Zigmond & Snaith, 1983) and a VAS pain scale as questionnaires to 
be completed by the patient as far as possible. When patients could not complete the 
questionnaires by themselves, the nurse administered the questionnaires by 
interview. The nurse always administered the modified simple questions first, to limit 
interaction with the subsequent questions. The nurse assessed the Barthel Index and 
the OPCS disability scores (Mahoney & Barthel, 1965; Wellwood et al. 1995) by 
direct questioning at the end of the interview. We asked patients to ensure that a 
friend or relative (a proxy) who knew them well was available at the time of the 
interview. The nurse asked each proxy to independently complete a questionnaire 
booklet including the modified simple questions on behalf of the patient. 
8.2.1.2 International Stroke Trial Series 
I also studied the relationship between responses to the modified simple questions 
and the assessments of health related quality of life, measured with the EuroQol and 
SF-36, in the cohort of patients included in the randomised comparison of these 
instruments (Section 5.2.1). I have described the selection of patients, allocation of 
patients to the questionnaires and the methods of questionnaire administration in 
detail in Section 5.2. The modified simple questions were re-administered with the 
health related quality of life questionnaires for both the study of the reliability and 
relationship between the different quality of life assessments (Chapters Six and 
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Seven), see Figure 8.1.1 used data from both these populations to determine the 
test-retest reliability of the individual questions and that of the overall classification of 
outcome using the modified simple questions. 
8.2.2 Statistical analysis 
I assessed the concurrent validity of the modified simple questions by calculating the 
sensitivity, specificity and accuracy with which the responses to each question 
predicted whether the patient scored as "good" or "bad" (i. e. score above or below the 
cut-offs for the appropriate standard instrument which separated "good" from "bad" 
outcome). The cut-offs were selected either if they had face validity or if they had 
been used in previous studies for each subscale (Lindley et al. 1994; O'Rourke, 1996; 
Dennis et al. 1997a; Dennis et aL 1997b). 
The modified simple questions may also be used to classify surviving patients into 
one of three hierarchical outcome groups: patients who respond with "yes" to the 
dependency question are classified as dependent, patients who respond with "no" to 
the dependency question and "yes" to the recovery question may be classified as 
independent and patients who respond with "no" to both questions may be considered 
independent and fully recovered, Figure 8.2. I investigated the validity of this 
classification by plotting histograms which showed the distribution of responses to our 
standard measures for patients who were dependent, independent and fully 
recovered. I further assessed the concurrent validity of this classification by 
calculating the median score and interquartile range for each standard instrument for 
each of these three outcome groups. I used the Kruskal-Wallis one way analysis of 
variance to compare the distribution of scores for each group. 
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I examined the agreement between patients' responses to the modified simple 
questions on test and retest using the kappa statistic (Brennan & Silman, 1992). 
also examined the agreement between patients and their proxies for their 
classification of the patients' outcome using the kappa statistic (Brennan & Silman, 
1992). 
All analyses were performed using "Access 2.0" (Microsoft Corporation) and the 
statistical software package °SPSS for Windows" (Release 6.1). 
8.3 Results 
8.3.1.1 Lothian Stroke Register Series 
The patients were assessed at a median interval of 72 weeks after the onset of their 
index stroke (interquartile range: 43 to 104 weeks). Of the 152 patients who 
participated in this study, 92 were able to complete the questionnaires themselves; 
the remaining 60 patients could only be assessed by interview. Their characteristics 
at the time of registration following their index stroke have been reported in detail in 
Chapter Three - (Table 3.1). 
147 (97%) patients completed both modified simple questions (three patients did not 
complete the modified dependency question and another two patients did not 
complete the modified recovery question). 54 (37%) patients replied "yes" to the 
dependency question and were classified as dependent, Table 8.2; eight of these 54 
dependent patients replied "no" to the question about problems from their stroke (but 
in fact five of these eight had been rated as having an Oxford Handicap Score of at 
least two or more before their index stroke) (Bamford et al. 1989; Rankin, 1957). The 
remaining 93 (63%) patients were independent in everyday activities; of these, 52 
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reported being left with problems after their stroke, whereas the other 41 appeared to 
have made an excellent recovery in that they denied any problems. 
8.3.1.1.1 Validity 
The sensitivity, specificity and accuracy of the modified simple questions for the 
assessment of outcome in the domains of mobility, self care, social functioning, pain 
and psychological functioning are reported in Table 8.3. The modified dependency 
question had excellent sensitivity, specificity and accuracy for the assessment of 
activities of daily living as defined by the Barthel Index. Not surprisingly, it was less 
accurate at predicting psychological dysfunction as defined by the HADS. The 
modified recovery question proved a highly sensitive question for the detection of 
problems in all of the domains assessed, but it lacked specificity. 
The median score and interquartile range for the standard instruments are shown for 
groups defined by their responses to both questions (Table 8.4). The median scores 
with the standard instruments were ordered appropriately and were statistically 
distinct. Figure 8.3 shows the distribution of responses to the Frenchay Activities 
Index for patients who were classified as dependent, independent or fully recovered 
according to the modified simple questions. Figure 8.4 shows the distribution of 
responses to the EuroQol questionnaire for patients classified by their responses to 
the modified simple questions. The best outcome in all domains (including overall 
health related quality of life with the "thermometer" - Table 8.5) was reported by the 
fully recovered group of patients. The mean utility scores with the EuroQol differed 
significantly among groups of these patients classified by their responses to the 
simple questions, Table 8.5. 
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8.3.1.1.2 Validity of the proxy assessments 
The study nurse, using the OPCS disability measure, rated six patients as having 
significant difficulties in communication. These six patients did not therefore provide 
data for the assessment of agreement between the patients and their proxies. We 
obtained proxy assessments of the patients' outcome with the modified simple 
questions for 121 of the 147 patients. Agreement between the patient and their proxy 
for the outcome classification with the modified simple questions was good 
(agreement = 87/121 = 72%; kappa = 0.57,95% confidence interval 0.45 to 0.69). 
There was a trend towards proxies assessing the patients' functioning as worse than 
that assessed by the patients themselves (21 versus 13, sign test p>0.05). 
8.3.1.2 International Stroke Trial Series 
8.3.1.2.1 Relationship between the simple questions and the EuroQol 
Figure 8.5 shows the distribution of responses to the EuroQol questionnaire for the 
patients classified by their responses to the modified simple questions. As before, 
each of the groups have distinct responses for all of the domains of the EuroQol and 
the pattern of responses was very similar to that observed in the other (Lothian Stroke 
Register) cohort (see Figure 8.4). For this larger cohort of patients, the mean 
estimates of overall health related quality of life were also ordered appropriately and 
were statistically distinct for each of the three levels (Table 8.5). The EuroQol utilities 
showed a similar pattern (Table 8.5). 
8.3.1.2.2 Relationship between the simple questions and the SF-36 
Although the responses to the modified simple questions appeared to be closely 
related to the patients' health related quality of life as defined by the EuroQol, I then 
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confirmed the relationship by relating the simple questions with the SF-36 (Table 8.6). 
For all but two of the domains (physical role functioning and mental health), the 
median scores for each domain were ordered appropriately and differed from each 
other. In the physical role functioning domain, the dependent and independent 
patients both scored zero out of a possible 100. This provides further evidence for a 
floor effect in this domain, see Section 7.3. Similarly, the median score in the mental 
health domain of the SF-36 was the same for patients who were classified as 
independent or recovered. 
8.3.1.2.3 Test-retest reliability of the modified simple questions 
In the study of the reliability of the EuroQol and SF-36 questionnaires, 443 patients 
returned repeat assessments of outcome - see Figure 6.1. These assessments 
included responses to the modified simple questions. A further 688 patients also 
returned repeat assessments of outcome which included the modified simple 
questions as part of the comparison of the EuroQol and SF-36 questionnaires - 
Chapter Seven, see Figure 7.1. Thus, 1,131 patients potentially completed the 
simple questions at test and retest, see Figure 8.1. Test-retest reliability was very 
good for both modified questions and the classification of overall outcome with the 
modified simple questions (Table 8.7,8.8,8.9). 
8.4 Discussion 
8.4.1 Modified dependency question 
I found that the modified dependency question was a valid measure of dependency in 
activities of daily living after stroke. It had excellent sensitivity, specificity and 
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accuracy for identifying dependency after stroke. Although the current study was not 
primarily designed to directly compare the validity of the modified dependency 
question with that of the original, it had a greater sensitivity than the original at 
identifying dependency after stroke (85% versus 61%); however, its specificity was 
slightly worse than that of the original question (85% versus 96%) (Lindley et al. 
1994). A multivariate test of the null hypothesis that the modified question has 
equivalent sensitivity and specificity to the original was marginally significant (Chi 
squared 5.93, df=2, p=0.052) and therefore suggests that the modification may have 
altered the question's measurement properties. The modified dependency question 
was also highly accurate at identifying poor mobility and social functioning after 
stroke. It was, not surprisingly, less accurate at identifying patients with psychological 
dysfunction. These indirect comparisons suggest that the modified version of the 
question has, at least, equivalent concurrent validity to the original as well as 
improved face validity (Lindley at al. 1994; Dennis at al. 1997b). I found the modified 
dependency question also had excellent test-retest reliability (kappa = 0.81); this 
compares very favourably with the inter-rater reliability of the original question (kappa 
= 0.51)(Dennis at al. 1997a). This difference may reflect the improved wording of the 
new question. Alternatively it may just reflect the differences between inter-rater and 
test-retest reliability or the method of questionnaire administration. Dennis and 
colleagues employed two raters who administered the simple questions on different 
occasions by face-to-face interview (Dennis at al. 1997a), whereas we administered 
the questions by post. 
8.4.2 Modified recovery question ("problems" question) 
We completely reworded the recovery question because patients found the original 
wording ambiguous and our assessments of its validity also revealed uncertainty 
about which aspect of outcome it addressed (Dennis at al. 1997a; Dennis at al. 
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1997b). The reworded question aims to detect those patients who are left without 
significant problems resulting from the stroke, rather than to identify patients who 
recover to the point of having no problems at all, whatever their cause. This 
alternative emphasis, although relatively subjective and non-specific, may be more 
relevant to both patients and their families. The reworded question had excellent 
sensitivity and moderate specificity for the detection of problems in all the domains 
examined (mobility, self care, social functioning and psychological functioning). 
These measurement properties differ clearly from those of the original recovery 
question (Dennis et al. 1997b) and support the validity of the reworded question. 
The reworded question also had substantially better reliability than the original (kappa 
= 0.78 versus kappa = 0.61) (Dennis et a!. 1997a). However, it is not clear whether 
this is because of the improved wording or differences in the study design - see 
above. It is also not clear from the current data how patients with problems after their 
stroke relate to those who reported that they had not made a full recovery with the 
original question. 
8.4.3 Combined use of modified questions to assess health 
related quality of life 
The modified simple questions may be used to classify surviving patients into one of 
three hierarchical outcome groups. Approximately half of the independent patients 
were left with significant problems as a consequence of the stroke. This illustrates 
the ceiling effect with simple measures of disability that focus exclusively on 
activities of daily living, i. e. if the dependency question was the only measure of 
outcome, then other significant limitations (e. g. problems with household 
maintenance, social and psychological functioning) would not be captured. Additional 
assessments of health are therefore required in independent patients who might 
otherwise be considered as having achieved a "good outcome" after their stroke. The 
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statistically distinct profile of scores for this group of patients with the standard 
instruments support the validity of this hierarchical classification. 
The validity of this classification is further supported by its close relationship with 
patients' responses to the assessments of health related quality of life. The same 
pattern of responses were observed, in both cohorts of patients, for assessments with 
the EuroQol and in the IST cohort for assessments with the SF-36. Therefore, the 
combined use of these modified simple questions, to classify patients as dependent, 
independent and fully recovered, appears to offer a simpler approach to the 
assessment of global health related quality of life, than with even the EuroQol. These 
assessments also had very good test-retest reliability which was of a similar order of 
magnitude to that observed for the assessments of overall health related quality of life 
with the EuroQol or general health with the SF-36 (Tables 6.2 and 6.5 respectively). 
Moreover, agreement between patients and their proxies for their responses to the 
modified simple questions was also moderately good (kappa = 0.57). There would be 
several potential advantages associated with the use of these simple questions for 
the assessment of health related quality of life after stroke. Firstly, because of their 
brevity and simplicity they are likely to place less of a burden on patients, and so may 
be more feasible than more complex measures. The advantages of short and simple 
measures, with a high frequency of response, are discussed in full in Chapter Five. 
Secondly, analysis of data based on a single classification of outcome by the simple 
questions would be simpler to both perform and interpret, than analysis of 
multidimensional data from a health related quality of life instrument, see Section 
10.3.1. Finally, treatment effects described in terms of the proportion of patients 
reporting a change in response to the simple questions would have more immediate 
interpretability than a change in numerical score or utility. 
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However, there are also disadvantages to replacing detailed assessments of health 
related quality of life with the cruder information provided by these questions. Firstly, 
the modified simple questions could only be used to provide a broad and global 
assessment of health related quality of life. Therefore, the opportunity of obtaining 
information about outcome in specific domains, for instance psychological 
functioning, would be lost. This would reduce the opportunity to explain how a 
treatment improves overall health related quality of life, e. g. by improving 
psychological functioning or by improving mobility. Secondly, the modified simple 
questions were developed as a disease-specific instrument. They do not, therefore, 
provide outcome information which can be used to compare directly the effects of 
different treatments in groups of patients with different diagnoses. However, such 
comparisons could still be performed, albeit indirectly, by using the data from Table 
8.5 to map patients' responses to the simple questions into health related quality of 
life utilities with the EuroQol. 
8.4.4 Would qualitative research methods help understand the 
meaning of patients' responses to the simple questions? 
The above studies were based on quantitative research principles. Quantitative 
research may be censured for lacking contextual detail and deriving trivial insights. 
Qualitative research belongs to the contrasting epistemological stance. it 
necessitates the study of relatively small numbers of non-randomly selected patients 
and employs deliberately unstructured, in-depth, face-to-face interview and 
observational techniques (Henwood & Nicolson, 1995). Findings are logged and 
analysed in a semi-structured way and grounded hypotheses emerge and are refined 
as the study progresses. Qualitative studies aim to unlock the "black box" of human 
thought and behaviour, and might be valuable in understanding the findings produced 
by the cross-tabulation of the modified simple questions. However, qualitative 
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methodology may be criticised as biased, lacking in power and generalisability 
(Carey, 1993). Furthermore, the validity of mixing of qualitative and quantitative 
techniques in one study is controversial (Carey, 1993). 
8.4.5 Conclusions 
Patients completed these modified simple questions either by interview or 
questionnaire in the presence of the study nurse. Although the study nurse did not 
routinely ask patients about their interpretation of either question, no significant 
ambiguities were noted. These modifications therefore appear to have improved both 
the face and content validity as well as the reliability of these simple questions. The 
current study has provided strong support for the concurrent validity of the modified 
questions when used either individually or together to classify patients into one of 
three hierarchical groups which are relevant to the patients' overall health related 
quality of life. Proxies were able to provide a moderately accurate and unbiased 
assessment of the patients' outcome after stroke with these modified simple 
questions. Therefore, the "modified" versions of the simple questions appear to be 
valid, and although they have not been formally compared, they seem preferable to 
the original. 
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8.5 Summary of Chapter Eight 
1. The responses of patients to both simple questions may be used to classify 
patients as dependent, independent but not fully recovered, and independent and 
fully recovered. The relationship between this classification and assessments of 
health related quality of life had not previously been tested. 
2. A previous study of the validity of the original simple questions had revealed 
ambiguities in their wording. For the present study, we examined the clarity, 
validity and reliability of a modified version of these simple questions. 
3. The modified dependency question had excellent sensitivity, specificity and 
accuracy for identifying dependency after stroke. Indirect comparison with the 
original wording suggest that it has, at least, equivalent concurrent validity to the 
original as well as improved face validity. 
4. The reworded recovery question aimed to detect patients left with significant 
problems as a consequence of their stroke. It had excellent sensitivity and 
moderate specificity for the detection of problems in a broad range of domains 
(mobility, self care, social functioning and psychological functioning). 
5. The combined use of the modified dependency and recovery questions, to classify 
patients as dependent, independent and fully recovered, provided a valid and very 
simple overall measure of health related quality of life after stroke. This 
classification had very good test-retest reliability and was also moderately accurate 
when assessed by proxies on behalf of the patients. 
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Table 8.1: The simple questions 
Original wording: 
Dependency question 
"In the last two weeks, did you require help from another person for everyday 
activities? " 
Recovery question 
"Do you feel that you have made a complete recovery from your stroke? " 
Modified wording: 
Modified dependency question 
"Do you need help from anybody with everyday activities? " 
Modified recovery question 
"Has the stroke left you with any problems? " 
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Table 8.2: 2x2 table illustrating the responses to the modified 
dependency and recovery questions (n=147) 
"Has the stroke left you with 
any problems" b 
Yes No Totals 
"Do you need help from anybody with 
everyday activities? " e 
Yes (dependent) 46 8 54 
No (independent) 52 41 93 
Totals 98 49 147 
a modified dependency question 
b modified recovery question 
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Chapter Eight 
Table 8.7: Test-retest reliability of modified dependency question 
(n=1,033) 
First assessment 
Dependent Independent 
Dependent 679 46 
Second assessment Independent 37 271 
Agreement = 92% 
Kappa = 0.81 (0.77 - 0.85) 
Table 8.8: Test-retest reliability of modified recovery question (n=1,083) 
First assessment 
Problems No problems 
Problems 679 46 
Second assessment No problems 37 271 
Agreement = 94% 
Kappa = 0.78 (0.73 - 0.83) 
Table 8.9: Test-retest reliability of the overall classification of outcome 
derived using both modified simple questions (n=1,020) 
First assessment 
Dependent Independent Recovered 
Dependent 679 38 8 
Second assessment Independent 27 98 21 
Recovered 9 11 129 
Agreement = 89% 
Kappa = 0.76 (0.71 - 0.80) 
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Chapter Eight 
Figure 8.2: A flow diagram illustrating how the simple questions could 
be used to classify patients into one of three hierarchical groups 
Question 
"Do you need help from anybody 
with everyday activities? " 
jNo 
Outcome 
Yes 
0 Dependent 
Yes 
"Has the stroke left you with any Independent 
problems? " 
No Fully recovered 
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Chapter Nine 
9 Quality of life after stroke: do patients prefer 
death or disabled survival? 
9.1 Introduction 
If clinicians understand the impact of stroke disability on a patients' quality of life this 
may help inform clinical decision making. For example, the decision about whether or 
not to use a potentially risky treatment such as thrombolysis in a patient with an acute 
ischaemic stroke will depend in part on the value ascribed by the patient to surviving 
the stroke in a non-disabled state. Patients considering whether or not to have 
thrombolysis may be prepared to trade off the immediate increase in the risk of death 
if treatment also increases the overall chance of survival without disability (Wardlaw 
et al. 1996). This trade off will be more acceptable to patients who fear the prospect 
of being alive but disabled after the stroke. Thus doctors, making urgent decisions 
about the relative merits of using, or not using, a particular treatment need reliable 
evidence on patients' preferences for different outcomes. Ideally, this information 
would be obtained from patients who have recently had a stroke. Without this 
information, clinical decision making in stroke patients who are acutely ill and unable 
to participate in the decison making process themselves will be affected by the 
personal prejudices of the individual doctor and his or her, necessarily subjective, 
view of whether the patient would rather be dead than disabled. For example, if the 
doctor himself feels that disabled survival is a fate worse than death, he may opt to 
use a potentially risky (i. e. fatal) treatment, when in fact the patient - had they been 
capable of expressing a view - might have opted for not being given the treatment. 
Two studies have examined non-disabled patients' preferences for hypothetical 
strokes of differing degrees of severity and concluded that many patients might prefer 
death to survival in a severely disabled condition (Solomon et a!. 1994; Gage et a!. 
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1996). This conclusion may be unjustified. Firstly, the studies examined only the 
attitudes of non-disabled patients to anticipated physical disability, and not the 
attitudes of patients actually disabled by stroke (which might well be very different). 
However, the attitudes of disabled stroke survivors are often impossible to assess 
directly because neurological deficits limit the patients' ability to complete 
questionnaires or participate in interviews. Secondly, the studies only examined 
attitudes to anticipated physical disability and so neglected the possibility that other 
domains of outcome (e. g. psychological functioning) might determine a patient's 
overall quality of life. Thirdly, and most importantly, their conclusions seem 
inconsistent with the report that the majority of long term stroke survivors are satisfied 
with their lives (King, 1996). 
I therefore used the EuroQol, a generic measure of health related quality of life, which 
I have validated for use after stroke (Chapter Three), to assess the health related 
quality of life of a large sample of disabled and non-disabled stroke survivors. I 
investigated the attitudes of severely disabled stroke patients to their disability by 
comparing assessments of the patient's overall health related quality of life with those 
of less severely disabled and non-disabled stroke survivors. I also compared the 
patient (or carer) valuations of the patient's health states with valuations which reflect 
the preferences of the general public for each of the patient's health states. I finally 
investigated whether the measurement of health related quality of life provides a more 
comprehensive picture of outcome after stroke, than measures of disability alone, by 
investigating which domains of health related quality of life distinguish between stroke 
survivors and age- and sex- matched community controls. 
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9.2 Methods 
9.2.1 Selection of stroke patients 
In a previous study I performed a direct assessment of the feasibility of a postal 
version of the EuroQol questionnaire after stroke (Chapter Five). I described the 
methods used to identify the patients, the format of the instruments and the method 
of questionnaire administration in Chapter Five. I used these patients' responses to 
the EuroQol questionnaire for the current analyses. 
9.2.2 Selection of control patients 
We selected control patients from participants in two national population surveys in 
which the EuroQol had been included. The first of these surveys was commissioned 
by the Department of Health to investigate the way that the general public values 
health states (Measurement and Valuation of Health (MVH) Study). In this survey, a 
representative sample of the United Kingdom population (n=3,235) completed the 
EuroQol questionnaire as part of a longer face-to-face interview (Gutlex at aL 1996; 
Kind at al. 1998). The second of these surveys also drew upon a nationally 
representative sampling frame and was conducted by the then Office of Population 
and Census Studies (OPCS) and involved 5,962 respondents (Omnibus Survey, 
1995). Both studies surveyed non-institutionalised individuals living in the community. 
We matched stroke patients by age and sex against individuals in the MVH dataset. 
Once selected as a match, individuals in the MVH dataset were removed from further 
consideration. We repeated this process using the Omnibus Survey dataset for 
stroke patients not matched by the MVH data. 
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9.2.3 Study instruments and definitions 
I used the modified dependency question (Do you need help from anybody with 
everyday activities? ) to assess dependency in activities of daily living after stroke, 
(Chapter Eight). I used a combination of patients' responses to the EuroQol 
questionnaire and the dependency question to classify patients according to the 
severity of their physical disability: 
Severe physical disability: I classified patients as "severely physically disabled" if they 
reported severe problems in either the mobility or self care domains (i. e. "I am 
confined to bed" or "I am unable to wash or dress myself"). 
Disabled: I classified patients as disabled if they responded with "yes" to the 
dependency question and did not report severe problems in either the mobility or self 
care domains of the EuroQol. 
Non-disabled' I classified the remainder as non-disabled. 
9.2.4 Statistical analysis 
I examined the attitudes of stroke survivors, or their carers, to their current health 
status by plotting the distribution of their estimates of overall health related quality of 
life against the severity of their current reported physical disability. I compared the 
overlap between the distributions by assessing the proportion of severely physically 
disabled or disabled patients who had scores within the range of scores for non- 
disabled patients. I also examined the attitudes of the general public to the stroke 
patients' health states by plotting the distribution of EuroQol utilities (Dolan et al. 
1995) for patients classified according to the severity of their current physical 
disability. Dolan and colleagues derived these utilities by asking the 3,235 
respondents of the MVH survey to directly value 45 (of the 243) EuroQol health states 
using a time trade off technique. The remaining health states were valued indirectly 
by a statistical modelling technique. 
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I also compared the overall health related quality of life of each stroke survivor with 
that of individually age- and sex- matched controls. I performed a conditional logistic 
multiple regression analysis (S-Plus) to investigate which domains of the EuroQol 
differed between patients with stroke and community controls, i. e. which domains are 
important in post-stroke outcome. 
9.3 Results 
905 patients returned a EuroQol questionnaire booklet after one reminder, (Chapter 
Five). On the basis of their responses to the EuroQol and the dependency question, I 
classified 187 patients as severely disabled, 476 as disabled and 210 as non- 
disabled. I was unable to classify 32 patients because they did not complete the 
dependency question. Only 15 (8%) of the severely disabled patients completed the 
EuroQol questionnaire themselves; by contrast, 229 (48%) of the disabled patients 
and 184 (88%) of the non-disabled patients completed the EuroQol questionnaire 
without help. The baseline distributions of age, sex and stroke syndromes differed 
amongst the severely disabled, disabled and non-disabled patients, are given in Table 
9.1 
There was a significant overlap in the distribution of the estimates of their overall 
health related quality of life for patients with differing levels of physical disability 
(Figure 9.1). Fifty six (34%) of the severely disabled patients and 237 (54%) of the 
disabled patients reported, or were assigned, overall health related quality of life 
scores which lay between the 5th and 95th percentile of the scores of the non- 
disabled patients; 393 (90%) of disabled patients and 68 (35%) of the non-disabled 
patients had overall health related quality of life scores below the 95th percentile of 
the scores of the severely disabled group. Similarly, there was a significant overlap in 
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the distribution of estimates of overall health related quality of life between stroke 
patients and age- and sex- matched community controls (Table 9.2). 
By contrast, the overlap in the distribution of utilities for patients with differing levels of 
physical disability was much less marked, Figure 9.2. None of the severely disabled 
patients had utilities which lay between the 5th and 95th percentile of the valuations of 
the non-disabled patients. Only 128 (27%) of the moderately disabled patients and 
one (<1%) of the non-disabled patients had utilities below the 95th percentile of the 
severely disabled group. Approximately 47% of the severely disabled patients had 
utility scores of less than zero (i. e. in the view of the general public their health states 
might be considered worse than death). 
Stroke patients reported significantly worse overall health related quality of life than 
age- and sex- matched community controls, Table 9.2. In a conditional logistic 
regression, five of the six domains of the EuroQol (self care, social functioning, pain, 
psychological functioning, and subjective assessments of overall health related 
quality of life) contributed independent information which helped separate stroke 
patients from control subjects, Table 9.3. In this model, stroke patients reported less 
pain than the control subjects after adjustment for the other variables. 
9.4 Discussion 
9.4.1 Do stroke survivors prefer death to disabled survival? 
There was a marked overlap in the subjective valuations of overall health related 
quality of life given by, or for, patients who were severely disabled, disabled and non- 
disabled. Many disabled patients reported, or were assigned, estimates of overall 
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health related quality of life which were similar to those reported by both the non- 
disabled stroke patients and the community controls. This suggests that many 
disabled stroke patients might regard their quality of life as acceptable and would not 
prefer death to being alive, but physically disabled. The distribution of utility scores 
(generated by the valuation of hypothetical health states by the general public - see 
Section 9.2.4) suggests a qualitatively different conclusion. The distribution of the 
utility scores had a completely different shape to that of the patient, or carer, 
estimates of overall health related quality of life. The scores of the severely disabled 
patients did not overlap as much with those of the disabled and non-disabled patients. 
Moreover, approximately half of the severely disabled patients had utility scores of 
zero or less which implies that their health state might be considered, at least in the 
eyes of the general public, worse than death. 
These apparently conflicting results might simply reflect a difference in the attitudes of 
respondents depending on whether they are directly valuing an actual real-life health 
state or a hypothetical health state. Alternatively, the personal experience of disability 
may have modified the manner in which an individual perceives his/her or a relative's 
current health state, i. e. many of the disabled stroke respondents might have also 
considered death as preferable to disabled survival before they suffered their 
disabling stroke. Subjects with poor health in a community based study gave higher 
valuations (i. e. closer to good health) for disordered health states (Kind & Dolan, 
1995), and in a study of individual quality of life in patients awaiting unilateral hip 
replacement, the patients had similar scores to the healthy controls (O'Boyle et al. 
1992). These experimental conclusions are also consistent with more anecdotal 
examples of the remarkable capacity with which individuals maintain hope and 
meaning in life despite adverse circumstances, e. g. victims of concentration camps 
(Fallowfield, 1990). 
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Over 40% of disabled stroke survivors reported, or were assigned, estimates of 
overall health related quality of life which were similar to those reported by the non- 
disabled patients. However, there was a substantial number of severely disabled 
patients who were assigned, or reported, overall health related quality of life below 
this range. It is plausible that a significant proportion of these patients have such 
poor health related quality of life that they might prefer death to disabled survival. It 
would be ideal if each of these groups of patients (i. e. those who subsequently 
achieve acceptable health related quality of life and those who do not) could be 
identified prospectively at the time they present to the hospital with their stroke. 
However, this would require very accurate prognostic models for the prediction of 
both disability and overall health related quality of life. Current models for the 
prediction of disability after stroke are only accurate enough for predicting outcome in 
large groups of patients, rather than for individuals (personal communication, Carl 
Counsell). As yet, no models for the prediction of health related quality of life after 
stroke have been described. Furthermore, it is unlikely that any such models will ever 
be sufficiently accurate. 
9.4.2 Are the patients (and the carer's) assessments of overall 
health related quality of life valid? 
The validity of our conclusions depend largely on the validity of the patient and carer 
assessments of health related quality of life with the EuroQol. I have demonstrated 
the concurrent validity of the EuroQol when administered by either questionnaire or 
interview after stroke, (Chapter Three). I found that patients' subjective assessments 
of overall health related quality of life with the EuroQol were best explained by the 
patients' mood, level of social functioning and pain, and so were likely to be clinically 
meaningful. In this current study many of the assessments of overall health related 
quality of life in patients with disability were completed by proxies rather than by the 
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patients themselves. However, this problem is not unique to this study; physical and 
cognitive problems prevent the direct assessment of quality of life in most severely 
disabled patients by any means. Moreover, it is unlikely to be important as I have 
previously demonstrated assessments by proxy to be moderately accurate, Chapter 
Four. Furthermore, proxy assessments tend to underestimate rather than 
overestimate the patients' health, at least for patients with mild to moderate disability, 
see Section 4.3. Unfortunately, the accuracy of proxy assessments for more severely 
disabled patients is not testable, see Section 4.4.4. 
The observed overlap in health related quality of life between disabled and non- 
disabled patients might have been exaggerated if the non-disabled patients had sub- 
optimal overall health related quality of life because of problems in the domains not 
related to physical functioning. Again, this seems unlikely to be important because I 
also observed a clear overlap between scores of the stroke patients and those of the 
age- and sex- matched community controls. 
The surprisingly high overall health related quality of life scores of the disabled 
patients could be interpreted as reflecting the patients' optimism about their prospects 
for recovery. However, this also seems unlikely, because these assessments were 
performed after a mean interval of approximately 60 weeks after the index stroke, at a 
time when most patients' neurological status would have been stable for at least a 
period of several months. 
9.4.3 Are the determinants of health related quality of life after 
stroke multidimensional? 
In this study, stroke patients reported, or were assigned, a wide range of scores of 
overall health related quality of life. This is consistent with the observation that any 
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two patients may have very different functional and emotional responses to the same 
clinical deficit (Guyatt et al. 1993). The wide range of estimates of overall health 
related quality of life for patients with apparently similar severity of physical disability 
also suggests that physical functioning is just one of several factors which determine 
the patient's overall health related quality of life. I investigated this further by 
comparing the health related quality of life of stroke patients with that of age- and 
sex- matched community controls. A conditional logistic regression indicated that five 
of the six domains of the EuroQol (self care, pain, psychological and social 
functioning, and subjective overall health related quality of life, but not mobility) 
provided useful independent information which helped to distinguish stroke patients 
from community controls. These findings suggest that any studies on the patients' 
views about hypothetical strokes, should include descriptions of problems in the 
relevant domains of health related quality of life, rather than just focusing on patients' 
views about physical impairments, i. e. Solomon and colleagues should have included 
psychological problems and pain in their hypothetical scenarios, rather than just 
neurological impairments. Similarly, any future studies of outcome after stroke should 
include measures of health related quality of life, rather than just measures of 
disability, as this will help provide a more global picture of the patients' outcome. 
Measuring all the domains of health related quality of life may improve the power of 
trials to detect treatment effects and focus attention on the outcomes which are more 
relevant to patients (Rothwell et al. 1997). 
9.4.4 Clinical implications and conclusions 
It may well be that healthy, non-disabled individuals with no personal experience of 
stroke would prefer to die from a hypothetical stroke than to survive in a disabled 
state. The present study shows that a significant proportion of disabled stroke 
survivors, or at least their carers, do not view survival in a disabled state as such a 
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bad thing as one might expect. Clinicians should bear these findings in mind when 
considering treatments which apparently trade off duration of survival against quality 
of survival. The EuroQol domains of self care, social functioning, pain, psychological 
functioning and subjective overall health related quality of life all provided 
independent information which helped separate stroke patients from community 
controls. Assessments of health related quality of life may therefore provide a more 
comprehensive description of patients' functioning after stroke than measures of 
disability. 
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9.5 Summary of Chapter Nine 
1. Many disabled patients reported, or were assigned, estimates of overall health 
related quality of life which were similar to those reported by both non-disabled 
stroke patients and community controls. This suggests that some disabled stroke 
patients, or their carers, regard their quality of life as acceptable and would not 
prefer death to being alive, but physically disabled. 
2. The utility scores (generated from general public valuations of the health states of 
severely disabled patients) differed substantially from the patient or carer 
valuations. In the view of the general public, many of these patients have health 
states which might be considered worse than death. These contrasting results 
might simply reflect a difference in the attitudes of respondents with direct 
experience of disability. 
3. Patients with a similar severity of physical problems reported a diverse range of 
estimates of overall health related quality of life. This suggests that physical 
functioning is just one of several factors which determine a stroke patient's overall 
health related quality of life. A conditional logistic regression indicated that five of 
the six domains of the EuroQol (self care, pain, psychological and social 
functioning, and subjective overall health related quality of life) provided useful 
independent information which helped to distinguish stroke patients from 
community controls. 
201 
m 
2 
I- 
.m 
r U 
m 
v 
C 
m 
CL 
v 
O) 
0 
72 
e0 
H 
'v 
m T" NN 
ÖC 
'v 
N 
Co 
U, 
0 
f- N 
rn 
Co 
. ý. -. ýý 
T- (3) 
L') 
of M 
NN 
ö 
oý öö 0) co co 0) 
`ý ýT N 
Co r- Lo 0 
%äe ö 
Cp ýN pf 
I- Iý 
o' 
rnCO 
"'Co 
ý. ý- N ý1; 
ýý 
r 
ýti 
a) 
Nn 
eJ-Q --, R -A *ý 
V TOG 
'CC O 
C C ) NGOsfý vC0 
ý 
NC 
e- ýp CON(Cr' rp 
ýý 
e 00r 
N 
0 
N 
E 
0 
c 
0 
N 
m 
C 
ý0 
ý Vx c ýQQ 
Icy 
9- 
e 
to wyv 
E LO 0 
YC 
CC 
t0 N 
Ü 
Ö 
C 
0 
Z 
NE 
Ö 
LD y 
yYC 
Yy 
Co =E 
"+O-, e0 ON 
"U py 
. 
000 00 
NCp 
C lp 
O 
Cý "C 
ON= 
M *E 
- Co ci. 
CO (0 (0 
äÜ 
Haha 
N 
O 
N 
m 
CD 
O 
m 
e0 
U1 
O 
C 
C 
O_ 
E 
m 
m a 
2 
m 
a 
3 
a m 2 
m 
m 
0 
w 0 
W 
w E 
p m W 
N 
G 
0 
I- 
0 
C 
0 
V 
E 
E 
0 
v 
d 
0 
C 
0 
C 
m 
.C 
E 
m 
W 
C 
0 
m 
Im 
V 
A 
CL E 
0 
0 
a 
co rn 
ui co CM co 
ßß 
C 
m 
C5 O 
H 
'p w 
OO 
V 
Eý 
N0 
Ot 
v 
Öm 
Uß_ w 
coo 
000 
000 
1n N Ul) 
M C7 
Nd C) 
ti ti ti 
Co 
4- C 
N 
C5 
O 
c 
z 
d 
O 
C 
ýä 
ti ai ö 
$o 
1ý MM 
M IA N. 
CO M 
C ýj 
v T2 
>% 79 to 
> 
az 
co 
U) 
U) 
E 
O C 
L 
N 
Ö 
8 
C 
t0 
N 
C 
2. N 
Y 
O 
.r N 
LA, 
E 
C 
2 
. -. 
0 
ö 
v 
a 
J 
O 
a 
I 
IM- N 
O 
v- O 
N 
r 
is 
N 
d 
Ö 
0 
Cß 
O 
C 
m 
t6 
L 
R 
m 
Y 
O 
.r N 
19 
C 
r c0 
a 
C O 
a) 
.r 
w O 
aß 
C 
U 
C 
a) V 
tr= 
C 
8 
0) 
a) L 
C 
L 
N 
N 
8 a) 
t 
N 
C 
N 
r 
t0 
a 
Y 
O 
N 
O 
7 
C 
} 
M 
O 
m e 2 
m 
a 
Ü m 
2 
ea 
E 
m a, 
V 
a, 
a, 
c 
a, 
c 
m 
a, 
CL 
I 
0 
m 
t 
c 
a 
c 
c m 
c 
c 
E 
O 
co 
C 
0 
0 
2 
0, 
2 
O 
O 
Tv 
C 
O 
C 
O 
ti 
W 
C 
O 
C 
E 
E 
O 
v 
U 
a°. IC) 
O 
w 
Co 
10 
0 
.c E 
0 
41 41 .., 
r- Co e V) CO 
NÖoC70 
r- e- . 
Mr0N 
Cq r-. 
Co J 
Co 
ÖD 
cca ua 
ýýnaacý 
NN 
U) 
c I- 
- ca c 
ca 
-°a 
ö 
L- 
0-en 00 
um 
w .5 
N r- 
0 
C .a 
Eä 
m CS 
z 1-2 o -" 
a 
m r' 
ä. ý 
YI 
20 
-5 
«0 
MO 
c_Q 
äý 
öö 
0 
- 
Co 
A tu ca 
O 
d 
`O = 
Wmvi 
a 
c 1°ý oc i) 
f3 "- E 47 E 
coc 
oo 
cm 
L- O 
1 
I 
O 
04 
m 
c Z 
L. m 
4 
co Ü 
N 
N N 
a) 
I- O 
O 
U) 
C 
I. - 
O 
Q 
'O 
cv 
2 
ß 
N 
ea 
d 
O 
v- O 
N 
ß 
E 
N 
O 
O 
> 
vZ 
CY 
OO 
CL 
Od 
C 
Om 
Ö 
_N C D 'p 
rN 
dO 
7 e0 
G_) N 
LJ. ý 
J 
0 
2 
0 
7 
(1) 
U_ 
L 
4-0 
I 
°0 
of 
oÖ-) 
6 
01 
0- 
61 
Oý 
OS 
S 
6'4 
1? 2 O2ý 
61 
OW 
Off, 
ocew 
6'- 
O1 
Oz 
6o, 
ß 0 
J 
0 
0 
2 
0 
U) 
a) 
E 
a) 
t- 
a) 
0 
a) 
U) 
0 
Z 
0 
70 a) 
Co 
U) 0 
a) 
M 
Ch 
0 
a) 
N 
C/) 
Lf) 
0 
N 
MNN LO OLO 
m c 
L 
O 
Y 
0 
L. 
V 
d 
Ä 
eo 
N 
0 
C 
C 
ß 
M 
_d B 
es 
ß 
O 
O 
d 
N 
d 
C 
N 
O 
O 
N 
O 
O 
I- 
W 
0 
C 
0 
NL 
CD 0 
a 
LL 0 aMNOO 
OJOOS y; inn Oße; UOOJsd 
0"L 0106 0 
6W0 0 090 
6CO03OLO 1,00 
cC 
69'0 0; 09'0 
69'0 0l 09'0 
6V *O 0 OtL O 
6£"0 01 o£"o 
a) ca 
6z"o 03 VO ö 
66.0 03 L"0 
v 0 
60.0 04 60.0 0 
0'0 01 60'0- 
06.0- 0; 6Vo- 
O Z"0- 01 6V0- 
WO 016V0- 
V, 0- 03 sv o- 
  
s"o- 06 O-- 
(0 
0 
N 
Chapter Ten 
10 Summary and Conclusions 
10.1 Measuring health related quality of life after stroke 
In the preceding chapters, I have presented the results of a series of studies to 
examine the measurement of health related quality of life in a large randomised 
controlled trial in patients with stroke. I initially discussed the definition of health 
related quality of life and the reasons for its measurement in Chapter One. I 
subsequently presented the results of a systematic review of the published studies on 
the measurement of health related quality of life after stroke (Chapter Two). This 
review highlighted that although little formal work had examined the measurement 
properties of quality of life instruments in patients with stroke, the feasibility of these 
assessments was likely to be a major problem. The issue of feasibility is critical when 
assessing health status in large numbers of patients. In this situation, measurement 
tools need a low administrative and patient burden. I therefore selected a very simple 
generic measure of health related quality of life (the EuroQol) and examined its 
validity when completed by patients or their proxies. I found it had excellent face and 
content validity and moderately good concurrent and discriminant validity. Proxy 
assessments of health related quality of life with the EuroQol were also generally 
feasible and accurate; particularly for the easily observable domains of functioning 
such as mobility and self care. Proxy assessments were less accurate, but still 
acceptable for the social functioning and pain domains and the assessment of overall 
health related quality of life. In contrast, proxy assessment of the patients' 
psychological functioning had poor accuracy. 
The SF-36 is another widely used generic instrument for the measurement of health 
status which had been validated after stroke (Anderson et al. 1996). Like the 
EuroQoi, it was designed to be delivered by post and self-completed, but had been 
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administered by interview because of concerns over feasibility in patients with stroke 
(Anderson at al. 1996). I compared the EuroQol with the SF-36 to inform the 
selection of health related quality of life instrument after stroke. This comparison 
raised a variety of scientific issues. 
10.2 Comparing instruments 
The question: "which is the best health related quality of life instrument? " is 
frequently considered by investigators during the planning phase of clinical studies. 
Most commentators suggest that investigators should select the instrument with the 
best measurement properties (validity, reproducibility, and responsiveness) in the 
particular population of interest. There are problems with this approach. Firstly, 
interpreting the results of studies which examine measurement attributes is not 
straightforward. This is partly because there is no "gold-standard" for the 
measurement of health related quality of life, but also because the results of the tests 
used to assess these measurement properties require subjective interpretation (for 
instance, tests of validity do not generally show that it is simply absent or present, but 
require qualitative interpretation). Consequently, this hinders the comparison of the 
available instruments. 
Most studies have examined the properties of single instruments in isolation, and so 
most comparisons have been indirect and potentially confounded by differences in 
case mix between studies. Some studies have compared instruments by 
administering both instruments sequentially in the same order to all patients (a non- 
random crossover design). Unfortunately, these studies are vulnerable to biases 
which arise from ordering effects (e. g. the response to the EuroQol might differ if the 
SF-36 is administered immediately before). These biases would be eliminated in a 
randomised comparison, as the process of randomisation aims to ensure that both 
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groups are similar at baseline. In such a study, it would be valid to administer only 
one instrument to each group of patients, and so eliminate potential problems with 
ordering, as well as test both instruments in a more directly relevant way. I therefore 
performed a direct randomised comparison of the EuroQol and SF-36 in survivors of 
acute stroke (Chapter Five). This gave a reliable and unbiased comparison of their 
relative feasibility. I found significantly better response frequency and quality of 
response in patients allocated to the EuroQol questionnaire. However, I was unable 
to extend this methodology to compare (in a reliable and quantitative manner) their 
reproducibility, as different statistical techniques are required to examine the 
reproducibility of continuous (SF-36) and categorical (EuroQol) data. However, a 
weaker qualitative comparison suggested their reproducibility was similar (Chapter 
Six). I was also unable to compare directly the validity of these instruments, as there 
is no widely accepted gold-standard for the measurement of health related quality of 
life. I used a randomised cross-over study to examine the relationship between the 
domains of either instrument. This suggested that both instruments were sampling 
broadly similar areas of health. Thus, in summary, although the EuroQol had a better 
quality and frequency of response than the SF-36, it was not clear which is the best 
instrument overall. 
The simple questions were developed to measure dependency and recovery after 
stroke. Both questions can be used together to classify patients into one of three 
hierarchical levels of outcome (dependent, independent but not recovered, 
independent and fully recovered). We modified the original wording of both questions 
to try and improve their validity and reliability (Chapter Eight). I examined the 
relationship between patients' responses to these questions and the assessments of 
health related quality of life. I found the combined use of the modified dependency 
and recovery questions - to classify patients as dependent, independent, and fully 
recovered - provided a simple and valid indicator of global health related quality of 
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life. Moreover, this classification had very good reliability which was equivalent to that 
observed for the assessments of overall health related quality of life with the EuroQol 
or the assessments of general health with the SF-36. It was also moderately 
accurate when assessed by proxies. These questions may prove to be an even more 
feasible means for the assessment of health related quality of life than the EuroQol. 
However, there would be several disadvantages to replacing generic health related 
quality of life instrument assessments with the simple questions. In particular, these 
relate to the loss of generic information, as well as the loss of information about 
specific domains of outcome, e. g. psychological functioning. The relative feasibility of 
the EuroQol and the modified simple questions requires examination. 
However, a health related quality of life instrument should not be simply selected on 
the basis of its measurement attributes. The key issue that the choice of measure 
must take account of the purpose was highlighted in Section 1.6.1. A generic 
measure of health related quality of life, such as the EuroQoL, is likely to be applied 
in three major areas after stroke: randomised controlled trials (and other 
epidemiological research), routine clinical care and medical audit. 
10.3 Applications for quality of life data 
10.3.1 Randomised controlled trials 
This thesis supports the EuroQol as a useful measure of health related quality of life 
after stroke. It is particularly suitable for use in large randomised controlled trials, 
audits and screening projects. The data generated by the EuroQol may be presented 
in a variety of formats. These include as a health status profile, patient derived 
estimates of overall health related quality of life or as utilities generated from the 
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health status profiles. Presenting EuroQol derived outcomes as health status 
profiles (e. g. Patient JD : Mobility - some problems, Self Care - unable to wash \ 
dress, Activities - unable, Anxiety \ depression - not, Pain - none) is likely to be 
immediately comprehensible to doctors, patients, and relatives. By contrast, the 
clinical significance of a reported change of x points in the overall health related 
quality of life estimates or health state utility is less clear. 
10.3.1.1 Should clinical trialists measure utilities, multidimensional 
health profiles and/or clinical events? 
Summary scores have the advantage of allowing conflicting changes in the individual 
domains to be combined into a single assessment (e. g. a novel treatment for stroke 
might improve physical functioning, but cause psychological adverse effects), as well 
as providing a means by which deaths may be included in the overall analysis. 
Summary scores, therefore, facilitate the comparison of health gains across different 
conditions and patient groups. However, this approach may be criticised as it may 
obscure important differences between individual dimensions (Fletcher et al. 1992), 
and is very dependent on the methodology used to generate the utilities - see 
Section 1.6.1. Ideally, trialists should report both domain specific and summary data, 
as they provide different and potentially complementary information (Revicki & 
Kaplan, 1993). 
Several of the leading workers in this area have suggested that the new generic 
health related quality of life measures should be used alongside disease-specific 
instruments to provide a generic core of information which could be common to most 
randomised controlled trials (Ware, 1993; Williams, 1995). Jenkinson and colleagues 
compared two generic measures (the EuroQol and SF-36) with disease specific 
measures in a randomised controlled trial of laser vaporization prostatectomy for 
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patients with benign prostatic hypertrophy (Jenkinson et al. 1997). They found a 
statistically significant improvement in symptoms between baseline and follow up for 
both groups with the disease specific measures. The SF-36 revealed a small decline 
in health for those receiving conservative treatment in two of the domains; however, 
the effect sizes for these changes with the SF-36 were small. In contrast, the 
EuroQol utilities and self-assessment thermometer indicated no change for either arm 
in the trial. Several interpretations of these results are possible: firstly, these results 
could support the view that generic measures are less relevant, and responsive, 
measures of outcome than disease specific measures. Alternatively, disease specific 
measures may have too narrow a focus and the changes observed may not be 
significant in a wider context. Equally, it may be that the clinical changes were too 
small to have an impact on the valuation procedure used by the EuroQol. This may 
be a limitation of the crude nature of descriptive system of the EuroQol (a change of 
one level in one dimension from perfect health is associated with a mean 16% 
reduction in utility (Jenkinson et a/. 1997)). However, the responsiveness of an 
instrument is likely to be specific to the particular characteristics of the patient group 
involved. For instance, in patients with rheumatoid arthritis, generic measures were 
as responsive as the disease-specific measures (Hurst et al. 1997). Similarly, in this 
thesis, although I did not examine the responsiveness of the EuroQol and SF-36 after 
stroke, I did find strong correlations between the stroke specific measures of outcome 
and the generic measures of health related quality of life. 
10.3.1.2 Whose values count? 
A randomised trial of the effect of antihypertensive therapy was one of the first 
influential trials to use quality of life assessments as a measure of outcome (Croog et 
al. 1986). It compared the effects of captopril, methyldopa and propanolol on blood 
pressure control and health related quality of life. It assessed outcome in a variety of 
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dimensions of health: well being and satisfaction with life, physical state, emotional 
state, intellectual functioning, and ability to perform social roles. The multi- 
dimensional nature of this data has important implications for its analysis and 
interpretation. Firstly, any study which examines multiple outcomes runs the risk that, 
simply by chance, one or more of the outcomes may spuriously appear significant 
(Cox et a!. 1992; Guyatt et aL 1993). Trialists are therefore encouraged to select and 
state their primary outcome(s) and main analysis in the protocol and final report 
(Begg et aL 1996). Therefore, for trials using health related quality of life 
assessments, trialists would need to select and pre-specify certain domains as the 
primary measure of outcome. However, this is not necessarily straightforward: we 
have previously shown (in patients with multiple sclerosis) that doctors' assessments 
of the relative importance of the domains of health related quality of life differed from 
those of patients; in general, the clinicians were more concerned than the patients 
about the physical manifestations of disease and the patients were more concerned 
with less tangible quantities such as mental health and vitality (Rothwell et aL 1997). 
Other researchers have investigated the differences between doctors and patients 
when making judgements about quality of life. Slevin and colleagues concluded that 
if a reliable and consistent method of measuring quality of life is required, it must 
come from the patients themselves and not from the doctors and nurses (Slevin et al. 
1988). Therefore, should the selection of primary outcome domain be based on the 
clinicians' or patients' opinion? Goodare and Smith argue that patients are by 
definition the best people to advise on which outcomes should be studied (Goodare & 
Smith, 1995). It does not necessarily follow, however, that the patient's viewpoint is 
more important, or valid, than that of the doctor. Doctors will usually have a better 
understanding of the natural course and possible clinical manifestations of a particular 
disease, and their opinions will be based on the experience of treating many patients. 
Nevertheless, doctors should bear in mind that their concerns might not agree with 
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those of their patients, and should work with patients - with mutual respect - when 
designing clinical trials and selecting outcomes (Goodare & Smith, 1995; Chalmers, 
1995). 
10.3.2 Routine clinical care 
As yet, health related quality of life measures have been used most in a wide range of 
group-level research applications, and relatively little attention has been given to their 
potential role in routine medical care and audit. It has been suggested that 
incorporation of health related quality of life assessments into routine clinical practice 
could theoretically serve a variety of purposes (Deyo & Carter, 1992; Lohr, 1992), 
including: describing patients' overall state; screening for unrecognised problems; 
assessing needs; setting treatment goals; monitoring disease or response to 
treatment; improving physician-patient communication; and standardising 
interactions between health care providers and patients. 
The notion, that quality of life assessments might be useful in everyday clinical 
practice, is supported by evidence that clinicians may be poor at, or not interested in, 
addressing issues that matter to patients (Slevin et al. 1988; Pearlman & Uhlmann, 
1997; Rothwell et al. 1997). Alternatively, some patients may have difficulty 
broaching specific areas, such as psychosocial concerns, and the routine clinical 
application of quality of life scales could serve the purpose of opening these areas up 
for discussion. It has also been suggested that the clinical use of health related 
quality of life measures might allow essential information to be communicated quickly 
and precisely (Thier, 1992). However, some patients might experience form filling as 
distressing, which may have the effect of distancing physicians from their patients 
(Thier, 1992). 
214 
Chapter Ten 
A recent randomised trial examined the efficacy of the routine use of a questionnaire 
which screened patients' outcomes in the physical, psychological and social domains 
(Rubenstein et al. 1989). Although clinicians found the information useful, the 
additional information did not appear to change the clinical management or outcome 
(Rubenstein et aL 1989). One possible explanation for this disappointing result may 
be that the questionnaire did not have the appropriate measurement properties for 
screening. Health related quality of life measures used for screening need to be 
evaluated in terms of their sensitivity (false negative results) and specificity (false 
positive results) (Fitzpatrick et al. 1992a). 
McHomey and Tarlov have suggested that if health related quality of life instruments 
are to be used at the individual-patient level, they should meet several measurement 
standards, (Table 10.1) (McHomey & Tarlov, 1995). Both the EuroQol and SF-36 
meet most of these standards in patients with stroke. However, neither instrument 
meets the reliability standards (Chapter Six). Therefore, on this basis, neither 
instrument is likely to be useful for monitoring the health of individual patients. 
However, this assumes that the instruments will be used in isolation. For instance, 
many individual components of the neurological examination (e. g. assessment of 
language or motor functioning) also have only moderate reproducibility (Shinar et al. 
1985), but are widely used (with other assessments) to monitor individual patients. 
In Chapter Nine, I found that patient estimates of overall health related quality of life 
gave a very different conclusion to valuations which were based on the views of the 
general public. The question of whose valuations should be used exposes tensions in 
the concept of quality of life assessment. Embedded within this concept, is a 
commitment to respecting the autonomy of persons to define their own conceptions of 
a good life. Therefore valuations of health which are derived from the views of the 
lay public, although appropriate for the purpose of allocating societal resources, may 
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not be ethically appropriate when applied to individual patients in routine clinical 
practice. 
10.3.3 Medical audit 
The combined pressures of umedical inflation", fiscal constraints, and a shift in 
attitudes to publicly funded services during the 1980s has made the search for 
measures of quality, efficiency and effectiveness in health care a government priority 
(Orchard, 1994). Whilst it has been suggested that three components of the health 
care system may be audited, the structure, process and outcome (Donabedian, 
1988), most emphasis is presently placed on the measurement of outcome. 
Of the available measures of outcome, case-fatality statistics are the most widely 
used (Clinical Outcomes Working Group, 1995). However, as death is only one 
aspect of the public health burden attributable to stroke (Chapter One), there is some 
interest in extending the scope of routinely collected data to include aspects of health 
related quality of life (Working Group on Outcome Indicators for Stroke, 1997). 
Indeed, the SF-36 resulted from the Medical Outcomes Study, which aimed to 
develop practical tools for the routine monitoring of patient outcome in clinical practice 
(Tarlov et al. 1989). 
Variations in case mix have a crucial influence on the interpretation of outcome data, 
particularly where such data are used to compare providers (Orchard, 1994). 
Therefore, to allow meaningful interpretation of these data, audits must try to correct 
for case mix. Davenport and colleagues have demonstrated how data on survival and 
disability after stroke could be adjusted for variations in case mix using simple clinical 
variables measured routinely at the time of the stroke (Davenport et al. 1996). Unless 
health related quality of life data can also be successfully adjusted for variations in 
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case mix, it is unlikely to be useful for the comparison of provider units (although it 
may still provide helpful information about local healthcare needs). 
10.4 Weaknesses of the study design 
This study has several limitations, some of which have been already discussed in the 
relevant chapters. However, there are three areas that require further discussion. 
They are; the selection of instruments for the study, the patient selection methods 
and the possibility of bias. 
Perhaps the most fundamental limitation relates to how I selected the health related 
quality of life instruments for this study. I selected the EuroQol because, in my 
opinion, it had the best face and content validity of the currently available generic 
health status measures for the assessment of health status in a large randomised 
controlled trial. Although I discussed the suitability of the instrument informally with 
the local stroke research group, I did not quantitatively assess its face and content 
validity. Moreover, I did not ask stroke survivors, or their carers, to examine its 
content, relevance or clarity. The importance of seeking the views of patients when 
selecting trial outcomes has been recently highlighted (Goodare & Smith, 1995). 
The methods used to select the patients included in the study might have affected the 
generalisability of its results. I selected a "convenience sample" of patients on our 
local hospital stroke register for the study of the validity of the EuroQol, Chapters 
Three & Four. This group represents a selected population of stroke patients in that it 
only includes hospital referred patients who survived long enough to fulfil the study 
eligibility criteria. An "ideal study" might have assessed the validity of the EuroQol in 
a community-based cohort. The population used for the study of the feasibility and 
reproducibility of the EuroQol was even more selected in that it only included 
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surviving patients who had been randomised in the International Stroke Trial. This 
group is likely to include less than 10% of all hospital referred stroke patients. This is 
not a major weakness, however, as the primary aim of the study was to examine the 
attributes of the instruments in a population of patients who might be included in a 
large randomised trial. 
Finally, the study of the validity of the EuroQol (Chapters Three & Four) might have 
been biased. The study nurse, who conducted the assessments by interview in the 
patients' homes, was aware of the aims of the study and could have influenced the 
patients' responses. However, it is unlikely that this has been a major source of bias, 
as the data from the postal administration of the EuroQol also supported its validity in 
patients with stroke. 
10.5 Future research possibilities 
Although the studies described in this thesis are complete, some of the work 
performed may be used as a foundation for future work. One of the aims of the study 
was to examine the validity of the EuroQol and compare it with that of the SF-36. 
One aspect of validity not examined was the predictive validity of either instrument. 
This aspect of validity refers to the extent to which patients' responses to a scale 
predict future important events, e. g. do patients' responses to the multiple domains of 
health related quality of life allow a better prediction of future events than current 
predictors (e. g. disability alone)? Assessments of predictive validity have rarely been 
performed because they demand a long period of follow-up. However, the large 
number of health related quality of life assessments performed in this study could 
serve as baseline assessments for a subsequent study of the predictive validity of the 
EuroQol, SF-36, and modified simple questions after stroke. 
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The studies performed in this thesis were guided by the need to identify the "best" 
instrument for the measurement of health related quality of life in a planned 
randomised controlled trial in patients with stroke. Throughout the thesis, I have 
highlighted some important issues which still need to be addressed. Firstly, it is 
unclear whether simple measures of health related quality of life (e. g. the EuroQol) 
are sufficiently responsive to detect clinically important change. Future research 
studies should examine the sensitivity to change of these measures. Secondly, the 
natural history of quality of life after stroke has not been well defined and further study 
is required to inform trialists about when it should be measured. Finally, the 
development of accurate models for the prediction of health related quality of life after 
stroke would serve a number of useful purposes, such as case-mix adjustment (see 
above) and the identification of patients at presentation who might be accepting of 
risky treatments (see Chapter Nine). 
In conclusion, the work described in this thesis adds new and significant information 
to the current understanding of how health related quality of life assessments should 
be applied in clinical studies in patients with stroke. 
219 
Chapter Ten 
Table 10.1: Proposed measurement standards for the individual-patient 
use of health related quality of life measures (adapted from (McHorney & 
Tarlov, 1995)) 
Criterion Proposed standard 
Practicality 5-15 minutes, and ease of scoring 
Breadth of health assessed 
Floor effects 
Ceiling effects 
Precision (cross-sectional) 
Precision (longitudinal) 
Validity 
Physical, role, social, and mental domains 
<15% 
<15% 
0.90 - 0.95 reliability 
0.90 - 0.95 reliability 
Group level 
Individual level 
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Appendix 1: The LSR Registration Form 
Personal details 
Please PRINT all details in BLACK ink 
Study No. Use reverse for details or narrative 
WGH Hospital No. WGO NHS no. 
DCN X-ray no. 
/ 
Surname Title 
Forenames 
Address 
Postcode Tel. No. 
Date of birth / / Sex M/F (circle) 
Next of kin / Contact person 
Address 
Postcode Tel. No. 
General Practitioner 
Address 
Postcode Tel. No. 
Patient of interest ? Y/N Reasons : 
(circle) 
(continue overleaf) 
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Admission details Name : No. . 
Inpatient :Y/N (circle) Time Date of admission 
Time is by 24 hour clock, dates are dd/mm/yy (f known) Date of discharge 
Consultant (circle) JLA / REC / MSD / RG / LK / CL / CM`K / JDM / PLP / WHP / TR / 
PAGS / RS / PFXS / AJS / CPW / DW / IW / RW / other : 
Time Date // of examination 
Examined by (circle) RJD / MSD / PD / PAGS / CPW / other : 
Summary of this event 
Focus of event : Brain / Eye (circle) Abnormal neurological signs on examination :Y/N 
(circle) 
Final diagnosis Stroke (> 24 h) Code I= possible (NOT permitted for RAO) 
Transient Ischaemic Attack (< 24 h) 2= probable (NOT permitted for RAO) 
Retinal Artery Occlusion (RAO) 3= definite 
Other (specify): 9= not applicable 
Include events within the last 6 months only. Leave no blanks. 
Patient history 
Code boxes 1= Yes, 2= No, 9= unassessable, Blank = may be completed later. 
Patient able to give adequate history 
Previous Myocardial Infarction Year (f known) 
Previous stroke with residual disability Year (f known) 
Previous stroke without residual disability Year (f known) 
Previous TIA (speck territories in narrative) 
Previous carotid endarterectomy Year (f known) 
(Code side of CE. 1 I=R, 2=L, 3= both, 9= not known) Side (if known) 
Hypertension (history or treatment at any dme) 
Angina pectoris known before stroke 
Atrial fibrillation known before stroke 
Breathless walking on an incline 
Cardiac surgery (specify): 
Intermittent claudication 
Peripheral vascular surgery 
Diabetes mellitus known before stroke 
Epilepsy known before stroke 
History of migraine with aura 
Oxford Handicap Scale before stroke 
(Modified Rankin Scale) 
Non-Caucasian (specify): 
Alcohol >2 units daily 
Current smoker 
Ex-smoker > 12 months 
Employed until this event 
Car driver in past 3 months 
Lives alone 
Known prior malignancy 
O Hm c sie: o- no . goes. 
I- minor sympwi u which Qo now interfere with fj/erryk 
2- some restrictlae to lifestyle, bw look Goer themrefves 
3=n Uflcmu rerutcdaw to Li estyb, pre rndns total independence 
4- severe bitte prewming Liepe dem e4rtexce bar not requiring 
cote t &Texdoi, 
5- severe hadice , roily depr denn. regrdriml artentop night od 
day 
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Treatment Code boxes 1= Yes, 2= No, 9= unassessable, Blank = may be completed later. 
At time of event Started since event 
Antiplatelet 
Anticoagulant 
Antihypertensive 
Anticonvulsants (f history of epilepsy) List all drugs in use at examination (in 
narrative) : 
Antifailure 
Contra-indications to antithrombotics 
General Examination 
Blood pressure Cervical Bruits (spec) RL 
(admission) l Noted by referring doctor E 
(examination) l Seen at examination 
Clinical heart failure (ie signs of LVF /RVF, not just on Rx, specify) Irregular pulse 
Clinical valvular heart disease (not simple flow munnur < 2/6, specify) Right handed 
Peripheral vascular disease (both foot pulses absent or femoral bnäts) Left handed 
Brain Symptoms > 24 hours Skip for patients NOT exhibiting brain symptoms longer than 24h 
History of ictus Time Date symptoms first noticed 
ne is by 24, E d«k, doses -e dm, ri Time Date of maximum deficit 
Symptoms present on waking Seizure(s) since symptom onset 
El 
Headache within 2 hours of onset - date of first 
Vomited since symptom onset -confirmed seizure ? 
Loss of consciousness at onset -type (1=General, 2=Partial, 
9=uncertain) 
Drowsiness since symptom onset - number (Use 
9 for 9 or more) 
Mental Test Score (Hodkinson, tick below, score 0-10) Stroke diagnosis 
Age 
1= right 
Time 2= left 
42 West St. (ask patient to recall at end) 
Side of 
brain lesion 
Q/ 3= brainstem 
cerebellum 
Name of Hospital 
(one only) 4= uncertain 
5= bilateral 
Year 
Recognise 2 people (eg. Dr. and Nurse) 
Date of birth I= TACS 
Clinical 2= PACS 
Dates of World War I or II classification 
Q3= 
LACS 
(one only) 4= POCS 
Present Monarch 5= uncertain 
Count down from 20 to I Clinical 
prediction of Total 
outcome at I 
(0 -6 on Rankin Scale) F 
(Code '88' if clinically unassessable) year 
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Persistent Neurological Signs Skip this page for padenis NOT exhibiting neurological signs at craminanon 
a nd skip for patients NOT exhibiting brain symptoms longer than 24h 
Glasgow Coma Scale (circle below, score 3-15) (circle) 
Eye Opening - Never 1 Dysphasia Fluent / 
To pain 2 
sound To 3 
/ Non-fluent 
Spontaneously 4 Other (speck) : 
Best Motor - None I 
Extend to pain 2 - Abn flex to pain 3 Dysarthria F 1 
Flex to pain 4 (Circle) 
Localises pain 5 
- Normal 6 1 Dyspraxia / Other cortical signs F 
Best verbal - None 1 Neglect / 
Noises only 2 / Sensory inattention 
Inappropriate 3 
Confused 4 Visuospatial dysfunction 
Normal 5 
Total Code boxes 1= Yes, 2= No, 9= unassessable, 
Blank = may be completed later. 
RL Deficit Severity Codes RL 
Hemianopia r-º Motor deficit code: 
Visual inattention I= no deficit, 2= mild, 3 moderate, 4= severe 
Gaze palsy to this side I Face 
Arm 
Abnormal swallowing 
a 
Drift 
Hand 
Motor deficit 
Elf II 
Fine finger movements 
((f yes, code next column) 
Leg 
Sensory deficit 
Q 
If 1-º Sensory and cerebellar abnormalities code: 
ff yes, code next column) 
1= normal, 2= reduced, 3- severely impaired / absent 
Cerebellar deficit 
Q 
If 1 Sensation - proprioception 
rf yes, code next column) 
Arm / hand 
Truncal ataxia Leg 
H 
Unable to sit independently Sensation - spinothalamic (pain and touch) 
Unable to stand independently Face 
Unable to walk independently Arm / hand 
Incontinence since stroke Leg 
Bilateral extensor plantars 
i_. 
Cerebellar function and co-ordination 
Neck stiffness Arm 
Definite brainstem signs Leg 
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Registration Code boxes I= Yes, 2= No, Blank = may be completed later. 
Enter patient into Register 
Q 
Enter patient into Follow up 
Q 
I Trials Studies 
Eligible Randomised 
IST 
IST 2 
CAPRIE 
MAST 
NASCET 
CAVATAS 
Investigations 
Test Or dered Date done 
Haemoglobin 
Haematocrit 
Platelets 
ESR 
Urea 
Glucose 
Cholesterol // 
If 1-º 
MRS 
ULTRASOUND 
SECONDARY INSULTS 
PICH 
Other CRI imaging 
Results 
g/dl 
x 109/1 
mm/hr 
mmol/1 
mmol/1 
mmol/I 
ECG 
n 
Doppler (but not in study) 
Trans-thoracic echocardiogram 
Trans-oesophageal echocardiogram // 
CT F-I // 
Atrial fibrillation 
Bundle branch block 
ST segment change 
LVH 
Acute MI 
Old MI 
Normal 
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Appendix 2: The EuroQol Questionnaire Booklet 
HEALTH OUTCOMES SURVEY 
Confidential 
If any of these details are incorrect, 
please change below: 
You were recently admitted to hospital, and we would like to know how you 
are now. We need to know what you have actually managed to do since 
leaving hospital, not what you used to do, or would like to do. 
Please tick one box on each line 
YES NO 
Has the stroke left you with any problems? 
Q Q 
Do you need help from anybody with everyday activities? 
II Q 
Do you live? (please lick one box) 
On your own 
With your partner or relatives 
Q 
Where do you live? (please tick one box only) 
In your own home 
a 
In a residential home 
In a nursing home 
Q 
In hospital 
Q 
Please turn over and fill in the following questions -0 
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By placing a tick (-: ") in one box in each group below, please indicate which 
statements best describe your own health state today. 
Mobility 
I have no problems in walking about 
Q 
I have some problems in walking about 
Q 
I am confined to bed 
Q 
Self-Care 
I have no problems with self care 
Q 
I have some problems with washing or dressing myself 
Q 
I am unable to wash or dress myself 
Q 
Usual Activities 
I have no problems with performing my usual activities 
Q 
(eg work, study, housework, family or leisure activities) 
I have some problems with performing my usual activities 
Q 
I am unable to perform my usual activities 
Q 
Pain/discomfort 
I have no pain or discomfort 
Q 
I have moderate pain or discomfort 
Q 
I have extreme pain or discomfort 
Q 
Anxiety/depression 
I am not anxious or depressed 
Q 
I am moderately anxious or depressed 
Q 
I am extremely anxious or depressed 
Q 
Compared with my general level of health over the past 12 months, my 
health state today is: (please tick one box) 
Better 
[j 
Much the same 
Fl 
Worse F-I 
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Best 
imaginable 
health state 
100 
940 
To help people say how good or bad a health state is, 80 
we have drawn a scale (rather like a Thermometer) on 
which the best state you can imagine is marked by 100 
and the worst state you can imagine is marked by 0. 
70 
We would like you to indicate on this scale how good 
or bad is your health today, in your opinion. Please do 
this by drawing a line from the box below to whichever 60 
point on the scale indicates how good or bad your 
current health state is. 
540 
Your own health 
I40 
state today 
340 
20 
I0 
0 
Worst 
imaginable 
health state 
Please turn over and fill in the following questions -00- 
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Did you find filling in this questionnaire: (please tick one box) 
Very 
Difficult 
Fairly 
Difficult 
Fairly 
Easy 
Very 
Easy 
Did you complete this form yourself? (please tick one box) 
YES 
NO, it was completed for me 
by a relative or friend 
Name of person filling in form 
Signature Date 
Thank you very much for your help with this survey. Please 
return this questionnaire using the FREEPOST envelope enclosed 
(no stamp is required). 
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Appendix 3: The SF-36 questionnaire booklet 
HEALTH OUTCOMES SURVEY 
Confidential 
If any of these details are incorrect, 
please change below: 
You were recently admitted to hospital, and we would like to know how you 
are now. We need to know what you have actually managed to do since 
leaving hospital, not what you used to do, or would like to do. 
Please tick one box on each line 
YES NO 
Has the stroke left you with any problems'? 
1-1 17 
Do you need help from anybody with everyday activities? 
QQ 
Do you live? (please lick one box) 
On your own 
Q 
With your partner or relatives 
Q 
Where do you live? (please tick one box only) 
In your own home F-1 
In a residential home 
Q 
In a nursing home F-1 
In hospital 
Q 
Please turn over and fill in the following questions '% 
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Now you have completed the first page, we 
would like to ask your views about your health. 
This information will help keep track of how 
you feel and how well you are able to do your 
usual activities. 
Answer every question by marking the answer 
as indicated. If you are unsure about how to 
answer a question, please give the best answer 
you can. 
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1. In general, would you say your health is: (circle one number) 
Excellent Very Good Good Fair Poor 
I12345 
2. Compared to one year ago, how would you rate your health in general now? 
(circle one number) 
Much better than 1 year ago 1 
Somewhat better now than 1 year ago 2 
About the same as 1 year ago 3 
Somewhat worse than 1 year ago 4 
Much worse than 1 year ago 5 
3. The following items are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so how much? (circle 
one number on each line) 
ACTIVITIES 
Yea, 
Limited 
A Lot 
Yes, 
Limited 
A Little 
No, Not 
Limited 
At All 
a. Vigorous activities, such as running, lifting heavy 
objects, participating in strenuous sports 1 2 3 
b. Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or playing golf 1 2 3 
c. Lifting or carrying groceries 1 2 3 
d. Climbing several flights of stairs 1 2 3 
e. Climbing one flight of stairs 1 2 3 
f. Bending, kneeling, or stooping 1 2 3 
g. Walking more than a mile 1 2 3 
h. Walking half a mile 1 2 3 
i. Walking one hundred yards 1 2 3 
j. Bathing or dressing yourself 1 2 3 
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4. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of your physical health? (circle one 
number on each line) 
[YES FN-O 
a. Cut down on the amount of time you spent on work or other activities 1 2 
b. Accomplished less than you would like 1 2 
c. Were limited in the kind of work or other activities 1 2 
d. Had difficulty performing the work or other activities (for example, it 1 2 
took extra effort) 
5. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of any emotional problems (such as 
feeling depressed or anxious)? (circle one number on each line) 
YES NO 
a. Cut down on the amount of time you spent on work or other activities 1 2 
b. Accomplished less than you would like 1 2 
c. Were limited in the kind of work or other activities 1 2 
d. Had difficulty performing the work or other activities (for example, it 
took extra effort) 
1 2 
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6. During the past 4 weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
neighbours, or groups? (circle one number) 
Not at all 
1 
Slightly 
4- 
Moderately 
3 
Quite a bit 
4 
Extremely 
5 
7. How much bodily pain have you had during the past 4 weeks? (circle one number) 
None Very Mild Mild Moderate Severe Very Severe 
123456 
8. During the past 4 weeks, how much did azjýj interfere with your normal work 
(including both work outside the home and housework)? (circle one number) 
Not at all 
1 
A little bit 
2 
Moderately 
3 
Quite a bit 
4 
Extremely 
5 
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9. These questions are about how you feel and how things have been with you during 
the past 4 weeks. For each question, please give the one answer that comes closest 
to the way you have been feeling. How much of the time during the past 4 weeks. 
((-'-cle one number on each line) 
All Most A good Some A None 
of the of the bit of of the little of of the 
time time the time time the time time 
a. Did you feel full of life? 1 2 3 4 5 6 
b. Have you been a very 
nervous person? 
1 2 3 4 5 6 
c. Have you felt so down in 
the dumps that nothing 
could cheer you up? 
1 2 3 4 5 6 
d. Have you felt calm and 
peaceful? 
1 2 3 4 5 6 
e. Did you have a lot of 
energy? 
1 2 3 4 5 6 
f. Have you felt 
downhearted and low? 
1 2 3 4 5 6 
g. Did you feel worn out? 1 2 3 4 5 6 
h. Have you been a happy 
person? 
1 2 3 4 5 6 
i. Did you feel tired? 1 2 3 4 5 6 
-10 
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10. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting friends, 
relatives etc)? (circle one number) 
All of 
the time 
1 
Most of 
the time 
2 
Some of 
the time 
3 
A little of I 
the time 
4 
None of I 
the time 
5 
11. Please choose the answer that best describes how TRUE or FALSE each of the 
statements is for you. (circle one number on each line) 
Definitely Mostly Don't Mostly Definitely 
True True Know False False 
a. I seem to get ill more easily 
than other people 
b. I am as healthy as anybody I 
know 
1 
1 
2 
2 
3 
3 
4 
4 
5 
F5 
C. I expect my health to get 
worse 
d. My health is excellent 
1 
] 
2 
2 
3 
3 
4 
4 
5 
5 
-ý 
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Did you find filling in this questionnaire: (please tick one box) 
Very 
Difficult 
Fairly 
Difficult 
Fairly 
Easy 
Did you complete this form yourself? (please tick one box) 
YES 
Name of person filling in form 
Signature 
Very 
Easy 
NO, it was completed for me 
by a relative or friend 
Date 
Thank you very much for your help with this survey. Please 
return this questionnaire using the FREEPOST envelope enclosed 
(no stamp is required). 
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Appendix 4: The OPCS Locomotion Subscale 
LI Cannot walk at all 11.5 
L2 Can only walk a few steps without stopping or severe discomfort / 9.5 
Cannot walk up and down one step 
L3 Has fallen 12 or more times in the last year 7.5 
L4 Always needs to hold on to something to keep balance 7.0 
L5 Cannot walk up and down a flight of 12 stairs 6.5 
L6 Cannot walk 50 yards without stopping or severe discomfort 5.5 
L7 Cannot bend down far enough to touch knees and straighten up again 4.5 
L8 Cannot bend down and pick something up from the floor and straighten 4.0 
up again 
L9 Cannot walk 200 yards without stopping or severe discomfort/ Can only 3.0 
walk up and down a flight of twelve stairs if holds on and takes a rest/ 
Often needs to hold on to something to keep balance / Has fallen 3 or 
more times in the last year 
L10 Can only walk up and down a flight of 12 stairs if holds on (doesn't 2.5 
need a rest) 
L11 Cannot bend down to sweep up something from the floor and 2.0 
straighten up again 
L12 Can only walk up and down a flight of stairs if goes sideways or one 1.5 
step at a time 
L13 Cannot walk 400 yards without stopping or severe discomfort 0.5 
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Appendix 5: The Barthel Index 
What the aatient ACTUALLY DOES ? 
1) FEEDING Independent =2 Needs some help =1 
Needs to be fed =0 
2) BATHING Able to wash all over =1 
Needs help =0 
3) GROOMING Totally independent =1 
Dependent in some way =0 
4) DRESSING Totally independent =2 
Needs help with some items =1 
Q 
Unable to do any without help =0 
5) BOWELS No accidents =2 
Occasional accident / help with enema =1 
Q 
Incontinent =0 
6) BLADDER No accidents =2 Q 
Occasional accident / use of device =1 
Incontinent, or catheterized and unable to =0 
manage alone 
7) TOILET Independent (on/off dressing and wiping) =2 
Minor assistance =1 
Unable to use =0 
8) TRANSFER Totally independent =3 
Minimal help needed =2 
Sit unaided, major help for transfer =I 
Unable =0 
9) AMBULATION Independent =3 Q 
Walk with the help of one person =2 
Independent in wheelchair for 50 metres =1 
Immobile =0 
10) STAIRS Independent =2 
Needs physical / verbal support =1 
Q 
Unable =0 
TOTAL: 
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Appendix 6: The Frenchay Activities Index 
In the last 3 mon ths how often have you been :- 
PFI) Preparing the main meal? 
Never Less than Once or Most days 
once ptwk twice p/wk 
PF2) Washing up? 
Never Less than Once or Most days 
once p/wk twice p/wk 
PF3) Washing clothes? 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
PF4) Doing light housework? 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
PF5) Doing heavy housework? 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
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In the last 3 months how often have you been :- 
PF6) Local shopping? 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
PF7) On Social Outings? 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
PF8) Walking outside for up to 15 minutes? 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
PF9) Actively pursuing a hobby? 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
PFIO) Driving a car or traveling on a bus? 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
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In the last 6 months have you been :- 
PF11) On any outings / car rides? 
DD 
Never Once or Between 3& At least 
twice every 12 times every weekly 
3 months 3 months 
PF12) Gardening? 
Never Light Moderate All that is 
Necessary 
PF13) Doing household or car maintenance? 
Never Light Moderate All that is 
Necessary 
PF14) Reading books? 
None 1 every Less than 1 More than1 
6 months every 2 wks every 2 wks 
PFI5) Gainful work? 
DII 
None Up to 10 Between 10 Over 30 
Hours p/wk & 30 hours hours per 
per week week 
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Appendix 7: The visual analogue pain scale 
Pain as bad as it could 
possibly be 
To help people say how bad their pain is, we have 
drawn a scale on which the pain experienced ranges 
from "no pain" to "pain as bad as it could possibly be". 
We would like you to indicate on this scale how bad your 
pain is today. Please do this by drawing a line from the 
box below to whichever point on the scale indicates how 
bad your pain is. 
Your pain 
today 
No Pain 
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Appendix 8: The Hospital Anxiety and Depression Scale 
Read each item and place a firm tick in the box opposite the reply which comes 
closest to how you have been feeling in the past week. 
Don't take too long over your replies your immediate reaction to each item will 
probably be more accurate than a long thought out response 
Please answer every question. 
PHI) 1 feel tense or 'wound up': 
Most of the time 
A lot of the time 
Time to time, occasionally 
Not at all 
PM) I still enjoy the things I used to enjoy: 
U Definitely as much 
Not quite so much 
U Only a little 
Ej Hardly at all 
PH3) I get a sort of frightened feeling as if something awful is about to 
happen. 
Q Very definitely and quite badly 
Q Yes, but not too badly 
QA little, but it doesn't worry me 
Q Not at all 
PH4) I can laugh and see the funny side of things: 
Q As much as I always could 
Q Not quite so much now 
Q Definitely not so much now 
Q Not at all 
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Please answer every question. 
PPUS) Worrying thoughts go through my mind 
QA 
great deal of the time 
QA lot of the time 
Q From time to time, but not too often 
Only occasionally 
PI 16) 1 feel cheerful 
Q Not at all 
Q Not often 
Q Sometimes 
Q Most of the time 
P117) I can sit at ease and feel relaxed: 
Q Definitely 
Q Usually 
Q Not often 
Q Not at all 
PH8) I feel as if I am slowed down: 
Q Nearly all the time 
Q Very often 
Q Sometimes 
Q Not at all 
Pli9) I get a sort of frightened feeling like 'butterflies' in the stomach: 
Q Not at all 
Q Occasionally 
Q Quite often 
Q Very often 
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Please answer every question. 
P11101 I have lost interest in my appearance: 
Definitely 
don't take as much care as I should 
I maN not take as much care 
I take dust as much care as euer 
1,1111 11 feel restless as if I haue to be on the mope: 
Very much indeed 
Quite a lot 
Not very much 
El Not at all 
PH12) I look forward with enjoyment to things: 
EI As much as I ever did 
F] Rather less than I used to 
LI Definitely less than I used to 
Hardly at all 
PHI)1 get sudden feelings of panic: 
Q Very often indeed 
Q Quite often 
Q Not very often 
Q Not at all 
P1114) 1 can enjoy a good book or radio or TV programme: 
U Often 
El Sometimes 
n Not often 
9 Very seldom 
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Appendix 9: My contribution to the work in this 
thesis 
The collection and analyses of the data in this thesis were carried out in the 
Neurosciences Trials Unit, whilst I was working as a Medical Research Council 
Clinical Training Fellow in the Department of Clinical Neurosciences in the University 
of Edinburgh (between December 1994 and September 1997). I was under the 
supervision of Dr Peter Sandercock and Dr Martin Dennis. Ethical approval was 
obtained for the International Stroke Trial and the Lothian Stroke Register. We were 
advised by the Chairman of the Lothian Ethical Committee that additional ethical 
approval was not required for the work contained within this thesis. 
My contribution to the thesis was as follows: 
From December 1994 to October 1995,1 was the principal assessor for the Lothian 
Stroke Register. In total, I registered over 200 patients and assessed many more. 
also personally randomised over thirty patients into the International Stroke Trial. 
I was responsible for the design of all of the studies described in the thesis, writing 
the protocol for these studies, and obtaining the financial support to fund this work. 
I managed the conduct of all the studies. I designed all the study materials and the 
specifications for the study databases and software. Mr David Perry and Mr Gary 
Robertson developed the software for data management in these studies. 
I organised and participated in the posting and the punching the questionnaire data. 
Mrs Fiona Waddell conducted the face to face interviews. 
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I analysed all the data, apart from the conditional logistic regression in Chapter Nine 
which was performed by Mr David Signorini. Statistical advice was provided by Mr 
Jim Slattery and Mr David Signorini. Control patients were obtained from the 
Measurement and Valuation of Health and Omnibus Surveys, Chapter Nine. They 
were selected by Dr Paul Kind, Centre for Health Economics, University of York. 
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Appendix 10: Publications arising from work 
within this thesis 
Papers 
Dorman PJ, Slattery JM, Farrell B, Dennis MS, Sandercock PAG and the United 
Kingdom Collaborators in the International Stroke Trial (IST). (1997) 
A randomised comparison of the EuroQol and SF-36 after stroke. 
British Medical Journal. 315: 461 (short report). 
Dorman PJ, Waddell F, Slattery J, Dennis MS & Sandercock PAG (1997) 
Is the EuroQol a valid measure of health related quality of life after stroke? 
Stroke. 28: 1876-1882. 
Doran PJ, Waddell F, Slattery J, Dennis MS & Sandercock PAG (1997) 
Are proxy assessments of health status after stroke with the EuroQol questionnaire 
feasible, accurate and unbiased? 
Stroke. 28: 1883-1887. 
Dorman PJ, Slattery JM, Farrell B, Dennis MS, Sandercock PAG and the United 
Kingdom Collaborators in the International Stroke Trial (IST). (1998) 
A qualitative comparison of the reliability of health status assessments with the 
EuroQol and SF-36 after stroke. 
Stroke. 29: 63-68. 
Presentations to learned societies 
Dorman P, Farrell B, Dennis MS, & Sandercock PAG (1996) 
Health-related quality of life after stroke: a randomised comparison of the EuroQol 
and SF-36 questionnaires in 2,252 survivors of acute stroke. 
Cerebrovascular Diseases. 6(S2): 152. 
Presented at the Joint 3rd World Stroke Congress and 5th European Stroke 
Conference, Munich, 1-4 September 1996. 
Dorman PJ, Dennis MS & Sandercock PAG (1997) 
Stroke trials: do patients prefer death or disability? 
Joint Meeting of the Australian Association of Neurologists and the Association of 
British Neurologists, Sydney, Australia, 29 April -2 May 1997. 
Dorman PJ, Waddell F, Slattery J, Dennis MS & Sandercock PAG (1997) 
Is the EuroQol a valid measure of health related quality of life after stroke? 
6th European Stroke Conference, Amsterdam, The Netherlands, May 28-31,1997. 
Cerebrovascular Diseases 1997; 7(S4): 10 
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